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SUMMARY
The f i r s t  p a t ien t I saw when I took up my c l in ic a l  
duties a t the Centre fo r  Rheumatic Diseases in  Glasgow 
was a 59 year old sp inster who had rheumatoid a r t h r i t i s  
fo r  39 years. She had been bedridden fo r  e ight years 
and had received oral co r t icos te ro id  therapy fo r  15 years 
The pa tien t was in  severe agony from m u lt ip le  vertebral 
body collapse and from r ib  and long bone fractures. On 
x-ray the bones were almost transparent, and extensive 
biochemical tes ts  revealed no evidence of osteomalacia.
The p a t ie n t 's  problem o f osteoporosis in tr igued  
me and on reading the l i te ra tu re  I was surprised to 
f in d  tha t very l i t t l e  had been done to study the 
problem o f bone loss in patients with rheumatoid 
a r t h r i t i s .  For example, i t  was not c lear from reading 
the l i te ra tu re  how much oral co r t icos te ro id  therapy 
was responsible fo r  bone loss compared to the disease 
i t s e l f .
Chapter I o f  th is  thesis describes an extensive 
rad io log ica l inves tiga tion  o f osteoporosis in patients 
w ith  rheumatoid a r t h r i t i s  in order to assess i t s  
extent and seve r ity . The resu lts  show tha t osteoporosis
in  rheumatoid a r t h r i t i s  is  a generalised phenomenon, 
which is p a r t ic u la r ly  evident in patients o f  both sexes 
over the age o f  45 years. In addition to the duration 
o f  the a r t h r i t i s ,  co r t ico s te ro id  therapy was shown to 
be the other important variable in  producing th is  
osteoporosis.
Chapter I I  describes an extensive c l in ic a l  study 
o f  calcium metabolism in patients with rheumatoid a r t h r i t i s  
in  an attempt to explore fu r th e r  possible factors in  the 
bone loss occuring in th is  disease. One o f the surpris ing  
resu lts  o f  th is  inves tiga tion  indicated tha t hypercalcaemia 
is  a not uncommon feature in rheumatoid a r t h r i t i s .  
Circumstantial evidence perta in ing to serum and urine 
biochemistry together w ith ten ta t ive  conclusions from a 
calcium absorption study suggested tha t the hypercalcaemia 
might be pa rt o f a "hyperpara thyro id-like" s ta te .
However, immunoassay o f  serum parathyroid hormone levels 
c le a r ly  ind icated tha t th is  hormone was not elevated 
and was thus not responsible fo r  these biochemical 
abnormalities. S im ila r ly  serum 25-hydroxyvitamin D levels 
were normal but an in te re s t in g  trend towards elevation 
o f  serum c a lc i to n in  leve ls was noted.
The study was then extended to examine the e ffec ts  
o f rheumatoid sera on a bone cultu re in v i t ro .  Bone
resorption a c t iv i t y  was demonstrated in the sera o f those 
patients who were hypercalcaemic. I t  is te n ta t iv e ly  concluded 
th a t th is  bone resorption is due to a substance, as ye t 
u n id e n t i f ie d ,  which has some, but not a l l ,  o f the properties 
associated w ith osteoclast ac tiva t ing  fa c to r .
These observations may subsequently be shown to have 
therapeutic im plica tions in the treatment o f rheumatoid 
a r t h r i t i s .
CHAPTER I
RADIOLOGICAL INVESTIGATION OF
OSTEOPOROSIS IN RH'EUKATOID ARTHRITIS
OSTEOPOROSIS IE REEUMATOID MTBEITIS
One of the major difficulties when researching the historical 
literature on rheumatoid arthritis is the lack of any definite 
diagnostic criteria for the various arthritides.
Certainly one can, from the many excellent clinical descriptions 
in older texts, establish with reasonable certainty those cases which 
would be regarded as rheumatoid arthritis by more modem criteria. 
Nevertheless, nomenclature at least up to the middle of this century 
has bedevilled the interpretation of clinical disease of joints.
The term rheumatoid arthritis was first applied by Alfred 
Baring Garrod in 1859* Although in many older writings one can read 
descriptions suggestive of rheumatoid arthritis, the disease was not 
actually described per se until 1800 when Landré Beauvais published 
his thesis on "Goutte Asthenique Primitif".
Juxta-articular osteoporosis is a well recognised radiological 
feature of early rheumatoid arthritis (Bywaters, I960), and in 
patients with severe long-standing disease generalised osteoporosis 
may also be found (Boyle and Buchanan 1971 )* Despite the fact that 
generalised osteoporosis may lead to pathological fractures of bones 
very little work has been published on osteoporosis in rheumatoid 
arthritis. This is perhaps surprising in view of the recognition of 
the widespread manifestations of rheumatoid arthritis, and the 
suggestion by some workers that the term 'rheumatoid disease* would 
be more appropriate (Ellman and Ball 1948)* Before reviev/ing what
is known regarding osteoporosis in rheumatoid arthritis a brief 
review of the general problem of osteoporosis woudd seem germane.
Essentially bone consists of collagen fibres in a groundwork 
of calcific inorganic matter (calcium phosphate and carbonate, 
fluorine, sodium, magnesium, zinc and many other trace elements).
Since bone is largely an inorganic substance lending rigidity and 
hardness to the skeleton there is an understandable tendency to 
consider bone mineral as if it were metabolically inert. It is 
therefore salutory to be reminded that bone has greater reparative 
power than any other tissue in the body save blood (Last 1$6$).
It should also be noted that 30 per cent of body sodium resides in 
the skeleton (Collins I966) and that at any point in time extensive 
exchange of elements is occurring between bone and other tissues via 
blood.
In I885 Pommer distinguished between osteoporosis and osteomalacia 
at the histological level, but for many years osteoporosis remained 
enigmatic. The clinical entity of osteoporosis v^as first clearly 
described in 1941 by Albright, Burnett, Cope and Parsons. Currently 
osteoporosis is defined as a condition in which the volume of bone 
tissue per volume of anatomical bone is reduced. In practice this 
is usually diagnosed radiologically.
Howell (1966) has stated that osteoporosis is the commonest 
metabolic bone disorder encountered in medical practice. Certainly 
if the definition of osteoporosis as porosity or thinning of bone 
is accepted the prevalence is extremely high in both sexes in the
older age groups (Urist I96O, Gitman and Kamholtz I963, Epker, Kelin 
and Frost I963, Smith and Rizek I966, Nordin, McGregor and Smith 
1966, Morgan, Spiers, Pulvertaft and Fourman I967, Smith, Anderson, 
Shimmins, Spiers and Barnett 1969)» A relationship between 
osteoporosis and fractures is well established (Newton-John and Morgan
1968) and it is of interest that the incidence of bone fractures rises 
with age (Khowleden, Buhr and Dunbar, I964)*
It has long been recognised that bone ceases to grow 
longitudinally with the closure of the epiphyses. However, some 
workers have provided evidence that growth continues after closure 
of the epiphyses by bone being laid down on both the external and 
internal surfaces of the shafts. (Epker and Frost 1969, 19^6, Smith 
and Eizek, I966, Gam, Hohmann, Wagner and Ascoli 19^7) » Trotter, 
Broman and Peterson (I960) provided a fuller picture of osteoporosis 
as it applied to the whole of the adult life span in an attempt to 
establish criteria of early as well as advanced osteoporosis. They 
established that the weight/volume ratio (apparent density) of whole 
dry bones obtained at autopsy fell with age similarly in both sexes 
and in whites and negroes from twenty years of age onwards. 
Subsequently Arnold, Bartley, Tont and Jenkins (1966) showed that 
ash weight per unit volume in lumbar vertebrae decreased from about 
thirty years of age onwards. Other workers results on post mortem 
material have tended to confirm this impression of bone density 
peaking at the third to fourth decade and subsequently declining 
(Atkinson 19^5» Saville I969, Sissons, Holley and Heighway 1967)*
In vivo studies employing X-ray densitometry techniques have also 
tended to confirm this post mortem evidence (Nordin, Young, Bentley, 
Ormondroyd and Sykes I968, Smith I97O).
Rose (1967) concluded on reviewing the literature, that in most 
cases, osteoporosis is not a disorder which comes on suddenly in late 
adult life, rather it is a condition to which all people gradually 
progress when they pass 20 years of age. Dent and Lyall-Watson (196&) 
concur with this and regard the term "senile osteoporosis" as a misnomer 
if it is meant to imply that something new and fresh is happening in 
old age.
The study of osteoporosis has been bedevilled by methodological 
difficulties in assessment. A variety of methods have been used: 
simple radiological measurements (Barnett and Nordin I960) 
quantitative microradiographic techniques (jowsey I966), tetracycline 
labelling (Frost 1963), densitometeric techniques (Anderson, Shimmins 
and Smith (1966) and calcium balance studies (Fraser, Harrison and 
Jones i960, Dymling I964, Nordin, Smith and Glass (1964), Rafferty, 
Spencer and Pearson I964). Hone of these methods, however, has proven 
entirely adequate in terms of accuracy.
The simplest methods of assessment are radiological where the 
cortical thickness of bone is measured. However, these are naturally 
on selected parts of the skeleton and do not necessarily apply to the 
skeleton as a whole. Modifications on the basic formula of the 
metacarpal index of Barnett and Hordin (1960) have been introduced 
(Morgan 1973a) but there is little evidence to suggest that any 
individual method is better than any other. From radiological 
assessments, percentile charts of bone density have been compiled 
(Exton-Smith, Millard, Payne and Wheeler I969, Smith 1970). These 
charts indicate that the density of bone reached a maximum at age 35
to 40 years of age in both sexes, and then falls especially in females, 
confirming the post-mortem data of Trotter, Broman and Peterson (196O).
X-ray densitometry is a more complex method of measuring the amount 
of mineral in a given segment of bone. It relies on the calculation of 
the absorption of X-rays by the mineral bulk. However, the variation 
in the amount of soft tissue overlying the bone and technical 
radiographic factors tends to complicate these procedures (Baker,
Shraer and Yalman 1959)* This technique was found to be more sensitive 
than the metacarpal index, but the correlation between the two methods 
was reasonable (Anderson, Shimmins and Smith I966) suggesting that in 
epidemiological surveys, the simpler metacarpal index was an adequate 
measurement of osteoporosis.
The aetiology of osteoporosis remains in dispute. Albright and 
Reifenstein (1948) produced experimental evidence to suggest that 
osteoporosis was due to a deficiency of matrix with calcium loss 
occurring secondarily. On the other hand, Hordin challenged this 
concept and produced evidence that calcium deficiency per se was the 
primary cause of osteoporosis (Hordin I961). The skeleton possesses 
approximately 1000 g. of calcium in the young adult, and Dent (I969) 
pointed out that only 90 mg of calcium loss per day was required to 
produce an average degree of osteoporosis in an older subject.
In any patient therefore who is losing bone mass, it is 
reasonable to assume that he or she is in negative calcium balance 
either by cause or effect. Calcium balance status at any point in 
time is dependent on dietry intake, absorption capacity, urinary 
excretion, faecal excretion and sweat loss. Studies of calcium 
balance are therefore difficult, time consuming and tend to have a 
fairly high degree of imprecision (error of 5 to 10 per cent) (Smith 1970)
Investigations of patients who have been immobilised have shovm 
negative calcium balances of as much as 600 mg. per day with markedly 
raised urinary calcium values (Rose I966). However, in many studies 
of calcium balance in patients with primary osteoporosis, the calcium 
balances are not markedly negative and urinary calcium levels do not 
tend to be elevated ( Who don 1959, Hordin I96I, Spencer, Mencsel,
Lewin and Samachson 1964, Rose I965). This suggests that the 
osteoporotic patient has a negative calcium balance, little more than 
normal individuals, confirming Dents’ rather pessimistic view of the 
difficulties of investigating osteoporosis from the calcium balance 
point of view (Dent I969).
Other aspects of the metabolic status in osteoporosis have 
similarly been rather unhelpful in defining its pathogenesis. Serum 
calcium levels are essentially within normal limits and in post­
menopausal women may lie in the upper limit of the normal range, and 
urinary calcium tends to follow a similar pattern. In the majority 
of patients with primary osteoporosis plasma phosphate and urinary 
phosphate lie within normal limits (Hordin 1975). Investigation of 
calcium absorption have led to some apparently conflicting conclusions. 
Dent and Friedman (1965) and Rose (1965), produced data which suggested 
that calcium absorption was low in cases of spinal osteoporosis.
However, Avioli, McDonald and Lee (I965) suggested that calcium 
absorption was no lower in such patients than in normal control subjects 
of the same age.
By now it will have been appreciated that the term osteoporosis 
is used for a condition about which relatively little is known. It 
has been convenient to apply this term to almost any condition or 
disease in which there is demineralisation of bone which does not fit 
into a definite pattern of known bone disease, e.g. hyperparathyrodism 
or osteomalacia. Thus, "osteoporosis" was claimed as a secondary
phenomenon to thyrotoxicosis (Albright and Reifenstein 1948)* Although 
the histological appearance of bone in hyperthyroidism is not different 
to that in primary osteoporosis, Follis (1953) demonstrated osteitis 
fibrosa in bone biopsies from patients with hyperthyroidism, suggesting 
that the bone disorder in thyrotoxicosis was not solely explained by 
osteoporosis. However, at this point in time, it is still generally 
accepted that osteoporosis may occur secondary to corticosteroid 
therapy (Murray I960) Cushings Syndrome (Sprague, Randall, Salassa, 
Scholz, Priestley, Walters and Bulbulian 1956), immobilisation of a 
limb (Sissons 1952, Stevenson 1952), alcoholism (Saville I965), primary 
biliary cirrhosis (Atkinson, Hordin and Sherlock 1956) and other 
clinical conditions (Hordin 1973)»
The question of treatment of osteoporosis is probably one of the 
most controversial topics in what is already a highly controversial 
condition. To date there is no general agreement that osteoporosis 
can be reversed (Rose I967), but some workers advocate therapy with 
calcium and small doses of Vitamin I) (Hordin 1975), or albumin infusions 
(Bent and Lyal Watson I966) in an attempt to improve calcium balance 
and improve symptoms arising from the osteoporotic state. The use of 
sex hormone therapy and thyrocalcitonin has not been shorn to reverse 
osteoporosis, but possible may retard its development. Suffice to say 
that evidence of a satisfactory response to treatment of this condition 
is lacking and the verdict on all therapies must remain the Scottish 
Legal one of "not proven".
As the "Sage of Horwich" in his treatise on Urri Burial, noted 
"Teeth, bones and hair give the most lasting defiance to corruption" 
and were it not for the fact that "Time which antiquates antiquities 
and hath an art to malce dust of all things hath yet spared these minor 
monuments" we might not have appreciated that rheumatoid arthritis was 
present in the world even in ancient times.
The oldest human hones showing evidence of "arthritis" were those 
found in Lower Egypt hy Petrie (I890) with a suggested date of circa 
1300 EC. Hext came the "arthritis" discovered by Eve (I89O) in 
ancient human remains in Egypt dated to the Ptolemaic period (second 
century BC), however, in retrospect these changes of "arthritis" were 
probably due to osteoarthritis. The bones of a Horse Viking, found in 
the Christianed fjord; skeletal remains in Pompeii doscovered by 
Chiaje (1853); those in the Convent of Marienthon in Pomerania by 
Virchow (I869) ; those in the Roman Sarcophagus at Smithfield by 
Dr. Herman Moore (I883) and those in the Catacombs of Paris found by 
Lebert (1859) all testified to the existence of arthritis in ancient 
peoples. However, it is not certain whether or not these were 
rheumatoid arthritis. In the latter part of the last century during 
the course of excavations undertaken by the survey department of the 
Egyptian Government in the tract of Hubia lying immediately south of 
the First cataract of the Hile over 6,000 skeletons were discovered 
ranging from early pre-dynastic times to the fifth century A.D.
Professor Elliott Smith and Dr. Wood Jones who examined these specimens 
stated in the Hubian Survey Bulletin that "the disease which shows 
itself with by far the greatest frequency in the bodies of all periods 
is rheumatoid arthritis" (Elliott-Smith and Wood Jones I910), An 
excellent photograph of bony destruction typical of rheumatoid arthritis 
(erosions, thinning of bones and bony ankylosis) of the hand and wrist 
occurring in a specimen from Ancient Hubia is evidenced by Lawford 
Knaggs in his book, to support the antiquity of rheumatoid arthritis 
(LawfordICnaggs 1926). These archaeological finds testify to the 
existence of rheumatoid arthritis in ancient times and also indicates 
its presence in various geographical areas. Significantly it was the 
bones which provided information and yet to a large extent the involvement 
of these same structures by the rheumatoid process has been relatively
ignored by medical scientists down the centuries. Certainly an excuse 
can be made for these workers prior to the twentieth century being 
unable to investigate the bony complications of rheumatoid arthritis 
because of the absence of X-ray facilities. William Balfour in 1816 
in his description of the disease mentions that rheumatism (rheumatoid 
arthritis) affects muscle, nerves, blood vessels and all manner of 
organs, but does not mention any effect on bone. However, Harwell 
(I865) in his book is in no doubt that in chronic rheumatic arthritis, 
(from his description of this disease it probably embraces both 
rheumatoid and osteoarthritis) "the morbid action does not begin in 
the synovial membrane, but in the bones".
Although many of his premises and conclusions are seen in hindsight 
to be wrong he does give a very good pathological description of the 
effect of rheumatoid arthritis on bone. "At a certain period of the 
inflammation the thickened and condensed bone becomes gradually lighter. 
The bone does not become soft, but rarified. The external shell of the 
bone and the walls of the cancelli have become thinned. The gradual 
rarefaction of the bone and the thinning of both internal and external 
lamellae are due, I believe, to the slow ossification of the bone cells 
which starves the intercellular osseous material and allows its gradual 
absorption. Hence the peculiar action termed osteoporosis, (enlargement 
of the Ha,versian canals) is produced by absorption of the bony linings 
of those channel^ '. Similarly, Bannatyne in I896 v^rites, "On examining 
sections of bone (from rheumatoid patients) and also of medullary tissues, 
I was struck by the appearance of some of the latter. They were large 
granular cells with many nuclei and in a few instances I found places 
where they occurred in depressions of the bone. From these 
circjunstances there could be no doubt as to their nature. They were 
osteoclasts and it is evident that the nature of the process is a 
rarefying osteitis".
In 1905 Odery Symes noted that when hones of patients with 
rheumatoid arthritis were examined hy X-rays, they appeared more 
translucent than normal hones. He also contrasted this finding with 
the fact that in osteoarthritis the hones were more opaque and 
considered these features might he a useful diagnostic point in the 
differential diagnosis of the two diseases. The claim that 
demineralisation of hone occurring in rheumatoid arthritis is due to 
osteoporosis, is now a commonly held concept. (Soila 1958, Byv/aters 
i960, Castillo, El Sallab and Scott I965, McConkey, Frazer and 
Bligh 1965, Saville and Kharmosh I967, Martel I968 and Bjelle and 
Hilson 1970), and the occurrence of localised "osteoporisis" in relation 
to the affected joints in patients with rheumatoid arthritis is well 
recognised (Soila I965, Bywaters I96O, Bjelle and Mlsson 1971»
Duncan, Frost, Villanueva and Sigler, I965, Martel 1968. Generalised 
osteoporosis is also said to be present in patients with this disease 
(Soila, 1958, Berens, Locki, Lin and Horcross, 1964» McConkey, Frazer 
and Bligh I965, Saville and Kharmosh 1967, Virtama, Helela and Kalliomaki 
1968, Mueller and Jurist 1973). The aetiology of the loss of bone 
occurring in rheumatoid arthritis is still not understood. Local 
inflammation, immobilisation, generalised catabolic processes and poor 
nutrition in kheumatoid patients have all been implicated as causative 
factors, but to date no concrete incriminatory evidence has been 
discovered. In addition, osteoporosis is a well Imown complication 
of corticosteroid therapy; hence in patients with rheumatoid arthritis 
receiving such therapy, it is quite likely that the osteoporosis 
associated with rheumatoid arthritis might be further aggravated.
However, there is a marked paucity of quantitative information in 
relation to the effects of age, sex, the severity of the clinical 
symptoms, the duration of the disease, and the effects of treatment on
bone mass in patients with rheumatoid arthritis. This is all the 
more surprising since quantitative measurements have been available 
for over a decade. The techniques range from the morphological 
measurements such as cortical widths of the metacarpal, femur and 
radius (Barnett and Hordin, I96O, Meema 19&3) to the use of X-ray and 
1-ray densitometric techniques (Hordin, Barnett, MacGregor and Hisbet, 
1962; Keane, Speigler and Davis 1959; Doyle I96I; Anderson, Shimmins 
and Smith I966; Cameron and Sorensen I963; Shimmins, Anderson, Smith 
and Aitken 1972; Shimmins, Smith, Aitken, Anderson and Gillespie 1972). 
Various studies have also shown that age and sex differences affect 
normal populations (Smith, Anderson, Shimmins, Speirs and Barnett,
1969) and may influence the effects of disease and therapy (Smith 1970)- 
Thus, most of the research into "osteoporosis" in rheumatoid artliritis, 
has been channelled towards an assessment of the degree and extent of 
déminéralisation present and also the role of corticosteroid therapy 
in its genesis. The vexed question of whether osteoporosis occurring 
in rheumatoid arthritis is simply a localised effect secondary to 
inflammation and immobilisation or a more non-specific generalised 
condition has yet to be answered.
PERSONAL QBSERVATIOHS
The object of the investigations in this chapter is to attempt 
to answer some of the problems related to osteoporosis in rheumatoid 
arthritis. First, I will describe studies using the metacarpal index 
(Barnett and Hordin, I96O) to define the relationship between 
osteoporosis and the clinical features of the disease and 
corticosteroid therapy. Secondly, by studying the relationship betv/een 
the metacarpal index and the clavicular cortical width (Anton, I969) 
and femoral index (Barnett and Hordin, I960). In these patients I will 
attempt to ascertain the relative importance of local and systemic 
factors in the pathogenesis of osteoporosis in rheumatoid arthritis.
MATERIALS AND METHODS
The methods used for measuring changes in hone mass of the 
femur and metacarpal was that described by Barnett and Hordin,
(i960). X-rays of the left femur and right second metacarpal were 
taken, the thigh and hand being placed in contact -v/ith the film, at 
a film focal distance of 100cm. The internal and external diameters 
of the bone at the midpoint were measured with a Vernier calliper.
The femoral and metacarpal indices were obtained by dividing the sum 
of the cortical widths by the external diameter so as to allow for 
differences in size, in order that direct comparisons could be made, 
for example, between male and female patients. The thickness of the 
upper cortex of the right clavicle, hereafter termed Clavicular 
Cortical Thickness (CCT) was measured at the midpoint of tlie clavicle 
from postero-anterior chest radiographs using a Vernier calliper.
(Anton 1969)
Subjects studied
Four hundred and fifty-three patients with rheumatoid 
arthritis were studied. The definition of rheumatoid arthritis used 
was the diagnostic criteria proposed by the American Rheumatism 
Association (Ropes, Bennett, Cobb, Jacox and Jessar, 1959)- The 
patient group was composed of 158 males and 295 females.
A metacarpal index result was obtained in each of these patients. 
In three hundred and sixty-one of these patients it was possible to 
obtain a femoral index score and in three hundred and seven patients 
it was possible to obtain in addition to the metacarpal and femoral 
indices a measurement of clavicular cortical thickness.
The results of the metacarpal and femoral indices were 
compared with control values obtained in normal subjects, these 
being the relatives and friends of patients admitted to the general 
medical and surgical wards of the Western Infirmary, Glasgow. The 
object of the study was fully explained and the subject asked if 
he/she would volunteer to have an X-ray of the hand and femur 
carried out. In this way, metacarpal indices of 312 male and 317 
female normal subjects were obtained and also the femoral index 
values of 119 female and 76 male normal controls.
A standard questionnaire was completed at the time to ensure 
that anyone suffering from disease liable to affect bone mass was 
excluded from the study. These normal subjects have been studied 
separately and reported on in detail elsewhere (Smith, Anderson, 
Shimmins, Speirs and Barnett, I968; Smith, Anderson, Shimmins, 
Speirs and Barnett, 19^9; Smith, 19?0). Normal values for the 
clavicular index were obtained from 221 relatives of patients who 
attended the Medical and Surgical wards of Stobhill General 
Hospital, Glasgow, care being taken to exclude people who had 
disease likely to affect bone mass.
Of these 221 volunteers, II4 were males and IO7 were females. 
The mean age of the male subjects was 47*4 + 15*2 years (range 21 
to 78 years), and female subjects, 48.1 + 16.6 years (21 to 79 
years).
RESULTS
Table 1:1 gives an analysis of the clinical and diagnostic 
features of the patients in the first part of this study. This 
includes the number of patients studied in each of four groups, 
comprising male and female patients both treated and not treated 
with corticosteroids. The statistics show the mean (+ 1 standard 
deviation) of age, the duration of the arthritis, titre of 
rheumatoid factor (Ball, 1952) > age of onset of menopause, serum 
albumin and globulin, haemoglobin concentration and erythrocyte 
sedimentation rate. Only minor differences emerged between the 
groups. The patients receiving corticosteroid therapy were on 
average slightly younger, and had had the condition for longer. 
However, these differences were not statistically significant.
The titre of rheumatoid factor was higher in those patients who 
had been given steroid therapy but this was not statistically 
significant. The mean haemoglobin was significantly higher in 
the male compared with female subject, but the steroid-treated 
groups did not differ significantly from the non-steroid treated 
subjects of the same sex. Serum albumin and globulin levels, and 
erythrocyte sedimentation rates did not differ significantly 
between the groups. The mean age of onset of the menopause was 
nearly identical in the two female patient groups at 45 «2 and 45*8 
years of age. Of the 158 male patients studied, 24 were receiving 
treatment with corticosteroids, and 134 were not. In Fig. 1:1 
(a and b) the metacarpal index was related to age in the non­
treated group (Fig.I:1a) and steroid treated group (Fig.I;1b).
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Figure 1:1
Tho Metacarpal Indices in  male pa tien ts  w ith  rheumatoid a r th r i t is  
p lo tted  against ago. Those patients not rece iv ing co rtico s te ro id  
therapy are shown in  (a) and those v/ho were rece iv ing co rtico s te ro id  
therapy are shown in  (b ).
The normal 5, 50 and 95 pe rcen tile  values are shown by continuous 
lihes. . -
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Superimposed on these results were the 5» 50 and 95 percentile 
lines obtained from the 512 normal male subjects.
Table 1:2 shows the percentage of patients below the 5th 
percentile in each group after sub-dividing the patients into groups 
45 years of age and above, and those below 45 years of age. This 
age division, is of course, arbitrary and was chosen because the 
mean age of the menopause occurred at this age in the female subject, 
and it therefore seemed logical to divide them into these groups for 
comparison.
Of the 114 male patients not on steroid therapy and aged 
45 years and over, 42 (56.8%) were below the 5th percentile 
(Table 1:2). Only 5 of the patients (l5%) under 45 years of age 
were below the 5th percentile. Only one male patient who was 
treated with corticosteroids was below the age of 45, and his 
metacarpal index lay on the 10th percentile. Of the 25 patients 
aged 45 and over, 7 (50%) were below the 5th percentile. Of the 
295 female patients studied, 109 were receiving treatment with 
corticosteroids and the remaining 186 were not. In ]?ig.I;2 (a 
and b), the metacarpal index was plotted in relation to age in the 
non-steroid treated group (Fig.I:2a) and the steroid-treated group 
(Fig.I;2b). Superimposed on these results were the 5, 50 and 95 
percentile values obtained from the 517 normal female subjects.
Table 1:2 shows the percentage of patients below the 5’tb percentile 
in these two groups after dividing them into groups showing those 
below 45 years and those above 45 years.
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TABLE 1:2
The Percentage of Patients below the 5th Percentile 
treated or not treated with corticosteroids
-Pig I :  2
The MetacarpaV Indices in  female pa tien ts  w ith rheumatoid a r th r i t is  
p lo tte d  against age. Those pa tients not receiv ing co rtico s te ro id  
therapy are shown in  (a) and those who were receiv ing co rtico s te ro id  
therapy are shown in  (b) .
The normal 5, 50 and 95 pe rcen tile  values are shown by continuous 
lin e s . ■ ^
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Of the 106 non-steroid treated female patients, 58 were 
helow 45 years of age and the remaining 128 were 45 years or over.
As in the male group, those patients 45 years and over appeared 
more severely affected than the patients under 45 years, 3^ *7% of 
those 45 years and over lying helow the 5th percentile compared 
with 22.4% of those under 45 years of age (Table 1:2).
Of the 109 steroid-treated patients, 26 were under 45 years 
and 40*7% of them were below the 5th percentile. Of the remaining 
82 female patients 45 years or over, 62.2% were below the 5th 
percentile.
In order to test for statistical differences between the normal 
subjects and the patients with rheumatoid arthritis, it is 
necessary to look for differences by decades. This is because of 
the fall in the metacarpal index which occurs with increasing age 
in normal male and female subjects. Pig.1:3a shows the mean and 
standard error of the metacarpal index for the normal male subjects 
and the male subjects with non-steroid treated rheumatoid arthritis.
No significant difference between the normal subjects and the patients 
was found under the age of 45 years.
In the patients aged 45 years and over, however, a highly 
significant difference was seen (P<0.001) at the three decades 
from 46 to 74 years of age, the patients all having lower 
metacarpal indices. In the small group of steroid-treated male 
patients (Pig.I:3b) statistical differences were apparent 
(P < 0.001) in the two decades between 56 and 74 years of ag-e, again 
the patients having lower metacarpal indices.
1: 3 : . ■ V' '"v  ^ T : . - \/. / ,/ . :
The mean and standard e rro r range in  the Metacarpal Index fo r  normal 
male and female p a tie n ts , and p a tien t groups are shown p lo tted  â g a in tt 
age. - ,  - ■ '
(a) shov/s the values fo r  male pa tien ts  w ith  rheumatoid a r th r i t is  and 
nomal male subjects.
(h) Male pa tien ts  w ith  rheumatoid a r th r i t is  treated w ith  co rticos te ro ids  
; and normaT subjects* 7 i
(c) Female pa tien ts w ith  rheumatoid a r th r i t is  and normal sub jects.
(d) Female pa tien ts  w ith  rheumatoid a r th r i t is  treated w ith  co rticos te ro ids  
vF and normal subjects.
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A similar picture emerged in the non-steroid treated female 
patients (?ig.I:3c). Significant differences were observed between 
26 and 34 years of age, but none between the ages of 3^ and 45 years. 
In the three decades between 45 and 74 years of age, the patients 
metacarpal indices were significantly lower than those of the normal 
subjects (P^ 0,001). In the steroid-treated group (Pig,I:3d) the 
female patients in the decades between 25 and 74 had statistically 
significantly lower metacarpal indices than the normal subjects.
The Effects of Duration of Rheumatoid Arthritis, and the Effects of 
Duration of Steroid Therapy on Bone Mass
The effects of duration of this disease and the effect of 
treatment with corticosteroids in the patients has been tested in 
two ways: firstly, as a direct measurement of the metacarpal index 
to the duration of the rheumatoid arthritis, or rheumatoid patients 
treated with steroid therapy; secondly, as a measurement of the 
percentile value in relation to the duration of the disease or steroid 
therapy. The latter is necessary to exclude any influence of age on 
the results. IVhen this was considered for the four groups as a whole, 
no significant relation to duration of the disease or duration of 
steroid therapy was found. However, scrutiny of Pig. 1:3 suggests 
that older patients are more severely affected and, therefore, male 
and female patients over the age of 45 years were examined.
The effects of the duration of rheumatoid arthritis in male 
patients over the age of 45 years are illustrated in Pig. 1:4 and 
detailed in Table 1:3. In the male patients, the metacarpal index
Fig I :  4 : F ^
The Metacarpal Index fo r  male pa tien ts w ith  rheumatoid a r th r i t is  is  
shown p lo tted  against the duration o f the disease. :F ^
There is  a wide sca tte r but the f a l l  in  Metacarpal Index is  
s ig n if ic a n t ly  re la ted  to the duration o f  the d1sease^ ^^ ^^ ^% .
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is inversely related to the duration of the disease. However» when 
considered as percentile values it fails to reach significance. In 
the steroid-treated group of male patients over 45 years of age, the 
fall in metacarpal index was inversely related to the duration of the 
disease (P^lO.Ol) and when considered as a fall in the percentile 
value (P<0.05). In the female subjects (Table 1:3) a hi^ly 
significant fall was found in both the metacarpal index and the 
percentile values in both the steroid and non-steroid treated groups 
over the age of 45 years of age.
The possible effects of age on bone loss in the non-steroid and 
steroid-treated patients are examined in Table 1:4» Since the bone 
mass, measured as the metacarpal index falls with age in both males 
and females, the bone loss over and under 45 years of age is 
expressed as the percentile value so that the relative changes from 
normality can be determined. As can be seen, the patients in all 
eight groups at 45 years and over have lower percentile values than 
those under 45 years of age. However, it is only in the non-steroid 
treated female patients that statistical significance is achieved.
There was only one male patient under 45 years of age who received 
steroid therapy.
The possible effects of the patient’s sex on bone loss in the 
non-corticosteroid treated groups, and those patients treated with 
corticosteroids, is examined in the same way in Table 1:5 using the 
percentile values of the metacarpal index. Ho significant differences 
emerged in any of the groups. Again there was only one male patient under 
the age of 45 receiving steroid therapy so no comparison could be 
made in this group.
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The effects of corticosteroid therapy were tested (Table 1:6) 
by comparing the percentile differences in metacarpal index in the 
non-steroid and steroid treated patients who were 45 years of age 
and over and those under 45 years of age. Again there was only one 
male patient under 45 years, so no comparison could be made in 
this group. In the male patients who were 45 years and over, no 
significant differences was seen. However, in the female patients 
who were treated with steroid therapy the bone mass was found to be 
significantly lower than that found in the patients with rheumatoid 
arthritis who had not been treated with steroid therapy.
However, difference in bone loss could arise between the patients 
above and below 45 years of age because of the duration of the 
arthritis or the duration of corticosteroid therapy. Prom Table 1:7 
it can be seen that the males above and below the age of 45 years 
of age had rheumatoid arthritis for a longer mean time than the 
female subjects, but these differences were not statistically 
significant. Male and female patients aged 45 years and above had 
had'rheumatoid arthritis for significantly longer than the patients 
under 45 years of age.
Male patients aged 45 years and over had been treated ydth 
steroids for significantly longer than the female patients of 45 
years and above. There was, however, no significant difference in 
the length of time that female patients under the age of 45 years 
had been treated compared with those over the age of 45 years.
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In three hundred and fifty-one of the patients investigated in 
the first part of this study it was possible to obtain a femoral 
index value. The results of the analysis of their clinical and 
diagnostic criteria are shown in Table 1:8, These are shown as the 
mean and 1 S.D. in each patient group. The mean age of the male 
patients was significantly greater than that of the female patients. 
This difference was still apparent after subdividing them into 
corticosteroid treated and non-corticosteroid treated groups, the 
male patients being significantly older than the female patients.
There was no significant difference in age between the steroid and 
non-steroid treated male patients or between the steroid and 
non-steroid treated female patients. A similar pattern emerged 
when considering the duration of the arthritis which was, on average, 
present for longer in the male than in the female subjects. The mean 
titre of rheumatoid factor was higher in both the male and female 
corticosteroid treated groups than in the non-steroid treated patients, 
though these differences did not reach statistical significance. In 
the female patients, the age of onset of the menopause was almost 
identical in the corticosteroid treated and non-corticosteroid treated 
groups. The mean serum albumin and globulin levels were slightly, but 
not significantly higher in the male patients. The mean erythrocyte 
sedimentation rate was not significantly different in any of the 
groups. The male patients had a significantly higher haemoglobin 
level than the female patients in all three groups. However, there 
was no significant difference between the steroid and non-steroid 
treated male patients and this was also true for the female patients.
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Bone loss is well known to occur in both male and female 
subjects with increasing age, as measured by the femoral index Nordin, 
McGregor and Smith Smith (1970). The femoral indices in the
patient groups have therefore been compared by decades with the 
control subjects. In Fig.I:5 the femoral indices of the 
noncorticosteroid treated female patient group is seen to be 
significantly lower than those of the control subjects in each decade 
between 25 and 74 years of age. In the female corticosteroid treated 
group, the femoral indices were significantly lower than in the normal 
subjects in all age groups, except in the decade 25 to 54 years of 
age (Fig.1:6). When the femoral indices in the steroid and non steroid 
treated groups were compared (Fig.1:7) the steroid treated groups at 
each decade had marginally lower mean values, but in no decade did 
this reach statistical significance,
%
In the male patients who had not been treated with corticosteroids, 
the mean femoral indices were all lower than those of the control 
subjects in each decade between 25 and 74 years of age (Fig.1:8), 
but only reached statistical significance between 45 and 64 years.
The number of male patients who were treated with corticosteroids 
was small (twenty-four), one patient was below 45 years of age, and 
the rest ranged between 45 and 74 years of age. The mean values were 
lower in each of the three decades, compared with the control subjects, 
but only reached statistical significance in the 55 to 64 year age 
group (Fig.1:9)' When the steroid treated male patients with 
rheumatoid arthritis weie compared with the non-steroid treated group 
in the three decades 45 to 74 years of age, no significant difference 
between these groups was found (Fig.I:10).
.'A,., '
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The niean and standard erro^ o f the femoraT index shown by decades in  
normal female subjects and in  the female pa tien ts  w ith  rheumatoid 
a r th n t is  not rece iv ing  co rtico s te ro ld  therapy.
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Fig I :  6
The mean and standard e rro r o f the femoral index shown by decades in  
normal female subjects and m  the female pa tien ts w ith  rheumatoid 
a r th r i t is  who were rece iv ing co rtico s te ro id  therapy.
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The mean and standard e rro r o f the femoral index shovm by decades in  
nom al male subjects and in  the male pa tien ts  w ith  rheumatoid 
a r th r i t is  not rece iv ing c o rtico s te ro id  therapy.
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The mean and standard e rro r o f  the femoraT index shown by decades in  
normal male subjects and in  the male pa tien ts  w ith  rheumatoid 
a r th r i t is  who were rece iv ing  c o rtico s te ro id  therapy.
70
6 1
50 -
MALE
FEMORAL
INDEX
30-
B B B
NS P<0-005 NS
10-1
0 
25
i Normal
B R. A.-Steroid Treated
I
35
I
45
I
55
I
65
-1
75
AGE -  years
Fig I :  10
The mean and standard e rro r o f the femoraT index shown by decades in  
male pa tien ts  w ith  rheumatoid a r th r i t is  not rece iv ing co rtico s te ro id  
therapy and those male pa tients who were rece iv ing co rtico s te ro id  
therapy.
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The relation between the femoral and metacarpal indices in the 
various patient groups is shown in Table 1:9* The patients have 
been divided into two groups - 45 years of age and above, and those 
below 45 years - since this is the mean age of the menopause after 
which the rate of bone loss accelerates. The males also have been 
divided into those 45 years and above, and those below 45 years, so 
that the different male and female age groups correspond. The 
relation between the femoral indices and metacarpal indices in the 
entire male and entire female groups is also shown. Only one male 
patient under 45 years of age was treated with corticosteroids. The 
femoral and metacarpal indices are clearly related except in the 
corticosteroid treated female patients under the age of 45 years. 
However, the highest correlation coefficient, 0.7^6 for the 
corticosteroid treated male patients, gives a coefficient of 
determinancy of only 0 .542.
In order to test this further, the femoral index and metacarpal 
index have been examined for concordance and discordance compared 
with the normal values. The results are shown in Table 1:10. The 
patients have been divided into male and female groups and each of 
these in turn into steroid treated and non-steroid treated. Finally, 
the groups have been sub-divided into those 45 years of age and above, 
and those below 45 years of age. In the male patients, concordance 
ranges from 62 to 100% when values for both the femoral index and 
metacarpal index lie within the 2 S.H. range of the normal values, and 
16 to 21,7% when both values lie without the normal 2 S.I). range.
In the female patients, the corresponding concordance ranges between 
45»2% and 62.7% and 4»^% and 12.6% for values within and without the 
2 S.H. range for normal subjects.
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Discordance ranged from 15% to 14*0% in the male subjects when 
the femoral indices were normal and the metacarpal indices abnormal, 
and 4 to 4*6% when the metacarpal index values were normal and the 
femoral index values were abnormal. In the female patients, 2.3% to 
37*7% and 3*6% to 33*3% were discordant when normal femoral indices 
and normal metacarpal indices were considered. Total concordance and 
discordance percentages are shown in the last two columns Table 1:10. 
Numbers of patients are small in some groups due to the division of 
the patients into eight categories. However, if the total value for 
each of the male and female subjects is considered, the metacarpal 
index is more frequently abnormal than the femoral index ™ 12,6% 
compared with 4% in the male patients, and 21.3% and 13*9% the 
female patients.
The duration of arthritis in the steroid and non-steroid treated 
groups of patients is shown in Table 1:11, Only one male patient below 
the age of 45 years was treated with corticosteroids. In the remaining 
groups, the steroid treated patients had had rheumatoid arthritis for 
a longer period than had the non-steroid treated patients. These 
differences reached statistical significance in the male patients of 
45 years of age and above, and in the female patients under 45 years 
of age. There is no significant correlation between the duration of 
the arthritis and the femoral index in either the steroid or non-steroid 
treated male patients, as is shown in Table 1:12, In the female patients, 
the femoral index is significantly correlated to the duration of the 
disease in both the steroid and non-steroid treated patients over the 
age of 45 years, but not under the age of 45 years. In Table 1:13 
correlation between the duration of steroid therapy and the femoral 
index is shown. There is a statistically significant correlation in 
both male and female patients over the age of 45 years.
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The third part of this study looks at the metacarpal and 
femoral indices together with the clavicular cortical thickness 
in three hundred and seven of the patients included in the initial 
part of the study.
Table 1:14 summarises the clinical and laboratory data of 
these patients and shows the mean (± i.S.S.) of the following: 
age; duration of arthritis; titre of rheumatoid factor; age at onset 
of the menopause; serum albumin and globulin concentrations; 
haemoglobin concentration and erythrocyte sedimentation rate. Only 
minor differences existed between the groups and none of these 
reached statistical significance. Fig 1:11 shows the changes in 
the clavicular cortical thickness (CGT) in normal and non­
corticosteroid-treated rheumatoid male subjects in 10-year age 
groups. Both groups show a fall with increasing age, however, and 
in each 10-year age group the patients had statistically significantly 
lower mean values than the normals.
The number of male subjects receiving corticosteroids was 
relatively small, and there was only one patient below 45 years of 
age (Fig. 1:12). Only those patients between 55 and 65 showed 
significantly lower values than the normals. The GOT in the 
corticosteroid- and non-corticosteroid-treated male subjects'is 
shown in Fig. 1:1$. Wo significant differences were found between 
the two groups.
The data from the female patients was examined in the same way.
In Fig. 1:14 it can be seen that the clavicular cortex decreases with 
age in both the normal subjects and the non-corticosteroid-treated 
female patients « There is a significantly lower mean CGT in each of
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The mean and standard eriror o f the c la v ic u la r score (C.C.T.) in  ten 
year age groups in  normal male subjects and in  male pa tien ts  w ith  
rheumatoid a r th r i t is  not rece iv ing  co rtico s te ro id  therapy. 
S ig n ific a n t d iffe rences between the normal subjects and pa tien ts 
studied are ind ica ted .
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The mean and standard e rro r o f the c la v ic u la r score (C.C.T.) In  ten 
year age groups in  the normal male subjects and in  the male patients 
w ith  rheumatoid a r th r i t is  who were rece iv ing co rtico s te ro id  therapy. 
S ig n ific a n t d iffe rences between the normal subjects and the patients 
studied are ind ica ted .
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The mean and standard e rro r o f the c la v ic u la r score (C.C.T.) in  ten year 
age groups in  male pa tien ts  w ith  rheumatoid a r th r i t is  and male patients 
w ith  rheumatoid a r th r i t is  who were rece iv ing co rtico s te ro id  therapy. 
S ig n ific a n t d iffe rences between the two groups are ind ica ted .
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the 10-year age groups when the patients are compared with the 
normal subjects.
Fig. 1:15 shows a comparison between the normal subjects and 
the corticosteroid-treated rheumatoid patients. Again, in each 
lO-year age group the patients show significantly lower values than 
the normal controls. There was, however, no significant difference-, 
between the corticosteroid- and non-corticosteroid-treated female 
patients (Fig. I:l6).
The relation between the duration of the arthritis in the patient 
groups is shown in Table 1:15. The female patients were divided into 
those above and below the age of 45 years (the average age at 
menopause), and the male patients were divided into the same age 
groups, for comparison. Significant results were found only in the 
male subjects. Both the corticosteroid and non-corticosteroid groups 
over the age of 45 years showed a significant fall in the CGT with 
increasing age.
The GOT has been correlated with the metacarpal and femoral indices
and the results are shown in Tables I:16 and 1:17. The patients were
divided into corticosteroid- and non-corticosteroid-treated groups. 
There was only one male patient below 45 years of age who had been 
treated with corticosteroids. Significant correlations were found 
between the GOT and the metacarpal index (Table I:l6) in all the 
groups except for the corticosteroid-treated female patients under the 
age of 45 years. There was a significant correlation between the GOT 
and the femoral index in all patient groups (Table I :17) except again
for the female patient group below 45 years of age receiving
corticosteroid therapy.
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Table 1:18 summarises the results of comparison of the 
clavicular cortical thickness with the metacarpal and femoral indices 
in terms of concordance and discordance of results. It can be seen 
that there is an overall high concordance of results, but that the 
metacarpal and femoral indices were more frequently subnormal in 
both male and female patients than the measurement of clavicular 
cortical width. The definition of a subnormal value in any of the 
measurements was a value lying below the value of 2 8.1. in the 
normal subjects, taken in decades.
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DISCUSSION
It is widely accepted that bone loss occurs in patients with 
rheumatoid arthritis, and that excess of circulating corticosteroids 
exacerbate the bone loss which occurs naturally with increasing age 
(Sissons, 1956; Villanueva, Klein and Frost, 1964; Saville, 1970; 
Robbins and Saville, 1971). However, there are a number of questions 
related to the magnitude of these losses which remain unanswered. In 
the first part of this study employing the metacarpal index alone, an 
attempt was made to answer the following questions
1. Is the magnitude of the bone loss in rheumatoid arthritis 
significantly greater than that which occurs in normal men 
and women with increasing age?
2. Is the bone loss related to the length of time the patients 
have had the disease?
3. Is increasing age an important factor in determining the 
amount of the bone loss?
4. Is the bone loss in rheumatoid arthritis more severe in the 
male or female patients?
9 . Does corticosteroid therapy significantly affect the degree 
of bone loss?
6. Is the younger patient (below 45 years of age) or the older 
patient more severely affected in the degree of their bone 
loss by the use of corticosteroids?
7* Do corticosteroids cause more bone loss in male or female 
patients?
In the initial part of the study i measured only the bone loss 
in the second metacarpal of the right hand measured by the 
metacarpal index of Bamett and Nordin (1960). Rheumatoid arthritis 
is known to affect the joints of the hand early and often more 
severely than other joints. Clearly local factors could therefore 
be important in the bone loss and I have not initially attempted 
to suggest that the changes seen in the metacarpal represent changes 
elsewhere in the skeleton.
When the patient groups were broken down into the corticosteroid- 
and non-corticosteroid-treated groups, the titre of rheumatoid 
factor was higher in the steroid treated groups but these differences 
were not statistically significant. The erythrocyte sedimentation 
rate, haemoglobin levels, plasma proteins and other clinical and 
laboratory indices in each group were very similar. Comparisons 
were therefore, possible betiveen the groups, and each group was in 
turn compared with nc-rmal subjects.
From the evidence accnm-ulated in the initial part of this study,
the answers to the seven questions posed seemed as follows:-
1. The bone mass was significantly decreased in both male and 
female patients compared with normal subjects. In the female 
patients the mean values of the metacarpal index are 
significantly lower than in the normal female subjects from
26 years of age upwards. In the males below 45» the mean values 
are lower than in the normals, but significant differences do 
not emerge except in those above the age of 45 years.
2. The bone loss, measured as the metacarpal index, falls 
significantly with the duration of the disease. Since the 
changes are also evident when the percentile metacarpal index 
is used this relation cannot be an artefact caused by older 
patients having had the disease for a longer time than the 
younger patients.
5. Since increasing age itself is accompanied by bone loss in normal 
subjects 'and would be expected to occur in the patients, it was 
necessary to compare the bone loss in the patients above and 
below the age of 45 years by comparing the mean percentile 
changes. The male patients aged 45 years and above had a lower 
mean percentile metacarpal index than those beZ.ow the age of 45 
years (24*42 compared with 34*40) but this difference was not 
statistically significant. The female patients aged 45 years 
and over did show a significantly lower mean percentile value 
than those below the age of 45 (P <0.02). However, it can be
seen from Table 1:7 that the older patients have, not 
surprisingly, had their disease for significantly longer. The 
bone loss was also significantly directly related to the 
duration of the disease. These differences could, therefore, 
arise simply due to this and do not necessarily indicate that 
the older patient is more susceptible to bone loss secondary 
to hormonal or other changes.
4 . Normal female subjects showed a greater loss of bone than 
normal males, with the accelerated bone loss occurring after 
the menopause. Disease may, therefore, have exacerbated bone 
loss to a greater extent in the female subjects. However, 
examination of the percentile values of the metacarpal index 
in male and female patients under 45 years of age, and 45 
years of age and above showed no significant differences between 
the male and female patients. That is, sex was not a 
significant determining factor in the magnitude of the bone loss 
in patients with rheumatoid arthritis.
5. Female patients with rheumatoid arthritis who had been treated 
with corticosteroids had significantly lower mean metacarpal 
indices than normal subjects between 26 and 75 years of age.
In the male patients on corticosteroids, significant lower 
values only emerged between the ages of 55 and 75 years. When 
the steroid treated female patients were compared with the 
non-steroid treated, the fomer group was found to have 
significantly lower percentile metacarpal values in both the 
under and over 45 year age groups. This suggests that 
corticosteroids had caused a greater degree of bone loss than
that which would have occurred as a result of the disease alone. 
However, the possibility that the steroid treated group may 
have had more bone loss due to the slightly (but not significantly) 
longer duration of the disease, cannot be completely ruled out.
6. There was no evidence to suggest that the steroid treatment has 
more severely affected the female patients of 45 years of age and 
over compared with the female patients below 45 years in spite of 
the longer duration of the steroid therapy and of the disease in 
the older steroid treated group. This comparison was not possible 
in the male patients because of insufficient numbers.
7. When the bone loss in steroid treated male patients of 45 years 
of age and upwards was compared with that in females in this age
group, there was a greater mean loss of bone in the female
patients, but this was not statistically significant.
The conclusion reached in the first part of this study was that 
rheumatoid arthritis led to a loss of bone in both male and female 
patients as measured in the second metacarpal. This loss was 
directly related to the duration of the disease. However, the bone 
loss was not significantly different when male and female patients were 
compared. The bone loss was greater in patients who had been 
receiving steroids than those who had not been so treated. There was
some evidence to suggest that the older patient was more severely 
affected by the disease, but since the older patient had. generally 
had the disease for longer this cannot be accepted as proven.
There was no evidence to suggest that female patients were 
significantly more severely affected by steroid treatment than the 
males.
Having shown that significant bone loss occurs in the metacarpal 
of patients with rheumatoid arthritis and taking into consideration 
the fact that rheumatoid arthritis is a generalised disease affecting 
many tissues remote from the joints such as the heart and lungs, the 
question of the extent of bone loss in rheumatoid arthritis is raised. 
Any such generalised loss of bone could be the result of immobility 
resulting from joint pain and stiffness, the generalised inflammatory 
nature of the disease or from the use of corticosteroids. It is fair to 
note that the joints of the hands and wrists are especially subject to 
rheumatoid changes and thus the local effects of the disease might be 
more liable to affect bone mass in the metacarpal, especially as it 
is a relatively small bone, rather more than the larger more central 
bones of the body.
The femoral index and the clavicular cortical thickness were 
considered less likely to be subject to local disease activity, thus 
these indices were measured and compared with the metacarpal indices 
in the same patients in order to assess the extent of bone loss 
occurring in rheumatoid arthritis. The changes occurring were noted 
and compared as individual indices with age and sex matched nomal 
subjects. In addition information relating to the effect on bone 
of corticosteroid therapy in rheumatoid arthritis was established.
The administration of corticosteroid hormones is known to produce 
osteoporosis in other conditions (De Martini Grokoest and Ragan,
1952., Teicher and Nelson, 1952., Reifenstein, 1958.) and this 
condition of bone is also known to occur in Cushings Syndrome 
(Khowlton, 1955'» Vang and Robbins, 1956). However, the effects 
of corticosteroids on patients with rheumatoid arthritis are less 
predictable.
Corticosteroids reduce the local and generalised inflammatory 
changes, and could therefore improve mobility. In this way, they 
could reduce bone loss, and the end result would be a balance between 
the two opposing effects of the steroid therapy.
The investigations showed that there is a significant loss of 
bone in the femur, compared with normal, age-matched subjects, 
measured as the femoral indes in both male and female subjects with 
rheumatoid arthritis. Moreover, the bone loss was much more 
significant in the female subjects. In the male subjects, 
significant bone loss was seen only in patients 45 years of age and 
over. There was a very similar pattern of bone loss in the patients 
with rheumatoid arthritis treated with corticosteroids, compared 
with normal, age-matched controls. When the bone loss in patients 
with rheumatoid arthritis was compared with the bone loss in the 
patients treated with corticosteroids, no significant differences 
emerged, either in the male or in the female groups, suggesting 
that the steroid therapy had not contributed to bone loss in these 
patients.
The study also showed that the clavicular cortical thickness 
was significantly diminished in both male and female patients with 
rheumatoid arthritis at all ages and in those patients who were 
treated with corticosteroids. Like the results of the femoral 
indices, but unlike those of the metacarpal indices, the clavicular 
cortical thickness was not shown to be significantly more reduced in 
patients treated with corticosteroids than those not so treated.
When the metacarpal index was compared with the femoral index, 
highly significant correlations were obtained between the two 
measurements, except in the corticosteroid treated female patients under 
45 years of age. These results suggested that similar changes are 
occurring in both these bones as the result of the rheumatoid 
arthritis. When tested for concordance, the results are j.n keeping 
with the occurrence of greater bone loss in the metacarpal, except 
in the female patients under 45 years of age, whether or not they 
were treated with corticosteroids. However, the numbers of subjects 
in the various categories are small, and the results should be 
interpreted with caution.
The male patients were, on average, older than the female 
subjects and had had rheumatoid arthritis longer, yet it is 
interesting to note that the female patients appeared to be more 
severely affected than the male patients, in terms of bone loss; this 
appears to be so, whether the patients were treated with 
corticosteroids or not. There was a much poorer correlation between 
the duration of rheumatoid arthritis and the fall in the femoral 
index than for the correlation with the metacarpal index observed 
earlier in the study. Only the female patients over the age of
45 years in both the steroid and non-steroid treated groups showed a 
statistically significant correlation. There was also a statistically 
significant correlation between the femoral index and duration of 
steroid therapy in the male and female patients over the age of 45 
years.
The results of the study also show that the clavicular cortical 
thickness is related to the metacarpal and femoral indices. The 
results of the study of concordance and discordance confirm this but 
also show that the metacarpal and femoral indices were more 
frequently subnormal than the clavicular cortical thickness,This 
suggests that while the C.C.T. is a useful measure of bone loss, it 
is less sensitive than the metacarpal and femoral indices.
These results also suggest that osteoporosis is a generalised, 
and not merely a localised condition, in patients with rheumatoid 
arthritis. This is more in keeping with the possibility that the 
bone loss is either primarily or secondarily due to the generalised 
inflammatory nature of the condition and not only to the 
immobilisation due to joint pain and stiffness.
Moreover, though the relationships of the various indices of 
osteoporosis may be causally related, it must be remembered that 
other factors such as age, sex, and the severity of the disease, 
as well as the duration of corticosteroid therapy, and of the 
rheumatoid arthritis, could be contributory to the significance of 
these results. On the present data, it would seem more likely 
that the duration of the rheumatoid arthritis, rather than the 
duration of the corticosteroid therapy, was the important 
contributory factor in the bone loss.
This is an interesting finding, as the development of osteoporosis 
is regarded as a hazard in patients treated with corticosteroids.
The results of the study on the femoral indices and clavicular 
cortical thickness did not indicate any potential aggravation of the 
hone loss occurring in rheumatoid arthritis by corticosteroid therapy, 
although the study on the metacarpal indices suggested a slight 
tendency for this to happen. This potential hazard therefore would 
appear to be minimal in patients with rheumatoid arthritis.
Having collated a large mass of data pertaining to osteoporosis 
in patients with rheumatoid arthritis, I thought it would he of 
interest to have further more sophisticated statistical analysis 
carried out using a digital computer.
This section deals with a detailed statistical computer analysis 
carried out in collaboration with the Department of Biomathematics, 
Oxford University (Dr. John A. Anderson). In addition, I thought it 
might prove of practical value if a statistical prediction of the 
degree of osteoporosis present in a patient could be ascertained, and 
the results of this study are also included in this section of the 
chapter.
STATISTICAL ANALYSIS
604 consecutive patients entering the Centre for Rheumatic 
Diseases were selected for inclusion in this study, many of these 
were previously included in the clinical study.
The patients were divided into two groups by sex. The females 
were further classified as rheumatoid factor positive and rheumatoid 
factor negative. All the males were rheumatoid factor positive.
The groups consisted of 4^5 females (of whom 88 were sero negative) 
and 199 male patients.
The rheumatoid factor negative patients had a milder form of 
the disease than the rheumatoid factor positive patients.
There were fifteen measurements to be recorded for each patient 
but there were a number of missing values.
The variables which could have been recorded for each patient
were:
(1) Sex F = 0 M = 1
(2) Diagnosis 
(5) Age
(4) Age at onset of disease
(5) Duration of disease in years
(6) Functional Grade
(7) X-ray classification
(8) Rheumatoid Factor Titre
(9) Erythrocyte Sedimentation Rate
(10) Metacarpal Index
(11) Femoral Index
(12) Clavicular Cortical Thickness 
(15) Dose of Prednislone
(14) Duration of steroid therapy
(15) Standard aluminium equivalent 
(’s.a.e.’)
(An assessment of physical 
capability measured on a 
four point scale)
(Measured on a three point 
scale)
The data were transferred into a file in the computer and 
verified.
Variables (IO), (II) and (12) were chosen to be the parameters 
of osteoporosis. The s.a.e. was only recorded for the females.
The groups of primary interest were the rheumatoid factor 
positive males and females. The other group (rheumatoid factor 
negative females) was included in the initial examinations of the 
data mainly for comparison.
Thus, measures of osteoporosis in each patient was based on 
some or all, of observations (IO), (II), (12) and (15) (for the 
females). The other observations were included as ^explanatory* 
variables.
Initially the metacarpal index, femoral index, clavicular cortical 
thiclaiess and the standard aluminium equivalent were assessed as 
measurements of osteoporosis in our patients.
l’or each of the groups separately the vectors of means and 
covariance matrices of these four variables were found. Missing 
values were taken account of in the following way. The mean of a 
particular score in a group was found by summing that score over 
all patients in the group and dividing by the number of patients who 
had the score recorded. The variances were calculated by subtracting 
the score mean from each score and using the formula
Var (X^ ) =
n -* 1
r
where X is the score mean
and i summed is over all patients (n) with the score recorded.
The covariance between any two scores was calculated using 
Cov (X^ , Xg ) . V  ) (X^g -  7^ )
m - 1
where i summed over all patients (m) with both scores recorded.
This estimate of the covariance was biased because and ^  
were not the means of their respective scores in this summation group 
but they were the means over all the patients. The correlations 
between two scores which were also calculated were also biased because 
the variances were not the true variances over the summation groups.
These biases should, however, have been small enough to neglect since 
the numbers of patients were quite large and it was hoped that the 
increased precision resulting from better estimates of the means and 
variances more than offset the small bias.
These means, variances and covariances and the correlation 
matrices are given in tables 1:19 ~ 1:22. The means of the bone 
scores and standard aluminium equivalent for the rheumatoid factor 
negative females were larger than those for the corresponding 
rheumatoid factor positive females perhaps suggesting that the 
osteoporosis was correlated with the severity of the disease.
The primary interest was in the correlations of the different 
bone scores and the standard aluminium equivalent throughout the 
groups. There did not, however, seem to be a consistent pattern 
over these groups.
All the correlations were positive. The rheumatoid positive 
females had smaller correlations, on average, than the other three 
groups, the femoral index and clavicular cortical thickness having 
a correlation of only 0 .15» In these other three groups the 
correlations between the bone scores were all greater than 0.$2, 
that of the metacarpal and clavicle always being the largest.
The correlations between the standard aluminiuia equivalent 
and the bone scores did not add further information. They were high 
(greater than 0.77) for the rheumatoid factor negative patients but 
except for the metacarpal in the rheumatoid factor positive, they 
were about 0.3*
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A principle component analysis was carried out on the 
correlation matrices. This was achieved^using a standard N.A.G, 
library routine to calculate the eigenvalues and eigenvectors of 
a real symmetric matrix. The first principal component and 
corresponding principal value are presented in table 1:2$. It 
can be seen that the first principal component has approximately 
equal components in all three groups, suggesting that it is a 
'size' component. So, if a single measure of the patient's 
osteoporotic condition were required an average of the standardised 
scores in the groups is suggested.
The standard aluminium equivalent did not appear to add much 
extra information and since none of the males had this measure 
recorded it was decided not to include the standard aluminium 
equivalent as a parameter in the assessment of the patients * 
osteoporotic condition.
The effect of corticosteroid therapy
To investigate the effect of corticosteroid therapy on the 
patients in the three clinical groups, the groups were further 
sub-divided into corticosteroid and non-steroid treated patients.
If steroid therapy were having an effect on the osteoporotic 
condition of the patient, the mean of the scores for the steroids 
should be significantly lower than those of the nor-steroids.
Female 
R*F.Positive
Maie 
R.F.Positive
Female 
R,F,Negative
2.26 ill 3.22
- .59 - .57 - .51
— . 39 - .58 — *43
— • 38 - .59 — *49
- .59 “ .56
Table 1:23
Principal Value and First Principal Component
The meæis, corresponding correlation and covariance matrices 
were calculated for both the steroid and non-steroid group as before. 
Tables I;24 and 1:25 give details of these. 'Students t* was 
tabulated for the differences in corticosteroid and non-corticosteroid 
treated groups. The rheumatoid factor positive females were the only 
patients who showed a significant effect due to corticosteroid therapy. 
In this group the mean ages of those on therapy and those not were 
approximately the same. The changes in the mean metacarpal and 
clavicular scores give a significant t value at the two per cent 
level while for the femur the difference between corticosteroid and 
non-corticosteroid groups giving significance at the ten per cent 
level. Metacarpal and femoral scores for the corticosteroid group 
became less correlated while the femoral and claviculau’ scores both 
had increased correlation with the metacarpal index.
There were only eleven rheumatoid negative females on corti­
costeroid therapy. For the rheumatoid factor negative female patients 
the metacarpal index score for those on corticosteroid therapy was 
appreciably lower than those not on therapy but the corticosteroid 
treated group had a large standard error. The decrease was not 
significant. Here again a general increase in correlation of bone 
score due to corticosteroid therapy was evident. The metacarpal and 
clavicular scores shewed a correlation of *99 which is probably slightly 
inflated by the fact that there were only six comparisons made. High 
correlations for the bone scores were a feature of the corticosteroid 
group.
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The rheTomatoid factor positive male patients on corticosteroid
therapy were on average 4*3 years older than those not on corticosteroid
therapy. The osteoporotic score correlations were high, those for the
corticosteroid treated patients being slightly lower than those of the
(
non-corticosteroids. Corticosteroid therapy did not appear to be 
having as much effect on the correlations in the males as it did in 
the females. The males did not show an overall significant decrease 
in osteoporotic scores due to corticosteroid therapy.
A principal component analysis was carried out (table 1:26) on 
the correlation matrices and again there was approximately equal 
weighting in the first principal component.
Thus, corticosteroid therapy did seem to be affecting the 
rheumatoid positive females but none of the other groups. The 
rheumatoid factor positive female patients had also much lower bone 
score correlations.
Females 
R,F* Positive
Males
R.P. Positive
Females 
R.P. Negative
Steroid
Hon
Steroid Steroid
Non
Steroid Steroid
Non
Steroid
1.84 1.52 2.4 2.72 2.07
" .59 .68 - .60 - .61 — . 60 - .59
- .93 • 59 - .55 - .55 - .55 - .54
— .61 .43 “■ .57 - .57 - .58 - *60
Table 1:26
The Principal Components and Principal 
Component of the Correlation Matrix of 
the male and female corticosteroid and 
non-corticosteroid treated patients 
with rheumatoid arthritis.
Dependence of Osteoporosis on other factors
Other possible factors which might contribute to the 
development of osteoporosis were now studied. This was achieved 
by using a regression analysis on the three clinical groups.
It was decided that an average of the osteoporotic scores 
would be a good indication of the patients general osteoporotic 
condition. The scores were standardised by dividing by their 
standard deviation which was calculated over all patients in the 
group. This measure of osteoporosis enabled the maximum number of 
patients to be included in the regression analysis.
A library regression analysis package was used (FAEAD) with 
the dependent variable the measure of osteroporosis and the 
independent variables expected to be of importance;
(2) age,
(3) duration of arthritis,
(4) functional grade
(5) X-ray classification
(6) Rose Waaler Titre
(7) Erythrocyte sedimentation rate
(8) Receiving corticosteroid therapy or not 
coded by 1 or 0.
In each group a multiple regression model was set up to 
minimise the residual sum of squares i.e. to explain as much of 
the variation as possible.
The first regression was carried out in each group using the 
linear model
Yi=o:-f-pXi + ei Xis the independent variable
a» p are constant 
Y is the dependent variable 
e is the error term
A linear regression was carried out with each of the seven 
variables as the independent variable and that one chosen which 
minimised the residual sum of squares. Now using this variable as 
one independent variable a multiple regression model was posed with 
two independent variables, the second being chosen from the 
remaining six so as to minimise the residual. At each stage a test 
of significance was carried out to ascertain if inclusion of the new 
dependent variable in the regression model made a significant 
reduction in the residual sum of squares. This process was continued 
until the inclusion of a further variable gave no significant 
reduction in the residual sum of squares. The results are presented 
in Tables I;27 - 1:29.
All the patients, except for the rheumatoid factor negative 
patients, showed a highly significant regression on age vri_th the tv/o 
groups of rheumatoid factor positive patients showing a significant 
regression on the duration of the disease having taken account of age,
Age, therefore, seemed to be the most important factor emerging 
from these results with perhaps the duration of the disease being 
important when age has been allowed for. The relationship of age to
Source
Independent variables 
in the model
d.f. Sums of Squares P.
1 44.8 71.4
Residua^ 302 190.0
^4 , ^2 2 52.49 445
Re sidual 301 181.31
^4 A g 1 8.69 14.43
X4 , Xg, 3 56 .2 31.5
Residual 300 178.6
X3.A4 , %2 1 2.71 4.53
X3, x^, Xg, Xg 4 58.2 24.6
Residual 299 176.6
Xg/X^, Xg, Xg 1 2.0 3.39
Table 1:2?
The results of the regression analysis carried out on 
three hundred and four rheumatoid factor positive 
female patients for whom the complete list of 
independent variables was available.
denotes significance at yfo
Source
Independent variables 
in the model.......... ■ d.f. Sums of Squares P.
Residual
1
154
20.9
125.6
**
25.6
X g , Xg 2 24.91 16.2
Residual 153 121.0
1 4.6 5.82 **
Xg, Xg, X3 3 28.91 12.5
Residual 152 117.6 -**
Xg/Xg, Xg 1 3.4 4.39
XgJ Xg, Xg, X^ 4 31.41 10.3
Residual 151 115.1
X/Xg, X3 , Xg 1 2.5 3.26
Table I;28
The results of the regression analysis carried 
out on one hundred and fifty six rheumatoid 
factor positive male patients for whom the 
complete list of independent variables was 
available•
** denotes significance at yja.
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the development of osteoporosis was considered in the rheumatoid 
factor positive males and females tables 1:30 and 1:31* The two 
groups of patients were classified as those receiving and those not 
receiving corticosteroid therapy. Figs. 1:1? to 1:22 give graphical 
descriptions of the tables. Only non-steroid treated males are shoivn 
because there were too few males receiving steroids in the age groups. 
One standard error above and below the mean is indicated on each graph. 
All the graphs show, for the non-steroid group, a fairly constant mean 
cortical width of the particular bone until the patient reaches his 
middle forties, about forty-five and then a uniform deterioration. All 
the graphs show the same effect. This suggests that there is some 
change in the body about this age after which the patient suffering 
from rheumatoid arthritis becomes more osteoporotic as he gets older 
even if he is not on corticosteroid therapy.
In figs 1:17 a^ i^d 1:19 the graphs for the hand and clavicular scores 
on the non-steroid treated groups were similar to those of the steroid 
treated females, except that the graph for the steroid group lies below 
that of the non-steroid group.
Corticosteroid therapy did not have such a marked effect on the 
femur, it happens on two occasions that those on therapy have a larger 
osteoporotic score mean that those not on therapy. It is interesting 
to note that the femur was not as highly correlated to the other two 
bone scores as they were to each other.
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Fig I:  17
The mean and standard e rro r o f the metacarpal index, p lo tte d  against 
age, in  non co rtico s te ro id  and s te ro id  treated female pa tien ts w ith  
rheumatoid a r th r i t is .
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Fig, I :  18 . : , ' : ' '
The mean and standard é rro r o f the femoral index p lo tted  agaihst age 
in  non co rtico s te ro id  and s te ro id  treated female pa tien ts  v/ith 
rheumatoid a r th r i t is .  ; ^
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The rnoan and standard e rro r d f the c la v ic u la r c o r t ic a l thickness in  
non co rtico s te ro id  and s te ro id  treated female pa tients w ith  rheumatoid 
a r th r i t is .
:vV*sV:^ . - \ ■■■ ^
CLAVICULAR 
CORTICAL  
THICKNESS 
(m m)
- -  STEROID 
—  NON STEROID2.2 -
2.0 -
1.8 -
1.6 -
1 .4 -
67574727 3717
AGE -YEARS
Fig I :  20
The mean and standard e rro r o f the metacarpal index in  non co rtico s te ro id  
treated male patients w ith  rheumatoid a r th r i t is .
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Fig I :  21
The mean and standard e rro r  o f  the femoral index In non co rt icos te ro id  
treated male patients w ith rheumatoid a r t h r i t i s .
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The mean and standard e r ro r  o f  the clavicuTar c o r t ic a l thickness 
in  non co rt icos te ro id  treated male patients w ith  rheumatoid f  
a r t h r i t i s .
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Since the change with respect to age took place after age 
forty five, some of the regressions on just those patients who had 
attained that age were repeated.
The observations which were included in the regression model 
as independent variables were
(2) age
(3) duration of the disease
(4-) steroid therapy coded by 1 or 0
The duration of the disease for patients getting rheumatoid
arthritis before they were forty five was modified by assuming, as 
suggested from fig.1:1? to fig,I:22, that the disease only markedly 
affects osteoporosis after the patient reaches forty five. The 
metacarpal index was chosen to be the dependent variable because it 
was now thought to be a more sensitive measure of the osteoporotic 
condition than the previous average of the standardised osteoporotic 
scores.
A linear model was posed for the regression of the metacarpal 
index on variables (2), (5) and (4 ). As expected, the regressions 
on age proved to be highly significant for both males and females.
Now having taken account of age, the regression of the metacarpal
index on duration of the disease and whether or not a patient had
been treated with steroids were calculated. The females showed 
significant regression on steroid therapy but not on the duration 
(Table 1:52 (a) ). The regression on the duration was not significant 
if both age and steroid therapy were talcen account of. In the
Source d*f • Sums of Squares P P
h  . ,
Residual
1
217
.41 xio^ 
2.55 XIO^
34.43 < 0.02
X/Xg .
X4A 2
Residual (X^ ) 
Residual (X^)
X3/X4 . Xg
Residual
1
1
216
216
1
215
•02 XIO^ 
•12 XIO^
2*31 XIO^ 
2.43 Xlo4
2.9
10.6
N,S.
< 0 .0 2
•01 XIO^
2,43 XIO^
.94
Table 1:32 (a)
The regression analysis of the metacarpal index 
on age (Xg), duration of disease (X^ ) and presence 
of steroid therapy (X^) in two hundred and nineteen 
rheumatoid factor positive female patients with 
rheumatoid arthritis*
previous regression analysis the regression on duration was 
significant (after age 43) but this sample included those patients 
under forty-five. The males showed significance on neither steroid 
therapy nor duration of disease (table I:32(b), this may have been 
biased by the fact that there were only 21 males on such therapy and 
ll4 not on therapy.
Since the regression of the metacarpal indices for the females, 
showed as significant for steroid therapy the regression on duration 
of the dose was calculated allowing for both age and the patients 
being on corticosteroid therapy; The regression was not significant 
(table 1:33) which is surprising.
Table 1:34 shows values of the duration of the disease 
tabulated in the different age groups for the rheumatoid factor 
positive female metacarpal indices only. For all osteoporotic 
indices within a specified duration of the disease there was a 
definite trend of decrease but within any age group the duration 
of the disease did not have any trend. This table may not be a 
completely fair representation as there were more patients available 
for comparison in cells along the diagonal.
Age, therefore, seemed to be the most important single factor 
determining the osteoporotic status of patients of both sexes. The 
results showed a definite increase in the severity of osteoporosis 
in patients over forty-five. Allowing for age, steroid therapy 
appears to contribute to the development of osteoporosis in the 
rheumatoid positive females over forty-five.
Source d.f. Sums of S-iuares P P
X2
Residual
1
133
.18 XIO^
1.58 XIO^
15.2 <0.02
X4A 2
X3A 2
Residual (X^ ) 
1 Residual (X^ )
1
1
132
132
.003 XIO^
,004 XIO^ 
1.577 XIO^ 
1.576 XIO^
.24
.24
N.3.
N.S.
Table 1:32 (b)
The regression analysis of the metacarpal 
index on age (Xg), duration of disease (X^) 
and presence of steroid therapy (X^ ) in one 
hundred and thirty five rheumatoid factor 
positive male patients with rheumatoid 
arthritis*
Source d.f. Sums of Squares F P
1 .03 XIO 2.7 N.S.
Residual 215 2.40 XIO
Table 1:33
The regression analysis of the metacarpal index on 
the duration of the dose of corticosteroid therapy 
(Xp), allowing for age (Xg) and presence of steroid 
therapy (X^ ) in the female patients with rheumatoid 
arthritis.
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Discussion
The evidence available from this study of rheumatoid arthritic 
patients suggested that osteoporosis in rheumatoid arthritis was 
directly linked to the age of the patient. The two groups of major 
concern, the rheumatoid positive males and females, showed a change 
in the development of osteoporosis in patients after they were forty 
five. The osteoporotic condition of the patients, as measured by the 
means of cortical thickness of three bones, the metacarpal, the 
femur and the clavicle, was found to be fairly constant for those 
patients under forty five and then to decrease linearily with age.
Those rheumatoid factor positive females over forty five who 
had received corticosteroids were significantly more osteoporotic 
than those who had not (taking into account the development with age), 
In fig 1:17 - Fig 1:19 this development of osteoporosis can be seen 
for steroid and non-steroid groups, those receiving steroids showed 
basically the same trend as those not receiving therapy except that 
the mean osteoporotic scores (for metacarpal and clavicle) were all 
slightly smaller. The femur did not give such a marked difference as 
the other two bones but the femur was shown not to be as highly 
correlated with the other osteoporotic scores in the steroid treated 
females as the scores were with each other. The question which must 
be asked on consideration of these gra.phs is whether those patients 
given steroids were more osteoporotic, in the first instance, than a 
patient of an equivalent age not given this therapy. In the first 
set of regressions for this group, however, the severity of the 
disease as measured by functional grade and X-ray classification
were not significant. The duration of disease was not significant 
when age was taken into account and duration of steroid therapy not 
significant when age and a patients being on corticosteroid therapy 
were eliminated.
The rheumatoid factor positive males given steroid therapy were 
not found to be more osteoporotic than those not on therapy. The 
crude difference between the three osteoporotic scores for these 
groups was more than offset by the natural development of 
osteoporosis with age. This might explain the very low F ratio for 
the significance of steroids eliminating age (table 1:32).
study B
PREDICTION OP OSTEOPOROSIS
As far as I am aware no-one has attempted to predict the degree 
of osteoporosis which would he expected in a patient with rheumatoid 
arthritis. I therefore decided to study patients who had been 
documented some years before and whom I was able to reassess at a 
later date. Could I evolve a statistical procedure whereby I could 
determine whether a patient had more extensive osteoporosis than 
expected from the clinical and laboratory features of the arthritis? 
That is the question which this section of the chapter attempts to 
answer.
METHOD M D  MATERIALS
Patients were selected at random from patients seen at the 
Centre for Rheumatic Diseases between the years 19^5 to I968.
Since the greatest changes in osteoporotic indices had been noted 
to occur around the age of 45 years, the patients studied were 
selected from the age group 55 to 60 years. In this way it was 
hoped to maximise change in the osteoporotic indices.
All patients studied satisfied the diagnostic criteria of the 
American Rheumatism Association for "definite” or "classical” 
rheumatoid arthritis (Ropes et al 1959)» There were 26 males with 
a mean age of 47«7 years (- S.D. 4*5> range 38 to 55) of -whom six 
were receiving oral corticosteroid therapy, and 29 female patients 
with a mean age of 46 .8 years (- S.D. 5*0, nange 35 to 70), of whom 
thirteen were receiving oral corticosteroid therapy. Relevant 
clinical and laboratory details of these patients at the beginning 
and end of the study are shown in Table 1:55*
Each patient had three osteoporotic indices measured: 
metacarpal, and femoral indices (Barnett and Nordin I960), and 
clavicular cortical thickness (Anton 1969). These measurements 
were made twice. The mean time interval between the two measurements 
for male patients being 6 .5 - S.D, 1.3 years and for females
8 .7 - 1.5 years.
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RESULTS
When the clinical and laboratory data obtained at the outset 
and at the termination of the study are compared (Table 1:35) ft can 
be seen that for male patients there was a significant improvement in 
the functional grade (Steinbrocker, Traeger and Batterman 1949) end 
the serum albumin levels, but a significant deterioration in the 
metacarpal index. In the female patients there was a significant 
improvement in serum albumin, and a reduction in titre of rheumatoid 
factor which was barely significant. Both the metacarpal index and 
clavicular cortical thickness measurements showed significant 
deterioration in the female patients.
Initially regressions were carried out of change in 
osteoporosis measurements against the time elapsed between the two 
measurements. None of these were statistically significant, but this 
is not surprising when it is noted that there is little variation in 
the time interval between observations. To avoid this problem it was 
assumed, not unreasonably, that the regression line of change in 
measure against change in time passed through the origin. With this 
model, the regressions were recalculated. As before, only patients 
reaching ages over 40 years by the time of the second observation 
were considered and the duration was taken to be the actual interval 
of time less any time spent below aged 40 years.
The patients were divided into four groups determined by sex 
and whether or not the patient was receiving corticosteroid therapy.
The regression model y = (3>c was fitted on each of these four groups 
separately, where y is the change in osteoporotic score and X is change
in time. The coefficient p was estimated by least squares to be 
p = x'xy/l with standard error e where is the residual
mean square about the regression line,   (Zxy)^/Zx^
The estimates of p, together with their standard errors are shown 
in Table 1:36. In all cases it can be seen that the gradients are 
negative, that is, on average the osteoporotic scores are decreasing 
in time. However, it is only for the metacarpal index that these 
gradients are significantly different from zero and even here, the 
gradient for the male steroid group (which had a small sample size) 
was not significant. The gradients of the metacarpal index in the 
four groups are fairly similar, except for the female steroid group 
but none of the between group differences are statistically significant.
The question then arises of trying to predict the change on the
metacarpal index of a patient over a period of say y.o years, (The
other indices were excluded from further consideration as their 
gradients were not significantly different from zero), A point
9
estimate of the change in index is given by yo =
but of course there is an associated standard error a
For small values of oto this will be approximately a. Table 1:37
gives values of the predicted change on the index and its standard
error over various periods of time. It can be seen that the
predicted changes have high standard errors, indeed it is only over
the 15 and 20 year periods that the predicted change exceeds twice
its standard error. Thus there is a high variability about the trend
line.
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As indicated earlier these conclusions are based on patients 
aged between 40 and 50 years of age who were followed for periods 
of approximately 8 years. Thus, the predictions over the 15 and 20 
years periods are extrapolations.
DISCUSSION
In the final part of this study I have attempted to answer 
the question: can one, knowing the clinical features of the
arthritis and whether or not the patient has had corticosteroid 
therapy, predict what the degree of osteoporosis will he over a 
period of time? Certainly the study has shown that osteoporosis 
develops over a period of time, hut the statistically predicted 
degree of osteoporosis has a very high standard error and 
consequently any prediction must have a high degree of error. This 
is probably due to the marked variation in clinical activity of 
arthritis which can occur during two points in time, as illustrated 
schematically in Fig, 1:23. In this respect it is interesting that 
although improvement occurred in several clinical and laboratory 
parameters in both male (functional grade and serum albumin 
concentration) and female patients (functional grade, haemoglobin and 
serum albumin concentrations, erythrocyte sedimentation rate, and 
titre of rheumatoid factor), osteoporosis continued to develop, especially 
in females. It would be necessary to measure ‘total* disease activity 
over a period of time if more accurate prediction of osteoporosis was 
to be obtained. This conceivably could be done by malcing assessments 
at regular short periods of time e.g. three monthly, although it is 
doubtful whether the results would justify the effort and time 
involved.
:Figkii^ 23: y y:;. .,'v ' , y:' ; y'/.
Schematic diagram o f possible var ia tions in  the a c t iv i t y  o f  
rheumatoid a r t h r i t i s  occurring beiÿ/een two points in time.
Possible variations in disease activity occurring 
between two points in time.
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I deliberately chose patients around the age of 45 years 
where change in osteoporosis was likely to be most marked. 
Presumably, therefore, if much younger or older patients had been 
studied the error in prediction would probably have been even 
greater. Only a very gross statistical outlier could be identified 
and it is quite probable that the variable responsible e.g. 
osteomalacia would be clinically apparent otherifise.
In summary, it must be concluded that although the degree of 
osteoporosis developing in a patient with rheumatoid arthritis can 
be predicted statistically, the margin of error was too great for 
it to be clinically meaningful.
SUMMARY
The results of the studies in this chapter on radiological 
osteoporosis in rheumatoid arthritis show that:
1. Bone mass as measured by the metacarpal index is
significantly decreased in both male and female 
patients compared to age and sex-matched normal 
subjects.
2, Bone mass falls significantly with duration of
disease.
3. Female patients over 43 years of age have significantly
more osteoporosis than those under 45 years, but this
trend is not present in male patients.
4, The sex of the patient in itself did not appear to be
a significant determining factor in bone loss 
occurring in patients with rheumatoid arthritis.
3. Female patients over 43 years of age treated with
corticosteroids had significantly more osteoporosis 
than those females over 43 years not so treated.
6. Corticosteroid therapy did not more severely affect
female patients over 43 years of age than those under 
that age.
7. Both femoral indices and clavicular cortical thickness
measurements show significant reduction in patients 
with rheumatoid arthritis of both sexes compared to 
normal values.
8. Correlation coefficients and concordance/discordance
analysis of the three indices of osteoporosis suggests 
that osteoporosis occurring in rheumatoid arthritis is 
a generalized phenomenon.
9. A predictive index of the development of osteoporosis in
rheumatoid arthritis was determined, but the margin of 
error was tco great to give clinically meaningful 
prediction.
CHAPTER I I
STUDIES OF CALCIUM METABOLISM IN RHEUMATOID ARTHRITIS
INTRODUCTION
Having established tha t rad io log ica l evidence o f osteoporosis 
was widespread in rheumatoid a r t h r i t i s ,  the question arose as to 
why th is  bone loss occurred. Osteoporosis resu lts  when bone 
resorption exceeds bone formation, ir respect ive  o f the rate o f 
each. Bone formation is  a function o f osteoblast a c t iv i t y  and 
bone resorption usually o f osteoclast a c t iv i t y .  There is ,  however, 
evidence th a t bone resorption may occur in the absence o f 
os teoc lasts , and be mediated by endothelia l ce l ls  (Cameron, 1961), 
mast c e l ls  ( G o l d h a b e r ,  1965; Frame and Nixon, 1968) and osteocytes 
(Meunier, Bernard and Vignon, 1971), and such fac tors  may be 
important in pathological states such as rheumatoid a r t h r i t i s .
The study o f  bone formation and resorption (osteoblast and 
osteoc last func tion ) a t molecular level is  extremely complex, but 
i t  is  possible to make certa in  in d ire c t  measurements in the c l in ic a l  
s i tu a t io n .  The in troduc tion  to th is  chapter provides a background 
to some o f the in ve s t ig a t ive  procedures which were employed to 
study the biochemistry and endocrinology o f bone metabolism in 
pa tien ts  w ith rheumatoid a r t h r i t i s .  In th is  in troduction  i t  w i l l  
be apparent th a t considerable time is  devoted to o u t l in in g  and 
discussing some o f these procedures, p a r t ic u la r ly  those re la t ing  
to the serum calcium fra c t io n s  and th e i r  derived values. This 
s e le c t iv i t y  is  f e l t  necessary in view o f the heavy dependence of 
the data in  the chapter on these same c r i t e r ia .
CALCIUM METABOLISM
Calcium is  the f i f t h  most common element in the human body, 
and accounts fo r  approximately 1300 g. i .e .  1.9 per cent, o f an 
average 70 Kg, man (Nordin, 1976). Nearly a l l  the calcium present 
in  the body is  present in bone, and constitu tes ju s t  over 20 per 
cent o f the wet weight o f  bones in the adult (Woodard, 1964).
The National Food Survey (1973) considered tha t the mean 
calcium intake per day was of the order o f 1 0 0 0  mg. per person, 
and Nordin (1976) considered tha t 95 per cent o f the U.K. population 
consumed 500 to 1500 mg. o f calcium per day. The p r inc ipa l source 
o f  d ie ta ry  calcium is  m ilk , which accounts fo r  approximately 50 
per cent o f  the to ta l  d a ily  calcium (Nordin, 1976).. The net 
calcium absorption from the ga s tro - in te s t in a l t ra c t  is  approximately 
25 to 30 per cent o f the d ie tary  intake (Nordin, 1976). The 
measurement o f true calcium absorption from the g a s tro - in te s t in a l 
t ra c t  is  complicated by the fa c t  tha t faecal loss o f calcium 
includes not only unabsorbed d ie tary  calcium but also loss of 
calcium in the d igestive ju ices . The magnitude o f endogenous 
faecal calcium loss has been estimated to be between 76 and 
260 mg. per day in normal subjects (Melvin, Hepner, Bordier,
Neale and Jo p l in ,  1970; S a v i l le ,  1973). Calcium absorption is  
measured in c l in ic a l  p ractice  by a sing le or double isotope 
method. In the former a dose o f radioactive calcium is administered 
in  a calcium c a r r ie r ,  and blood levels o f ra d io a c t iv i ty  are 
monitored over a period o f time. In the la t t e r  procedure two
d i f fe re n t  calcium isotopes are administered, one o ra l ly  and the 
other in travenously. The rate o f absorption from the gastro­
in te s t in a l  t ra c t  is  measured by the difference between the spec if ic  
a c t iv i t ie s  o f the two isotopes in plasma. There is  a progressive 
reduction in calcium absorption in normal persons with advancing 
age, and th is  is  espec ia lly  so in the female, perhaps due to 
reduced oestrogen leve ls (Nordin, 1973). Increased calcium 
absorption is  often present in  primary hyperparathyroidism 
(Hodgkinson, 1963; Stanbury, 1968; Sjoberg, 1970), id iopa th ic  
hypercalc i u r ia  (Henneman, Benedict, Forbes and Dudy, 1968; Libermann, 
Sperling, Atsmon, Frank, Modan and De Vries, 1968; Caniggia, Gennari 
and Cesari, 1965; Nordin, Peacock and Wilkinson, 1972), 
hypervitaminosis D and may also be present in sarcoidosis 
(Anderson, Dent, Harrer and P h ilpo t,  1954; Henneman, Dempsey, Carrol 
and A lb r ig h t ,  1956; Reiner, Sigurdsson, Nunziata, M alik , Poole and 
J o p l in ,  1976).
The normal excretion rate o f calcium in the urine is  less than 
8  mmols per day, 20  per cent o f  the calcium being ionised and the 
remainder complexed (Fourman and Royer, 1968). The urinary 
excretion o f calcium is  depressed with chron ica lly  low d ie tary 
calcium (Nordin, Hodgkinson and Peacock, 1967), advancing age 
(Davis, Morgan and R iv l in ,  1970; Bulusu, Hodgkinson, Nordin and 
Peacock, 1970; Nordin, 1973) and renal fa i lu re  (Cochran and 
Nordin, 1971; Morgan, 1973). Urinary calcium excretion is  greater
in  males due to th e i r  greater body weight (Nordin, e t a l ,  1967), 
but the sex d iffe rence disappears when calcium is re la ted to 
crea tin ine  (Bulusu, e t a l ,  1970). During the summer months in 
some climates there is  increased calcium excretion in the urine, 
probably due to u l t r a v io le t  synthesis o f vitamin D resu lt ing  in 
an increased absorption o f calcium from the g a s tro - in te s t in a l 
t r a c t .  There is  a diminution in  urinary calcium excretion w ith  
exercise (Nordin, e t  a l ,  1967), Prolonged bed rest or 
immobilisation causes a marked increase in the ur inary  excretion 
o f  calcium (Whedon and Shorr, 1957), which does not appear to be 
due to increased in te s t in a l  absorption of calcium (Nordin, e t a l ,  
1967) and re s t r ic t in g  d ie ta ry  calcium does not influence th is  
phenomenon (Howard, Parson and Bingham, 1945), Whedon and Shorr 
(1957) considered th a t the fundamental cause o f hyperca lc iu ria  
occurring w ith  immobilisation was due to the absence o f weight 
bearing on bones.
Fourman and Royer (1968) estimated tha t the f i l t e r e d  calcium 
load at the renal glomerulus was approximately 225 mmols per day, 
and tha t approximately 215 mmols o f th is  was reabsorbed by both 
the proximal and d is ta l  tubules. Intravenous in fus ion o f calcium, 
increases calcium concentration in the glomerular f i l t r a t e ,  and 
i t  is  believed th a t approximately h a l f  o f  th is  increase is  
excreted in the urine (Peacock, and Nordin, 1968; Peacock, 
Robertson and Nordin, 1969). I t  is  not possible to determine the 
calcium " th resh o ld " ,  o r tubu lar maximum reabsorption o f calcium 
(TmCa) because there is  an upper l im i t  to which the plasma calcium
level can be raised which is  compatable with l i f e .  Nevertheless, 
Marshall, Peacock and Nordin (1973) have calculated a theore tica l 
TmCa by ex trapo la ting  from data obtained from calcium infusions in 
normal subjects and patients with osteomalacia. The TmCa is best 
expressed in m.mol/l o f  glomerular f i l t r a t e  as th is  excludes 
va r ia t io n  due to d ifferences in renal mass and as TmCa/GFR is more 
appropriate than the absolute TmCa (Nordin, 1976). Tubular 
reabsorption o f  calcium is  a h igh ly  complex process and can be 
calcu la ted from the d iffe rence between f i l t e r e d  and excreted 
calcium i f  both are expressed in the same un its . Thus,
Cp = Cap + Ca^
where Cap = F i l te re d  load o f calcium
Ca^ = Excreted calcium
Ca^ = Reabsorbed calciumR
Tubular reabsorption can be obtained from p lo t t in g  the plasma 
calcium against Cap, and normal ranges have been derived (Nordin, 
1976).
In c l in ic a l  p ractice  the urinary ca lc ium /creatin ine (Ca/Cr) 
ra t io  obtained while the subject is  fas t ing  has proved a 
convenient method fo r  estimating increase in net bone resorption. 
The ra t io  may be elevated in normal post-menopausal females, 
hyperparathyroidism and conditions associated w ith  hypercalcaemia 
provided renal fa i lu re  is  not present (Nordin, Horsman and Aaron, 
1976). I f  calcium absorption and/or intake is  excessive an
increased Ca/Cr ra t io  may derive from the previous day's absorbed 
calcium even a f te r  a 12 hour fa s t ,  especia lly  so, i f  the GFR is  
reduced since th is  would delay excretion of absorbed calcium 
(Nordin, e t  a l , 1976).
SERUM CALCIUM
Rona and Takahashi (1911) showed by passing plasma through a 
protein-impermeable membrane tha t plasma calcium consisted o f a 
protein-bound n o n -d if fu s ib le  fra c t io n  and a free d i f fu s ib le  
f ra c t io n .  This confirmed the hypothesis o f a free and p ro te in -  
bound fra c t io n  o f  serum calcium proposed some fo r ty  years e a r l ie r  
by Pribam (1871). Following the observations o f Rona and Takahashi 
there was uncerta in ty as to the nature o f the prote in-b ind ing and 
composition o f  the d i f fu s ib le  f ra c t io n  (Neuhausen and Marshall, 
1922; Greenberg and Greenberg, 1932; Thomson and C o l l ip ,  1932; 
Tendeloo, 1936) u n t i l  the c lass ica l experiments o f McLean and 
Hastings (1934, 1935a, 1935b). These workers established the f i r s t  
acceptable d ire c t  measurement o f serum ionised calcium employing 
an iso la ted  fro g 's  heart preparation. They also showed tha t the 
f ro g ’ s heart responded only to the ionised calcium, but not to 
protein-bound or complexed calcium (McLean and Hastings, 1935a, b). 
In a d d it io n , McLean and Hastings showed that there was a l in e a r  
re la t io n sh ip  between serum calcium concentration and serum protein 
le v e ls ,  and from th is  they constructed a nomogram from which serum 
ionised calcium could be derived given the values fo r  to ta l 
serum calcium and prote in concentrations.
It) j
I t  is  nov^  recognised tha t serum calcium exists in three 
fra c t io n s : approximately 50 per cent is  ionised, 40 per cent is
prote in  bound, and 10 per cent is  ligand bound. The measurement, 
there fore , o f the to ta l  serum calcium can at best be only useful 
as a d iagnostic screening te s t ,  since although the concentration of 
ionised calcium corre lates reasonably well w ith the to ta l  serum 
calcium (Ladenson and Bowers, 1973) elevation or diminution o f 
ionised calcium, may occur in the presence o f a normal to ta l  serum 
calcium concentration (McLean and Hastings, 1935b; Walser, 1962; 
P i t t in g e r ,  Chang and Faulkner, 1971; Ladenson and Bowers, 1973) 
(Table I I : I ) .  The serum ionised calcium is ,  as McLean and 
Hastings demonstrated the phys io log ica lly  important f ra c t io n  of 
serum calcium and i t s  measurement is  therefore o f great importance.
The calcium in blood which is  bound to prote in is  mostly in 
the form o f calcium albuminate (Pfordte and Ponsold, 1971;
Pedersen, 1972e; Van Slyke, Hastings, H i l le r  and Sendroy, 1928), 
Albumin accounts fo r  90 per cent o f prote in-b inding at pH 7,4 
(Pedersen, 1971b, 1972 a-c, e). The e f fe c t  o f changes in pH on 
calcium pro te in -b ind ing has been long established namely tha t 
increases in pH cause increase in protein binding both in vivo 
and in  v i t r o , and conversely decreases in pH reduces protein 
binding (Moore, 1970; Seamonds, Towfighi and Arvan, 1972), Prasad 
and FI ink (1957) suggested tha t pCOg and bicarbonate have greater 
e ffec ts  on calcium prote in-b ind ing than changes in pH, but 
Pedersen (1971a) c le a r ly  showed tha t there was up to a 20 per cent
Condition'
Effect on 
ionised calcium
Effect on 
total calcium
Acute acidosis Elevated Normal
Chronic acidosis Hormal Decreased
Acute alkalosis Decreased Normal
Chronic alkalosis Formal Elevated
Hyperparathyroidism Elevated Elevated
Hypercalcaemia of malignancy Elevated Elevated
Vitamin D 'poisoning* Elevated Elevated
Hypoparathyroidism/tetany Decreased Decreased
Renal failure Variable Decreased
Table II: I
Effect of various conditions on serum ionised and total calcium 
concentrations.
change in calcium prote in-b ind ing with a change in pH from 7 to 8 
and th is  was independent o f the mechanism of the pH change, Decrease 
in p ro te in -b ind ing o f calcium has also been observed with decrease 
in  temperature (Toribara, Terepka and Dewey, 1957; Munday and Mahy, 
1964; Robertson and Peacock, 1968; Pedersen, 1969), The albumin
s ite s  fo r  binding o f calcium may be competed fo r  by other ions,
such as magnesium (Pedersen, 1969; Pedersen, 1972b). However, only 
changes in pH have been shown, as y e t ,  to have any po ten tia l c l in ic a l  
relevance. I t  is  o f in te re s t ,  however, tha t Gosling, Robinson and 
Sammons (1975) have shown tha t during haemodialysis ionised calcium 
f e l l  and bound calcium increased. Although there was a r ise  in 
blood pH they could not explain these changes in serum frac tions  as
being so le ly  due to the pH change.
I t  is  s t i l l  uncertain what the re la t iv e  strengths o f calcium 
binding are to d i f fe re n t  g lobu lin  fra c t ions . Early work (Gutman 
and Gutman, 1937; Drinker, Green and Hastings, 1939; Rawson and 
Sunderman, 1948; Prasad and FI ink , 1958) showed considerable 
va r ia t io n  in  calcium binding a f f i n i t y  w ith in  the various g lobulin  
f ra c t io n s ,  and there was l i t t l e  evidence o f binding of calcium to 
gamma g lo bu lin .  Held and Freeman (1964) found no s ig n i f ic a n t  
d ifferences between binding o f  calcium to albumin, alpha and beta 
g lo b u lin , and confirmed very l i t t l e  binding to gamma^globulin,
Pfordte and Ponsold (1971) studied calcium binding to u l t r a c e n t r i ­
fugated preparations o f d i f fe re n t  proteins and showed tha t beta 
g lobu lin  bound more than the other g lobulin  frac t ions  and between 
3.7 to 6.5 times more than albumin. Unfortunately ne ither Held
and Freeman (1964) nor Pfordte and Ponsold (1971) mentioned the 
ionised calcium concentration at which th e i r  studies were carried 
out, and the l a t t e r  authors fa i le d  to provide evidence o f 
sa tu ra t ion  o f  binding capacity o f  serum proteins at a level of 
to ta l  serum calcium o f 25 m.mol/l.
The protein-bound serum calcium in normal subjects has a 
mean value o f  about 1 m.mol/l, (Dale and Kellerman, 1967; Raman, 
1971, Putman, 1972). C learly  changes in to ta l serum calcium may 
be expected i f  there are marked a lte ra t io n s  in concentration of 
serum pro te ins , p a r t ic u la r ly  albumin. However, i t  is  not ye t 
c lea r exactly  what e ffec ts  changes in serum prote in concentration 
have on the level o f  to ta l  serum calcium and on the protein-bound 
and ionised fra c t io n s .
There are fou r case reports in the l i te ra tu re  o f patients with 
dysproteinaemias or m u lt ip le  myeloma who had increased to ta l serum 
calcium concentrations due to abnormal binding o f calcium to 
abnormal plasma pro te in  (Glueck, Wayne and Goldsmith, 1962;
Lingarde and Z e t te r v a l l ,  1973; Soria, Soria, Dao, James, Sousser 
and B iIsk i-P asqu ie r, 1976). However, to date there is  l i t t l e  
other evidence to suggest tha t th is  type o f anomaly is  in  any way 
common. In hepatic c ir rh o s is  c o n f l ic t in g  resu lts  have been found. 
Thus, Adamski and Smarz (1969) found increased calcium p ro te in - 
binding and a decreased ionised calcium concentration, whereas 
Moore (1971) found decreased prote in-b ind ing and increased ionised
calcium in pa tien ts  w ith  the same disease. In an extensive study 
Pedersen (1972e), as might be expected, concluded tha t patients 
w ith hypergammaglobulinaemia exh ib ited a decrease in calcium binding 
per gram o f serum p ro te in , and tha t th is  decreased progressively 
as the garma g lobu lin  concentration rose. This decrease o f 
binding occurred ir respec t ive  o f  whether the hypergammaglobulinaemia 
was d if fu se  or monoclonal.
CORRECTION OF SERUM CALCIUM FOR HYPOALBUMINAEMIA
Changes in  concentration o f serum pro te ins , espec ia lly  
albumin, have a marked e f fe c t  on the to ta l serum calcium 
concentration. As s ta ted, attempts have been made to correct the 
serum calcium concentrations fo r  changes in serum prote in leve ls , 
and, indeed, as fa r  back as 1935 McLean and Hastings introduced 
th e i r  nomogram fo r  th is  purpose. Payne, L i t t l e ,  Williams and 
M ilner (1973) studied 200 consecutive serum specimens sent to 
a biochemistry laboratory fo r  " l i v e r  function te s ts " .  These sera 
showed a wide range of abnormal protein concentrations. The 
authors found tha t the to ta l serum calcium concentration corre lated 
c lose ly  w ith albumin leve ls  ( r  = 0.867), but less c lose ly  w ith 
to ta l  p ro te in . They suggested a simple formula fo r  adjusting 
calcium concentration derived from the regression equation o f 
calcium on albumin.
Adjusted calcium = calcium -  albumin + 4.0, where calcium is  
in  mg./lOO ml. and albumin mg./lOO ml. Using th is  formula Payne 
e t al (1973) found tha t 95 per cent o f the serum calcium
concentrations a f te r  adjustment fo r  regression o f  calcium on albumin 
were id e n t ica l w ith  the l im i ts  of the normal range in healthy 
in d iv id u a ls . The Gaussian d is t r ib u t io n  o f corrected serum calcium 
values suggests tha t any skewing w ith d iagnos tica lly  s ig n i f ic a n t  
calcium values is  minimal (Cook, Levell and Payne, 1970). I t  is  o f 
in te re s t  tha t the regression c o e f f ic ie n t  o f calcium on to ta l prote in 
obtained by Payne e t al (1973) (0.689) was o f the same order (0.676) 
obtained by Dent (1962) based on serum calcium and plasma spe c if ic  
g ra v ity .  The regression c o e f f ic ie n t  o f calcium on albumin obtained 
by Payne e t al (1973) was considerably higher, however, (0,989) than 
th a t (0.707) obtained by O rre ll (1971) on some 945 serum specimens, 
but o f  the same order as th a t obtained by Jones, Peters, Morgan, 
Coles and Mai l i c k  (1967) and Cockel, Kendall, Becker and Hawkins 
(1971) in sera from patients with a va r ie ty  o f disorders in fluencing 
serum prote in  concentrations, such as malabsorption, hepatic 
c i r rh o s is ,  m a lnu tr it io n  and rheumatoid a r t h r i t i s .  The lower 
regression c o e f f ic ie n t  obtained by O rre ll (1971) fo r  calcium on 
albumin may have been due to inc lus ion o f sera from patients with 
nephrotic syndrome. In th is  condition there is  evidence that 
pa tien ts  may have higher calcium concentrations (Jones, Peters, 
Morgan, Coles and M a ll ick , 1967) than patients w ith s im i la r  levels 
o f  serum albumin possibly due to the presence o f other abnormal 
serum proteins which more e f fe c t iv e ly  bind calcium than albumin 
(Pedersen, 1972e). In add it ion , i t  is  possible, as suggested by 
Payne e t al (1973), tha t patients studied by O rre ll (1971) may 
have included some with hypercalcaemia due to other causes. At 
zero albumin concentration the in te rcep t on serum calcium found by
Payne e t al (1973) was 1.43 m .m ol/l, which corresponds to the u l t r a -  
f i l t e r a b le  calcium concentration. This value is  close to tha t 
reported by others (Robertson, 1969; Pedersen, 1970; Rose, 1972), 
but lower than th a t found (1.70m.mol/1) by O rre ll (1971), The 
formula which Payne e t al (1973) proposed was based on correction to 
the mean serum calcium concentration ra ther than the mean serum 
albumin concentration, because the between-batch co e ff ic ie n ts  of 
va r ia t io n  at normal serum calcium concentration were 1 . 2  per cent 
fo r  calcium but 3.5 per cent fo r  albumin.
I t  is  o f  in te re s t  th a t in the same ed it ion  o f the B r i t is h  
Medical Journal Berry and his colleagues (Berry, Gupta, Turner and 
Burns, 1973) came to s im i la r  conclusions and recommended a correction 
fa c to r  o f 0.023 m.mol/l. change in  calcium fo r  each 1 g/1 change in 
albumin. Berry e t al (1973) also validated the correction fo r  
sp e c if ic  g ra v ity  (Dent, 1962) but recommended a more exact adjustment 
o f  0.23 mg. o f calcium per 100 mis. fo r  every 0.001 change in 
s p e c if ic  g ra v ity .
The publications o f these two papers sparked o f f  a l i v e ly  
correspondence in  the B r i t is h  Medical Journal and C lin ica l Chemistry. 
Sanderson (1974) could not understand why he obtained d i f fe re n t  
corrected serum calcium leve ls using the formulae proposed by 
Berry e t  al (1973) and Payne e t al (1973). These differences arose 
as a re s u lt  o f  d ifferences in the reference values fo r  serum albumin, 
which were 46g/l and 40g/l respective ly . However, i t  is  important to 
note tha t the regression co e ff ic ie n ts  o f to ta l plasma calcium on
IkU
albumin derived by both these groups were very s im ila r  (Berry, Dent, 
Flynn, Gupta and Turner, 1974).
P a r f i t t  (1974) c r i t i c is e d  the formulae fo r  correcting serum 
calcium fo r  changes in  serum albumin concentration on the grounds 
th a t these formulae were only accurate i f  the serum ionised calcium 
was normal. He proposed tha t a proportional ra ther than an absolute 
correction be employed and tha t such could be deduced from the 
McLean and Hasting's nomogram (1935a, b). The nomogram refers to 
concentration in water ra ther than plasma, but a computer programme 
to solve the quadratic equation on which the nomogram is based, has 
been w r i t te n  ( P a r f i t t ,  1969). P a r f i t t  (1974) also suggested a more 
complicated proportional co rrec t ion , which he claimed gave more 
accurate correc tion  fo r  changes in protein due to posture (Husdan, 
Rapoport and Locke, 1973) than Dent's o r ig ina l spe c if ic  g ra v ity  
formula (Dent, 1962). The formula proposed by P a r f i t t  (1969) 
assumes th a t 55 per cent o f to ta l  calcium is  d i f fu s ib le ,  w ith a 
reference value o f to ta l  prote in o f 7.2 g./lOO ml. The formula 
proposed was
Corrected calcium = measured calcium/0.55 +
Total Protein/16.
This formula P a r f i t t  claimed agreed c lose ly w ith the nomogram fo r  
calcium values ly ing  between 1.5 and 3,5 m.mol/l.
Payne e t al (1974a) agreed w ith  P a r f i t t ' s  c r i t ic is m  tha t 
s ig n i f ic a n t  errors might be introduced in correcting to ta l  serum
calcium fo r  albumin concentration when the ionised calcium level 
was e i th e r  abnormally high or low. However, they pointed out tha t 
the adjusted values are higher than they should be i f  the ionised 
calcium is  high and lower than they should be when the ionised 
calcium is  low, w ith  the consequence tha t the c l in ic a l  usefulness 
o f  th e i r  correction formula was enhanced. Marshall and Nordin 
(1974), however, took issue w ith  th is  conclusion o f Payne et al 
(1974a) and pointed out tha t w ith a low ionised calcium level the 
adjustment applied is  la rger than i t  should be, whereas w ith a 
raised calcium level i t  is  smaller. Consequently they maintained 
tha t only where the adjustment is  subtracted from the measured to ta l 
w i l l  the enhancement claimed by Payne e t al (1974a) be observed.
This would, argued Marshall and Nordin, only occur i f  the serum 
albumin concentration were higher than normal. Moreover, they 
pointed out th a t when the serum albumin is  low the adjustment must 
be added, so g iv ing  an adjusted to ta l higher than i t  would be with 
a low ionised calcium, and lower than i t  would be w ith a high 
ionised calcium. Marshall and Nordin (1974) recommended the 
McLean-Hastings nomogram as the most appropriate method fo r  allowing 
fo r  changes in  serum pro te in  concentrations "because i t  is  based on 
a proportionate change in to ta l  calcium with protein ra ther than an 
absolute change". An improved nomogram would be based on the serum 
albumin ra the r than the to ta l serum protein concentration, and th is  
these authors have now produced (Hodgkinson and Knowles, 1976). In 
reply to Marshall and Nordin, Payne e t  al (1974b) suggested tha t 
t h e i r  proposed nomogram might be o f more value in determining
non-protein bound calcium, and tha t the correction formula which 
they had proposed was s t i l l  a v a l id  screening procedure.
In 1975 Pain, Rowland, P h i l l ip s  and Duncan challenged the 
concept o f using a correction formula fo r  estimating to ta l serum 
calcium when the serum albumin was reduced. These authors 
c r i t i c is e d  the use o f an "average" regression c o e f f ic ie n t  fo r  
serum calcium on albumin obtained from a pool o f  sera from a large 
number o f  subjects. They found a wide ind iv idua l va r ia t io n  in the 
regression co e ff ic ie n ts  and therefore recommended tha t the 
in d iv id u a l 's  own regression c o e f f ic ie n t  should be established by 
a tourn iquet te s t  which increases the serum protein concentration 
in the veins o f  the constr ic ted  arm (Husdan, Rapoport and Locke, 
1973). Pain e t al (1975) found tha t although the average 
regression c o e f f ic ie n t  fo r  to ta l serum calcium concentration on 
serum albumin concentration was 25 yU.mol. o f  calcium per gram of 
albumin, there was more than a sevenfold va r ia t ion  in regression 
co e ff ic ie n ts  between in d iv id u a ls ,  the 95 per cent f id u c ia l  l im i ts  
being 7 to 53 yU.mol/g. The method which Pain and P h i l l ip s  (1976) 
suggested fo r  determining an ind iv idua l regression c o e f f ic ie n t  was 
to obtain blood a t 0, 5, 10 and 15 minutes with venous occlusion. 
Husdan, Rapoport, Locke and Oreopoulos (1976) c r i t ic is e d  th is  
method proposed by Pain e t al (1975, 1976) on the grounds of 
impractabi1 i t y  in c l in ic a l  practice and on the fa c t  tha t venous 
occlusion over a period o f  15 minutes especia lly  when the hand
ts pumped might re s u lt  in accumulation o f la c t ic  acid and f a l l  in 
pH, w ith a consequent increase in ionised calcium and f a l l  in 
protein-bound calcium. Other correspondents (Payne and L i t t l e ,  
1976; Ramsay and Shelton, 1976; Hodkinson, 1976; Payne, L i t t l e ,  
Williams and M ilne r, 1976) also disagreed with the conclusions o f 
Pain and his colleagues on s im i la r  grounds.
Calcium Binding and Globulins
Hodkinson (1974) questioned the v a l id i t y  o f adjusting fo r  low 
serum concentration when estimating to ta l serum g lobu lin  on the 
grounds tha t hypoalbuminaemia is  frequently associated w ith  
hyperglobulinaemia, and tha t g lobulins may contribute s ig n i f ic a n t ly  
to the p ro te in -b ind ing o f calcium. That th is  occurs in  certa in 
paraproteinaemias.is unquestionable (Glueck, e t a l , 1962; Lingarde 
and Z e t te rv a l l ,  1973; Soria, e t a l ,  1976) but the cases reported 
are very few. However, as pointed out by Payne, e t al (1974a) the 
co rre la t io n  between calcium and to ta l g lobulins is  re la t iv e ly  
weak (0.299 fo r  200 paired sera). Furthermore, as previously 
mentioned the in te rce p t o f the regression l in e  a t zero albumin 
concentration found by Payne e t al (1973) was close to reported 
values fo r  normal plasma u l t r a f i l t e r a b le  calcium. In add it ion , as 
previously mentioned, Pedersen (1972d) estimated tha t less than 
4 per cent o f  normal to ta l  calcium was bound to g lobu lin . Thus, 
the average regression c o e f f ic ie n t  obtained by Payne et al (1973) 
and other workers (Dent, 1962; Robertson, 1959; Pedersen, 1970; 
O r r e l l ,  1971; Rose, 1972; Berry e t a l , 1973) is  not l i k e ly  to be 
serious ly  a ffected by changes in serum g lobulin  concentrations.
The current consensus o f opinion regarding the correction of 
calcium is  in  favour o f employing some formula or nomogram fo r  
routine purposes (B r i t is h  Medical Journal, 1977; Husdan, e t a l , 
1976). However, i t  is  necessary fo r  each laboratory to establish 
i t s  own ranges and c r i t e r ia  fo r  correction . A recent e d i to r ia l  in 
the B r i t is h  Medical Journal (1977) concludes tha t fo r  most c l in ic a l  
purposes "the "corrected" plasma calcium is an adequate measure o f 
ionised calcium, on almost a l l  occasions".
SERUM IONISED CALCIUM
There is  a general agreement tha t ionised calcium is  the 
m etabo lica lly  ac tive  f ra c t io n  o f serum calcium and is  under hormonal 
co n tro l.  I t  therefore fo llows th a t a d ire c t  measurement is  h igh ly 
desirable in  inve s t iga t io n  o f  disturbances o f calcium metabolism.
The f i r s t  workers to measure the serum ionised calcium 
concentration were McLean and Hastings (1934). These authors used 
a bio-assay employing a f ro g 's  heart preparation. Others have also 
employed bio-assay techniques (Paupe, 1955; Yendt, Connor and 
Howard, 1955; Soulie r and Crosnier, 1958), but these have not 
proved as re l ia b le  as the McLean and Hasting's method (Marshall, 
1976). However, the bio-assay procedure is  unsuitable fo r  routine 
labora tory  use, and has been superseded by spectrophotometry and 
se lec t ive  ion electrodes. The la t t e r  method has been most widely 
employed and has been the procedure employed in th is  thes is , There 
has been only one comparative study of the two labora tory methods
(Raman, 1972), and th is  showed a s ig n i f ic a n t  co rre la t ion  ( r  = 0.72, 
c o e f f ic ie n t  o f  determination 51.8 per cent) w ith a tendency fo r  
higher values to be obtained by the spectrophotometric method.
The development o f ion -se lec t ive  electrodes dates back to the 
discovery o f the hydrogen ion se lec tive  glass electrode a t the 
beginning o f the century (Eisenman, Rudin and Casby, 1957). The 
pH electrode is  now a standard piece o f equipment in  most c l in ic a l  
labo ra to r ies . Calcium electrodes, although ava ilab le fo r  several 
decades, were however unsuitable fo r  use in serum because of 
"poisoning" by proteins and because s e le c t iv i t y  fo r  calcium over 
other cations was inadequate (Truesdell and C h r is t ,  1967), The 
major advance in measurement o f  ionised calcium in serum came with 
the development o f ion-exchange calcium electrodes which had a 
high s p e c i f ic i t y  fo r  calcium ions (Ross, 1967). This method has 
enabled accurate measurement o f serum ionised calcium under 
anaerobic conditions using small amounts o f serum.
Measurement o f serum ionised calcium using an ion -se lec t ive  
e lectrode is  fraught w ith  technical d i f f i c u l t i e s  (Moore, 1970).
The pH o f the serum has profound e ffec ts  on u l t r a f i l t r a b le  calcium 
(Toribara, Terepka and Dewey, 1957; Prasad, 1960; token, Havel, 
Gordan and W hitt ing ton , 1960) and a comparable e f fe c t  on the 
electrode measurement o f  ionised calcium (token, e t a l , 1960; Moore,
1970) (Table I I : I ) .  I t  is  therefore important fo r  comparative 
purposes th a t measurement o f serum ionised calcium be carried 
ou t, o r  standardised to a pH o f 7.4 (Watson, 1975). Ion
in te rference obviously may be important when an electrode method is  
used. I f  the serum sodium is ,  fo r  example, increased i t  may 
in te r fe re  w ith  the estimation (Watson, 1975], In c l in ic a l  practice 
the serum sodium concentration is  usually  normal ly ing  w ith in  a 
narrow range and in terference is  therefore uncommon. Although 
th e o re t ic a l ly  other ions may cause d i f f i c u l t i e s  and should be 
considered when measurements are made on pathological specimens, 
fo r  c l in ic a l  purposes serum sodium correction usually su ff ices , 
Temperature may also a f fe c t  measurement (Hansen and Theodorsen,
1971). Thus, fo r  example, in normal sera the ionised calcium 
concentration is  4 per cent lower a t 37^C than a t room temperature 
(Watson, 1975). I t  is  therefore important tha t measurement of 
both sera and standard so lu tion  be performed a t the same 
temperature, preferab ly  at body temperature (Watson, 1975). 
Technological problems may also e x is t  and include va r ia t ion  in 
pressure o f the pump system, sample flow ra te , d r i f t  i n s t a b i l i t y  
and sluggish response (Rushton e t a l , 1973; Watson, 1975],
There is  considerable va r ia t io n  in  the mean values o f serum 
ionised calcium as estimated by the ion se lective method (Table 
I I : I I ) .  However, the in t ra - in d iv id u a l va r ia t ion  is  acceptable; 
(vide in f ra )  Ladenson and Bowers (1973) reported a va r ia t ion  o f 
1.2 per cent. Marshall (1976) found a va r ia t ion  o f 2.5 per cent 
and also found the in te r - in d iv id u a l va r ia t ion  to be 3.7 per cent, 
Robertson (1976) concluded: "The variance o f the ionized calcium
w ith in  and between normal fas t ing  ind iv idua ls  is  very small and
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o f  the same order as the variance o f the ana ly tica l methods by which 
i t  is  measurea''. The day-to-day va r ia t ion  is  no greater than 
0.025 m .m ol/ l,  which is not surpris ing when the level o f serum 
ionised calcium is under hormonal con tro l.
S l ig h t (0.05 m.mol/l) but not s ig n i f ic a n t  d ifferences in 
serum ionised calcium have been noted between the sexes (Walser, 
1961; Hattner, Johnson, Bernstein, Wachman and Brackman, 1970; 
Petersen, 1972d; Husdan, e t a l , 1973], There does, however, appear 
to be a reduction in the serum ionised calcium concentration in 
people over the age o f 60 years (Lingarde, 1972; Marshall, 1976),
With a few exceptions (Moore, 1970; P i t t in g e r ,  e.t a l , 1971), 
most workers have found a good corre la t ion  between the serum 
ionised calcium and the to ta l serum calcium concentration 
(Ladenson and Bowers, 1973), However, i t  has been shown tha t both 
an increased and decreased serum ionised calcium concentration may 
occur in the presence o f a normal to ta l serum calcium level 
(Table 11:1) (McLean and Hastings, 1935b; Walser, 1962; P i t t in g e r ,  
Change and Faulkner, 1971; Ladenson and Bowers, 1973), This 
re in forces the importance o f d ire c t  measurement o f the serum ionised 
calcium wherever possible in any study o f abnormalities in calcium 
metabolism.
REGULATION OF CALCIUM HOMEOSTASIS
Serum calcium is  maintained in health w ith in  re la t iv e ly  
narrow l im i t s ,  and is  the re su ltan t o f the rate a t which calcium 
enters the blood and the rate i t  leaves the blood (Figure 11:1),
As previously mentioned calcium enters the .blood stream by 
absorption from the g a s tro - in te s t in a l t ra c t  and in normal adu lts , 
net absorption is  approximately 6 m.mol per day. The 
net input from,bone is  the d iffe rence between the rate at which 
bone is  being resorbed and the rate at which bone m inera lisa tion  is  
taking place: genera lly  in healthy subjects these two rates are
equal. Net renal loss o f calcium is  the d ifference between the 
to ta l  f i l t e r e d  calcium and the amount o f calcium reabsorbed by 
the tubules. Normally th is  net excretion must approximate to the 
net absorbed calcium from the g a s tro - in te s t in a l t r a c t  (Figure 11:1)
Thus, the three major tissues involved in calcium homeostasis 
in  add it ion  to blood are in te s t in e ,  bone, and kidney. In 
vertebrates calcium homeostasis probably involves a t leas t three 
major serum fa c to rs ,  parathyroid hormone (PTH), ca lc i to n in  and 
vitamin D.
The physio log ica l ro le  o f  PTH is  to raise the plasma calcium 
concentration to  th a t level necessary to maintain normal c e l lu la r  
metabolism, and the parathyroid glands are stimulated by 
hypocalcaemia to produce PTH. The hormone has an action w ith in  
minutes upon the kidney to increase the tubular reabsorption o f 
calcium, so reducing u r inary  calcium loss. PTH also acts very
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ra p id ly  upon the pool o f  calcium, which Is possibly contained In 
"bone f l u i d " ,  to mobilise calcium In to  the blood. In add it ion , 
os teoc las t ic  resorption o f  bone Is stimulated a f te r  serveral hours, 
which resu lts  in bone breakdown and release o f bone mineral.
A f te r  a period o f  one to two days PTH also appears to enhance 
in te s t in a l  absorption o f calcium from the d ie t  via i t s  e f fe c t  on 
vitamin D metabolic pathway. These actions o f PTH are demonstrated 
diagrammatically in  Figure 11:2. In Figure 11:3 the hydroxylation 
steps involved in the conversion of vitamin D to the active 1,25 
dihydroxycholecalc i fe ro l which l ik e  PTH is  involved in maintenance 
o f nom al calcium and phosphate metabolism are ou tl ined . The 1,25 
dihydroxycholecalc i fe ro l has a d ire c t  e f fe c t  upon the rate of 
in te s t in a l  absorption o f  calcium. PTH is  thought to e i th e r  
increase the production or enhance the ac tiva t ion  o f renal 
1-hydroxylase which in  turn causes increased production o f 1,25 
di hydroxycholecalc i f e r o l , thereby exerting i t s  in d ire c t  action on 
the in te s t in a l  absorption o f  calcium (Parsons, 1976).
Where there is  excess secretion o f PTH then the rates o f both 
bone formation and resorption are accelerated, although the la t t e r  
predominates g iv ing r ise  to an overa ll bone loss. In te s t in a l 
absorption o f  calcium is  also increased, which also contributes to 
hypercalcaemia. Although renal excretion o f calcium is  increased, 
the proportion o f the f i l t e r e d  load o f calcium which is  reabsorbed 
by the renal tubules w i l l  also be increased, and so contr ibu te  to 
the hypercalcaemia. The increased excretion of calcium and phosphate 
by the kidney can lead to the formation o f renal stones.
Fig 11:2 ' ' ' y , : - ;  .f"y/; -
Diagrammatic representation of the nidde of action of parathyrpid 
hormone (P.T.H.) on calcium fluxes occurring between the main body 
pools, A + sign indicates an increase in flow due to the effect
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Chemistry o f PTH
Mammalian PTH is  a s ing le  polypeptide chain comprising 84 
amino acids (Brewer and Ronan, 1970; N ia l l ,  Keutmann, Sauer, Hogan, 
Dawson, Aurbach and Potts , 1970). The complete amino-acid sequence 
is  no t, as y e t ,  known fo r  human PTH, but is  known fo r  bovine and 
porcine hormones (Reiss and Canterbury, 1973; Russell, 1976). The 
s tru c tu ra l requirements fo r  b io log ica l a c t iv i t y  has been determined, 
and shown to l i e  in  the f i r s t  32 to 34 amino acids reading from the 
N terminal (Po tts , Murray, Peacock, N ia l l ,  Tregear, Keutmann, Powell 
and Deftos, 1971; Keutmann, Dawson, Aurbach and Potts, 1972), There 
is  some evidence from in  v i t r o  receptor assay systems th a t the amino 
acid a t pos it ion  1 (serine fo r  human and porcine, alanine fo r  bovine 
hormone) is  important fo r  b io log ica l a c t iv i t y  (Potts , e t a l ,  1971).
Biosynthesis and Secretion o f  PTH
In common w ith other hormones, e.g. in su lin  (S te iner, Clark, 
Nolan, Rubinstein, Margoliash, Aten and Oyer, 1969) PTH is  
synthesised as a prohormone, which contains s ix  extra amino acids 
on i t s  N-terminal end, and a fu r th e r  precursor (pre-pro PTH) with 
a to ta l  o f  115 amine acids has also been id e n t i f ie d  in in v i t r o  
studies (Habener, Kemper, Ernst, Rich and Potts, 1975). There is  
evidence tha t PTH is  secreted from the parathyroids as the 1-84 
hormone, but is  cleaved w ith in  minutes of entering the c irc u la t io n  
to  y ie ld  a carboxy-terminal fragment or fragments. These fragments 
comprise about two th ird s  o f the in ta c t  molecule, and when there is
normal renal function the c irc u la t in g  h a l f - l i f e  is  at least ten -fo ld  
longer than tha t o f the in ta c t  hormone (the T| is  approximately 20 
to 40 minutes). In renal fa i lu re  the T| may be several hours. The 
fa te  o f  the cleaved amino terminal one th i rd  is  not ye t known 
(Habener and Potts , 1976), but since th is  is  the b io lo g ic a l ly  active 
f ra c t io n  o f PTH, the relevance o f assaying b io lo g ic a l ly  in e r t  
fragments generated by metabolic cleavage s t i l l  poses»serious 
questions (Z ane lli  and R a ffe rty ,  1976),
Measurement o f PTH
Berson and Yalow (1958), Berson, Yalow, Aurbach and Potts 
(1963), were the f i r s t  to develop a radio-immunoassay fo r  PTH, They 
subsequently suggested tha t PTH in  plasma was possibly heterogeneous 
(Berson and Yalow, 1968). There is  evidence tha t PTH derived from 
the parathyroid glands and PTH in serum may d i f f e r  as a re su lt  o f 
fragmentation o f the hormone e i th e r  w ith in  the gland (Silverman 
and Yalow, 1973) or on i t s  release in to  the blood stream (Habener, 
Mayer, Dee and P otts , 1976). Detailed descriptions o f radio­
immunoassay methods have been published by Arnaud, Tsao and L it t le dyke  
(1971) and Segre, Habener, Powell, Tregear and Potts (1972) and the 
methodology has been extensive ly reviewed by Segre, Tregear and 
Potts (1975) and by Habener and Potts (1976), The b r ie f  ou tl ine  
o f  radio-immunoassay o f PTH which follows is  la rge ly  based on the 
studies o f the above authors. Most immunoassays o f PTH have 
employed bovine PTH and raised antibodies to e i th e r  the whole 
hormone or to fragments o f the hormone. The is o la t io n  in quantity
o f human PTH (Keutmann, B arling , Hendy, Segre, N ia l l ,  Aurbach, 
Potts and O'Riordan, 1974) has made i t  possible to measure PTH 
using human antigen. There are a number o f antigenic s ites  on 
PTH, whether human, bovine or porcine, and antisera raised against 
the in ta c t  hormone are heterogeneous containing antibodies to 
d i f fe re n t  parts o f  the amino-acid chain. Antibodies have been 
raised to both the amino-terminal and the carboxy-terminal 
(B a r l in g , Hendy, Evans and O'Riordan, 1975; Papapoulos, Hendy, 
Tomlinson, Lewin and O'Riordan, 1977) and i t  has been possible 
to show tha t the active  amino-terminal fragment has a short 
b io lo g ica l h a l f - l i f e  o f only a few minutes, whereas the carboxy 
terminal has a h a l f - l i f e  o f  several hours (Bar ling , e t a l ,  1975; 
Papapoulos, e t a l ,  1977). Radio-immunoassays o f PTH in patients 
w ith  hyperparathyroidism have given co n f l ic t in g  resu lts , A 
s ig n i f ic a n t  number o f hyperparathyroid patients having values o f 
PTH w ith in  the normal range (Lequin, Hackeng and Schopman, 1970; 
Arnaud, L i t t le d yke  and Tsao, 1970; Buckle, 1974) in contrast to 
Reiss and Canterbury (1971) who found elevated leve ls o f PTH 
in  a l l  cases o f  hyperparathyroidism. Since antibodies raised 
against PTH are directed against d i f fe re n t  immunological 
determinants, the a b i l i t y  to detect in ta c t  metabolic fragments 
must vary from laboratory to laboratory.
Segre, e t  al (1972) studied the fragments o f PTH measured 
by radio-immunoassay. By using anti sera directed against the 
amino-terminal and carboxy- terminal determinants they were able
to  conclude tha t b io log ica l a c t iv i t y  resided in the amino-terminal 
determinant and tha t the m a jo r ity  o f the c irc u la t in g  hormone was 
in a c t ive . One o f  the paradoxes, however, is  tha t in c l in ic a l  
practice radio-immunoassay methods dependent on antibodies against 
the carboxyl-term inal end o f the molecule apparently give more 
re l ia b le  resu lts  in the diagnosis o f  hyperparathyroidism. The 
reason fo r  th is  paradox may be due to the fa c t  tha t in ta c t  PTH and 
the amino-terminal fragment have very short h a l f - l iv e s ,  whereas the 
b io lo g ic a l ly - in a c t iv e  carboxyl-terminal end of the molecule has a 
longer h a l f - l i f e  (Silverman and.Yalow, 1973). Further work is  
required to characterise the various fragments o f PTH to determine 
th e i r  nature and b io log ica l a c t iv i t y  and to assess th e i r  value as 
diagnostic tes ts . U n ti l  such time as there are standard an ti-se ra , 
radio-immunoassays o f PTH w i l l  probably continue to give c o n f l ic t in g  
resu lts  between d i f fe re n t  labora tories . I t  i s ,  the re fo re , important 
tha t each labora tory  ind ica te  i t s  resu lts  in both normal and 
hyperparathyroid subjects and to record the nature o f the antibody 
employed in the radio-immunoassay.
Calc iton in  was f i r s t  discovered by Copp and his colleagues (Copp, 
Cameron, Cheney, Davidson, and Henze, 1962), I n i t i a l l y  i t  was 
uncertain whether ca lc i to n in  was derived from the thyro id  or 
parathyroid glands, but in  most mammals i t  has now been c lea r ly  
established to be derived from the 'C* ce l ls  o f the thyro id  
(Pearse and Carvalheira, 1967). The stimulus to production and 
release o f  c a lc i to n in  from 'C  ce lls  is  hypercalcaemia and the
hormone has also been shown, in  a bone cu ltu re  s i tu a t io n ,  to in h ib i t  
the resorp tion o f  bone (Friedman and Raisz, 1965; G a il la rd  and 
Thesingh, 1968). Adm in istration o f ca lc ito n in  induces in  mammals 
hypocalcaemia, p ropo rtiona te ly  d is tr ib u te d  between the protein-bound 
and u l t r a f i l t r a b le  fra c t ions  (Gitelman, Kukolj and Welt, 1965), 
hypophosphataemia and hypomagnesaemia (Copp, e t a l ,  1962; Hirsch, 
Voelkel and Munson, 1964; Milhaud, Perault-Staub and Moukhtar, 1965; 
Tenenhouse, Arnaud and Rasmussen, 1965; B e l l ,  Barret and Patterson, 
1966; Robinson, Martin and McIntyre, 1966; Haymovits and Rosen,
1967; Rasmussen, Anast and Arnaud, 1967). Calc iton in  also has a 
number o f  other actions inc lud ing reduction in faecal calcium 
excre tion , increased calcium and phosphate urinary excre tion , 
and reduction in  ur inary  hydroxyproline (Milhaud and Moukhtar, 1966; 
Robinson, e t a l ,  1966; A rd a i l lo u ,  Vuoguant, Milhaud and Richet,
1967; Klein and Talmage, 1968; Hioco, Bordier, M iravet, Denys and 
Tun-Chot, 1969; Pak, Ruskin and Casper, 1969; A ldred, Kleszynski 
and Bastian, 1970; B i jv o e t ,  Veer, De Vries and Van Koppen, 1971).
In add it ion  to producing hyperca lc iu ria  and hyperphosphaturia, 
ca lc i to n in  also causes a d iu res is  w ith increased excretion o f  sodium, 
potassium, c rea tin ine  and bicarbonate (Aldred, Kleszynski and 
Bastian, 1970) and th is  does not seem to be secondary to a 
hypocalcaemic induced secretion o f PTH, since there is  no marked 
change in renal excretion o f c y c l ic  AMP (B ijvo e t,  e t  a l ,  1971). 
However, i t  is  important to note tha t the physiological ro le  of 
c a lc i to n in  in  man, as opposed to i t s  pharmacological a c t io n , is  as 
ye t unclear.
The radio-immunoassay o f CT has proved easier than tha t o f 
PTH. CT has been shown in  d i f fe re n t  species to have 32 amino acids 
w ith  a loop o f  seven amino acids formed by a disulphide bond at the 
amino terminal (Brewer and Ronan, 1970); Schneider and Sherwood,
1974) and the e n t ire  sequence is  essential fo r  b io log ica l a c t iv i t y  
(Potts and Deftos, 1974). However, the major problem w ith the 
immunoassay o f CT in man has been the u n r e l ia b i l i t y  o f the assay 
in  detecting basal leve ls o f the hormone in normal subjects 
(Tashjian, e t a l ,  1972; Deftos, e t a l ,  1972). I t  i s ,  o f course, 
possible tha t in the normal state there is  no CT present in human 
blood. The hormone has been read ily  detected in patients with 
medullary carcinoma o f the thyro id  and forms an important diagnostic 
c r i te r io n  in the detection o f the disease and the screening o f 
fam ily  members fo r  pre-symptomatic forms o f th is  disease (Russell, 
1976).
PERSONAL OBSERVATIONS
Hypoalbuminaemia and hyperglobulinaemia are well recognised 
biochemical features o f rheumatoid a r t h r i t i s  (Cockel, et a l ,  1971) 
The serum calcium concentration is ,  however, generally normal.
The fa c t  th a t hypercalcaemia may be concealed by hypoalbuminaemia 
prompted an inve s tiga tio n  in to  patients with rheumatoid a r t h r i t i s  
to ascerta in th is  p o s s ib i l i t y .
I t  was f i r s t  necessary to design a va l id  correction fac to r  
to  te s t  th is  hypothesis.
Design o f Correction o f  Serum Calcium Concentration fo r  
Hypoalbuminaemia
A regression analysis o f  calcium on albumin was carried 
out on the re su lts  from 100 normal healthy subjects, h a l f  o f whom 
were female. Their age ranges were as fo llows: 17 to 69 years 
fo r  females, and 18 to 70 years fo r  males. Since both the serum 
albumin and calcium concentrations lay  w ith in  very narrow normal 
ranges a regression analysis could not be performed. I t  was 
therefore necessary to extend the X axis by inc lud ing 50 patients 
w ith hypoalbuminaemia from a va r ie ty  o f causes, but w ith no known 
disease which might a f fe c t  calcium metabolism. Half o f these 
patients  were female, and th e i r  age range corresponded to tha t of 
the normal subjects (20 to 72 years). A regression equation was 
then calculated on the to ta l  150 subjects (Fig. 11:4), I t  is  o f
Fig 11:4 T;
The regression o f serum calcium concentration (mmol/I) on serum 
albumin concentration (g/1) obtained from 150 normal contro ls 
Y = (0,0194 X X) + C where X is  serum albumin in  g/1, Y is  serum
calcium in  mmol/I and C is a constant equal to T.434.
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in te re s t  th a t when the serum albumin concentration is  zero the 
regression l in e  cuts the Y axis at 1.43 m .m o l. / l . ,  which 
represents the u l t r a f i l t r a b le  calcium concentration, and corresponds 
to tha t found by Robertson (1969), (1.40 m .m o l. / l ) ;  Pedersen 
(1970), (1.40 m .m o l . / l . ) ;  Rose (1972), (1.45 m .m o l . / l . ) ;  and 
Payne et al (1973), (1.42 m .m o l. / l . ) .  O rre ll (1971) found 
a somewhat higher value fo r  u l t r a f i l t r a b le  calcium (1.70 m .m o l. / l . )  
probably in part due to the fa c t  tha t the subjects studied included 
patients with nephrotic syndrome, a condition in which there is  
evidence o f a tendency to hypercalcaemia (Jones, et a l ,  1967).
The regression equation derived from the analysis
was
V = (0.0194 X X) + C
where X = serum albumin in  g . / l .
V = serum calcium in m.mol./l
and C is  a constant equal to 1.434
(value o f Y when X = 0)
The mean albumin fo r  the population was 47.0 g . / l . ,  and the 
fo l low ing  correction  fa c to r  fo r  serum calcium concentration was 
constructed.
Ca (corrected) = (47 - a lb . )  x 0.0194 + Ca
where Ca is  the measured serum calcium in m.mol . / I .
Alb. is  the serum albumin in g . / l .  
and Ca (corrected) is  the serum calcium in m.mol . / I .  corrected 
fo r  albumin.
This ind icates tha t calcium concentration changes by 0.0194 m.mol . / I  
fo r  every 1 g . / l .  change in  albumin and tha t therefore fo r  every
1 g . / l .  by which the plasma albumin exceeds the normal mean of
47.0 g . / l .  0.0194 is  subtracted from the to ta l plasma calcium
and a corresponding addition is  made when plasma albumin is  less 
than 47.0 g . / l .
Using the above formula fo r  correction o f serum calcium 
concentration fo r  hypoalbuminaemia, 23 o f 50 randomly selected 
patients with . "d e f in i te "  or "c la s s ic a l" rheumatoid a r t h r i t i s  
by the d iagnostic  c r i t e r ia  o f  the American Rheumatism Association 
(Ropes, e t a l ,  1959) were found to have hypercalcaemia (serum 
calcium > 2.50 m .m o l. / l , ) .  These patients a l l  were sero­
p o s it ive  fo r  rheumatoid fa c to r  and a l l  had a r t ic u la r  erosions on 
jo i n t  x-ray. A l l  patients were ambulant.
I t  was therefore decided to study the 23 patients who 
were hypercalcaemic a f te r  correction  fo r  hypoalbuminaemia in 
greater d e ta i l .  A l l  o f  the patients were studied w ith in  s ix  months 
o f  the i n i t i a l  observation o f th e i r  being hypercalcaemic. The 
studies describe the va l id a t io n  o f the correction fa c to r  and 
de ta iled  biochemical and hormonal studies o f  calcium metabolism.
In ad d it ion , experimental studies on an in v i t r o  bone 
model are described which suggest the p o s s ib i l i t y  o f a bone- 
resorbing fa c to r  present in  the serum o f patients w ith rheumatoid 
a r t h r i t i s .
SECTION 1
Biochemical Studies in  Hypercalcaemic Patients with Rheumatoid 
A r t h r i t i s
MATERIALS AND METHODS
Patients
Twenty-three female patients su ffe ring  from "d e f in i te "  
or "c lass ica l' ' '  rheumatoid a r t h r i t i s  as defined by the diagnostic 
c r i t e r ia  o f the American Rheumatism Association (Ropes, et a l ,
1959) pa rt ic ipa ted  in the study. Each patient was attending the 
Centre fo r  Rheumatic Diseases as an ou t-pa tien t and was selected 
on the basis o f  having had a serum calcium concentration greater 
than 2.60 m .m o l./ l .  a f te r  correction fo r  hypoalbuminaemia as 
ou tlined  above, in  the s ix  month period p r io r  to the study.
One pa tien t was receiv ing no drugs, one was receiving 
digoxin and a d iu re t ic ,  one was on phenobarbitone fo r  e p i le p t ic  
seizures, three were receiving low dose co r t icos te ro id  therapy 
( i . e .  < 10 mg. prednisolone per day), and the remainder were 
receiving a v a r ie ty  o f non-steroidal anti-inflammatory agents.
None o f the pa tien ts  in th is  study was on excessive m ilk intake, 
v itamin D or calcium supplements. The pa tien t group had a mean 
age o f 51.7 years with an age range o f 22 - 72 years. Other 
c l in ic a l  parameters inc lud ing duration of disease, functional grade 
(Steinbrocker, e t a l ,  1949), age a t menopause and duration o f  time 
since onset o f menopause were also recorded.
The pa tien ts  were requested to fa s t  and take no medication 
from 6.00 p.m. on the evening p r io r  to commencement o f the study 
and a l l  blood samples were taken between 8.00 a.m. and 9.30 a.m. on 
the fo llow ing  morning.
Laboratory Procedure
Blood samples were withdrawn without haemostasis; urine 
co llec ted  in  d i lu te  hydroch loric  acid , over a period o f  4 hours.
As each blood sample was co llec ted i t  was divided in to  a l iquo ts . 
Those a l iqu o ts  necessary fo r  hormone estimations were immediately 
immersed in  ice . Thereafter the ind iv idua l a liquo ts  were handled 
as described below.
A 10 ml. sample o f c lo t te d  blood was separated w ith in  h a lf  
an hour and the serum used fo r  estimation o f calcium, magnesium, 
p ro te ins , albumin, phosphate and a lka line  phosphatase. A fu r th e r  
10 ml. o f blood was co llec ted  in  a lith ium -heparin  tube and also 
separated w ith in  h a l f  an hour and used fo r  estimations o f plasma 
e le c t ro ly te s , urea and c rea t in in e . In addition routine l i v e r  
func tion  te s ts ,  i . e .  serum b i l ib ru b in ,  aspartate transaminase 
(AST 2 .6 .1 .1 .)  and alananine transaminase (ALT 2 .6 .1 .2 .)  were 
carr ied  out. Calcium and magnesium were measured by atomic 
absorption spectrophotometry using the Perkin-Elmer 403 (Fell 
and Peaston, 1973). Serum to ta l  proteins were estimated by the 
B iu re t reaction as automated fo r  Auto-Analyzer (Technicon Auto 
Analyzer method N14a) and serum albumin by the bromcresol green
binding method as modified fo r  Auto-Analyzer (Northam and 
Widdowson, 1965). P urif ied  dried human albumin (Boehrlngwerke) 
vras used as primary standard. Phosphate was measured in  serum 
and urine by the molybdate reaction as modified fo r  Auto-Analyzer 
(Yee, 1968) and serum a lka lin e  phosphatase a c t iv i t y  was measured at 
37°C using LKB 8600 Reaction, Rate Analyzer and Boehringer reagents 
Plasma e le c tro ly te s ,  urea and crea tin ine  were measured on SMA 
6/60. Creatin ine was also estimated by the a lka lin e  p icra te  
reaction (Technicon Auto-Analyzer method N llB ),
The serum calcium leve ls  were corrected fo r  albumin 
employing the formula described above. A biochemical mineral 
metabolism screen was carr ied  out on each subject. This involved 
u t i l i s i n g  data from blood and urine to ca lcu la te  certa in  derived 
values:
i ) Fasting Urinary ca lc ium /creatin ine ra t io
i i )  Urinary calcium excretion (CaE) per l i t r e
glomerular f i l t r a t e  (Nordin, Hodgkinson and 
Peacock, 1967). 
i i i )  Theoretical maximum tubular reabsorption capacity 
fo r  Calcium, Tm Ca (Nordin, Horsman and Aaron,
1976).
iv )  The most re l ia b le  indices o f renal handling o f 
phosphate (Paterson, 1973) i .e .  TmPO^ /GFR 
(Theoretical tubu lar maximum reabsorption of 
phosphate corrected fo r  glomerular function 
(B i jv o e t ,  1969; B ijvo e t,  Morgan and Fourman, 1969) 
and I.P .E . (Index o f phosphate excretion)
(Nordin and Bulusu, 1968).
Both the indices 1 i)  and i i i )  were calculated by the formula employed 
in  the MRC Mineral Metabolism Unit Leeds, and the ra tiona le  has 
been ou tl ined  in  the in troduction  to th is  chapter.
A 10 ml. c lo t te d  sample o f blood, from which a i r  was 
excluded immediately a f te r  withdrawal was used fo r  the estimations 
o f ionised calcium.
Measurement o f Serum Ionised Calcium Concentration 
The Instrumentation
The measurement system used was a m odification o f a 
commercially ava ilab le  serum calcium flow-through electrode
"k
measurement system (Orion Research, model 99 - 20) . The 
calcium se lec tive  electrode was o f the l iq u id  membrane type using 
a phosphate ester ion-exchanger and was designed to allow anaerobic 
measurement in small volumes o f a continuously flowing sample 
(Orion Research, model 98 - 20). This was used in conjunction with 
a s i l v e r / s i l v e r  ch lo r ide  reference electrode which had a single 
restra ined flow l iq u id  ju n c t io n , and was also o f  the flow-through 
type (Orion, model 90 - 03). The essential features o f these 
electrodes are i l lu s t ra te d  in Figure I I :  5.
The electrodes were housed in a small oven which was kept 
a t  a constant temperature o f 37°C. The door o f th is  oven was 
modified by the inse rt ion  o f  a perspex window with holes to 
accommodate the electrode leads and sample feed tubing.
*  Orion Reserach In c . ,  11 Blackstone S t . ,  Cambridge, Mass. 02139, U.S.A
Diagrammatic representation o f  the calcium se lective  electrodeiiand 
reference electrode used in  the measurement o f serum ionised calcium 
concentration.
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Samples were fed through the electrodes 
from 1 ml. disposable p la s t ic  syringes* via narrow bore p la s t ic  
tub ing, and a continuous non-pul s a t i le  flow of 33 ul/m in was maintained 
by a sp e c ia l ly  designed syringe pump (Orion, model 88 - 20).
The electromotive force (EMF) o f the ce l l  was measured 
by a pH/mV electrometer (Orion, model 801), with a d ig i ta l  d isp lay 
accurate to  + 0.1 mV. A potentiometric s t r ip  chart-recorder 
(Servoscribe, RE 511) was connected to the recorder output o f 
the electrometer to provide a continuous record o f the EMF changes, 
the chart speed being set a t 12 c m /h o u r .  The p r in c ip le  advantage 
o f the chart recorder over the d ig i ta l  d isplay was in  the evaluation 
o f electrode s t a b i l i t y  and d r i f t  tendencies, but i t  also allowed 
fu r th e r  scale expansion o f the EMF readings as required. Figure 
I I :  6 summarises diagrammatically the instrumentation in  to to .
When measurements o f ionised calcium were performed 
on serum samples, a small amount o f tryps in  powder was added to 
each o f these standard solu tions (6 mg. per 10 m l.)  in  order to 
i n h ib i t  the accumulation of prote in on the electrode membrane and 
in  the connecting tubing. The tryps in  was not used when 
measurements were re s tr ic te d  to aqueous standard so lu tions.
*  Becton, Dickinson and Company L td . ,  Dublin, Ire land.
Diagrammatic representation o f  the to ta l  system o f instrumentation 
employed i n  the. measurement o f sefum ionised calcium concentration
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Method o f Operation
The calcium electrode was prepared according to the 
manufacturer's in s tru c t io n s  ( In s tru c t io n  Manual; Orion Research 
In c . ) .  using the Orion serum calcium ion-exchange so lu tion and 
in te rna l reference so lu t ion . The reference electrode was 
f i l l e d  w ith a so lu t ion  o f 1 mol/1 KCl saturated with AgCl, which 
was prepared in  the labora tory . A fte r  preparation, the electrodes 
were in s ta l le d  in  the constant temperature cabinet and l e f t  fo r  a 
minimum o f 16 hours ( i . e .  overnight) to come to equ il ib r ium  at 
the required temperature o f 37°C. Then, before use, the 
electrodes were shaken, as one would shake down a c l in ic a l  
thermometer, to  dislodge any a i r  bubbles which might have appeared 
in  the f i l l i n g  so lu tions during warming.
At the s ta r t  o f a measurement run the reference electrode 
was examined to  ensure th a t there was an adequate reservo ir  and 
unobstructed flow  o f  the f i l l i n g  so lu tion . 10 ml. o f  each 
standard so lu tion  was then placed in a clean p la s t ic  tube, tryps in  
powder was added fo r  serum samples, and the tubes were suspended 
in  a water bath a t 37°t. Samples were drawn up in  1 ml. p la s t ic  
syringes which were then sealed with closed Luer hubs and suspended 
in  the water bath to  maintain the sample a t 37®C.
The base-line standard was run through the electrode f i r s t ,  
u n t i l  a s tab le EMF reading was achieved. This took a variable 
length o f time from 30 to 120 minutes. A standard so lu tion  was
used to obtain a base-line standard. In a typ ica l measurement 
run, once the electrode had s ta b i l ise d  on th is  so lu t ion , another 
standard so lu tion  was run fo r  about 5 minutes followed again by 
the o r ig in a l  so lu t ion . This sequence was repeated w ith the base­
l in e  standard so lu t io n , before continuing with fu r th e r  aqueous 
standards or serum samples. The base-line standard was run 
before and a f te r  every other so lu tion measured, and the d ifference 
in the electrode EMF between each serum sample and the base-line 
standard was noted from the d ig i ta l  d isplay o f the electrometer 
and measured from the chart recording. At the completion o f a 
measurement run the tubing was cleared o f the standard so lu tion 
and l e f t  dry u n t i l  the next run.
Measurement o f  sample pH
When the pH o f the sample was measured ( i . e .  in  a l l  serum 
samples and in some aqueous standards) i t  was done immediately 
fo llow ing  the ionised calcium measurement in tha t sample.
The pH was measured using a conventional c a p i l la ry  
electrode system (E lectron ic  Instruments L td .,  model SHH 33 system) 
in  conjunction w ith  a standard expanded scale pH meter (Radiometer, 
pH M 22r). The glass electrode consisted o f a pH sens it ive  glass 
c a p i l la ry ,  phosphate buffer/KCl in te rna l f i l l i n g  so lu tion  and Ag/ 
AgCl in te rna l reference element; the reference electrode was a 
calomel reference element in  3.8 mol/1 KCl with s ing le ceramic 
plug restra ined flow l iq u id  junc tion  incorporated in to  a c a p i l la ry
tube. Both h a l f - c e l ls  were surrounded by water jackets through 
which water a t 37®C was c ircu la ted  from the water bath. Samples 
were introduced to the electrode system by means o f suction by a 
pump.
A s ing le  phosphate bu ffe r ,  pH approximately 7.4 a t 37°C 
was used to ca l ib ra te  the pH meter and the pH o f th is  'working' 
b u ffe r  together w ith the slope response o f the electrode were 
p e r io d ic a l ly  checked against ampoules o f standard bu ffe r solutions 
(Radiometer, Type SI510 pH 7.383 a t 37^0, and Type SI500 pH 6,841 
a t  37^0). The pH measurements were performed in the fo llow ing 
way. The working bu ffe r ,  pre-heated to 37°C in the water bath, 
was aspirated through the electrode and the meter reading observed 
when stable. More bu ffe r was aspirated and the meter reading observed 
again. Once a s tab le , repeatable reading was achieved, the meter 
was adjusted to read the pH o f the bu ffe r. The sample o f unknown pH 
v/as then aspirated several times (usually  3 times fo r  serum) u n t i l  
a stable reading was observed. This reading was noted and the pH 
o f  the bu ffe r  rechecked. Provided the second reading o f bu ffe r 
pH corresponded to i t s  o r ig in a l se tt in g , the pH recorded fo r  the 
unknown sample was accepted, otherwise the whole procedure was 
repeated u n t i l  s a t is fa c to ry  resu lts  were obtained. The sample pH 
was noted to the second decimal place and the precision o f  the 
measurement is  estimated to be w ith in  the l im i ts  o f  + 0.01 pH u n it .
The electrode c a p i l la r ie s  were l e f t  f i l l e d  with working 
bu ffe r so lu tion  when not in use. Corrections were applied to the 
observed ionised calcium resu lts  to take account o f d ire c t  sodium 
in te rfe rence , and fo r  th is  purpose a l in e a r  re la t ion sh ip  was 
assumed between log ^Ca^^ 2  sodium concentration (Watson,
1975). The ionised calcium a t the measured pH was then adjusted to 
correspond to a standard pH value o f 7.40. For any serum specimen 
the re la t ion sh ip  between the logarithm o f the ionised calcium 
concentration and pH is  l in e a r  but the slope o f the regression 
l in e  varies w ith albumin concentration and, to a lesser degree 
with the actual ionised calcium le ve l.  Accordingly, in order 
to make pH correc tions , th is  slope was calculated fo r  each sample 
using a formula derived from theore tica l studies of calcium 
binding to albumin (Pedersen, 1972a) and from the resu lts  of 
observations o f the influence o f  pH on serum ionised calcium with 
varying albumin and calcium concentrations (Watson, 1975).
R ep roduc ib il i ty  o f Ionised Calcium Measurement
To assess the re p ro d u c ib i l i ty  o f measurement during a single 
run, 20 ml. o f fresh serum was prepared from a sample o f blood 
from a normal adu lt. The serum was stored in a 20 ml. p la s t ic  
syringe, free o f a i r  bubbles. Samples o f 0.5 ml. were withdrawn 
in to  1 ml. p la s t ic  syringes by means o f  a three-way stopcock, and, 
a f te r  pre-heating to 37°C, the ionised calcium concentration and 
pH were measured. These measurements were performed on 20 samples
from th is  bulk source. The ce l l  EMF was recorded by a chart 
recorder and the EMF readings from the d ig i ta l  d isp lay o f the 
electrometer were also noted fo r  each sample. For purposes o f 
comparison the ionised calcium concentration fo r  each sample 
was computed independently from the measured recorder de flec tions.
The resu lts  obtained from the recorder revealed a range of 1.19 - 
1.22 m.mol . / I .  w ith a mean o f 1.20 + I.S.D. 0.009 m.mol . / I . (c o e f f ic ie n t  
o f  va r ia t io n  o f 0.76%). Thus the re p ro d u c ib i l i ty  would seem quite 
sa t is fa c to ry  in the presence o f a re l ia b le  reference standard.
The normal range o f serum ionised calcium concentration was 
established in  an ace and sex matched group o f healthy subjects 
who were e ith e r  members o f s ta f f  or re lated to members o f  s ta f f  
a t  the Centre fo r  Rheumatic Diseases and in whom there was no 
evidence of disease associated with disorder o f calcium metabolism.
The samples o f blood were obtained in the fas t ing  state and under 
the same s tr in gen t conditions described fo r  the pa tien t group.
Calcium Absorption Study
Subjects
A separate group o f 23 female patients with "d e f in i te "  
or " c la s s ic a l" rheumatoid a r t h r i t i s  and with skeletal evidence o f 
osteoporosis had calcium absorption measurements carr ied  out.
Ten o f these patients were receiv ing co rt icos te ro id  therapy 
(ranging from 5-10 mg. o f prednisolone per patient per day) and 
the remainder were receiving standard non-steroidal anti-inflammatory
drugs. Unfortunate ly i t  was not possible to carry out these 
tes ts  in  the 23 patients who underwent the de ta iled biochemical 
and hormonal study.
Ten normal healthy female subjects with no known evidence 
o f disease re la t in g  to calcium metabolism volunteered to act as 
con tro ls . A l l  were members o f s ta f f  o f the Centre fo r  Rheumatic 
Diseases or re la t iv e s  o f same. I t  was not possible to arrange la rger 
numbers fo r  control purposes because o f reluctance on the part o f 
those approached to be admitted to hosp ita l.
Due to the paucity o f numbers o f normal con tro ls , an approach 
was made to  Professor B.E.C. Nordin, M.R.C. Mineral Metabolism Unit 
a t  Leeds Royal In f irm ay, who k ind ly  supplied resu lts  from a larger 
number o f normal contro ls employing exactly the same dose o f 
calcium c a r r ie r  and technique o f measuring calcium absorption used 
in  th is  study. From th is  source the resu lts  from 28 normal female 
subjects o f  s im ila r  age to local contro ls were used fo r  comparative 
purposes. The age ranges o f both normal groups and the patients with 
rheumatoid a r t h r i t i s  were comparable.
Method
The method o f assessing calcium absorption was as described 
by Nordin (1967). Each subject was fasted fo r  12 hours p r io r  to 
the study and then received o r a l ly  5 uCi o f ^^Ca in a c a r r ie r  o f 
50 mg. o f calcium ch lo ride . Following adm inistra tion o f the
e n t ire  dose o f  the radioisotope plus c a r r ie r ,  blood samples were 
taken a t 30 minute in te rva ls  fo r  a period o f 3 hours. Each blood 
sample v/as centrifuged and the resu ltan t plasma sample counted in 
a gamma s c in t i l l a t io n  counter (GAMMA-GUARD) fo r  ^^Ca a c t iv i t y .
In order to convert these plasma a c t iv i t y  values in to  indices o f 
calcium absorption account must be taken o f the bodyweight o f 
the subject since th is  determines the size o f the plasma and 
e x t ra c e l lu la r  f lu id  calcium pool in  which the radioisotope is  
d i lu te d . This stable calcium pool has been shown to correspond 
approximately to the plasma calcium concentration in  m illigrams 
per l i t r e  m u lt ip l ie d  by 15 per cent o f the bodyweight in kilograms. 
Thus the plasma a c t i v i t y  of ^^Ca per l i t r e  is  m u lt ip l ie d  by 15 
per cent o f  bodyweight (Kg) to provide a measure o f  the actual 
amount o f radiocalcium present in the pool a t any given time 
(Nordin, 1967).
HORMONE ASSAYS
Serum from a liquo ts  immersed in ice were separated w ith in  
twenty minutes and frozen at -20^0. These were used fo r  the fo llow ing 
analyses:
1) Parathyroid hormone: was assayed by two centres employing
d i f fe re n t  immunoassay techniques:
Technique 1 Serum immunoreactive parathyroid hormone ( i  PTH) 
concentration was measured by a double antibody radioimmunoassay 
technique (Fairney, Jackson and Clayton, 1973) using a human
parathyroid adenoma cu ltu re  media standard (W il ls ,  Fairney, Varghese, 
T a t le r ,  Ba il lod  and Moorehead, 1974). Professor Claude Arnaud 
g i f te d  the parathyroid adenoma cu ltu re  media standard and the 
Medical Research Council the parathyroid antiserum. The anti serum 
used cross reacts w ith both the amino and carboxyl terminal ends 
o f  the PTH molecule. The assay s e n s i t iv i t y  and precision is  such 
th a t i t  is  capable o f d i f fe re n t ia t in g  between low and normal 
leve ls  o f PTH. This assay was k ind ly  performed by Dr. Angela 
Fairney at St. Mary's Hosp ita l, London.
Technique 2 In the second assay, plasma samples were assayed
in  two d i lu t io n s  in  dup lica te , using plasma from patients with 
hypoparathyroidism as d i lu e n t.  The assay procedure was a 
m odif ica tion  o f tha t o f  Berson, Yalow, Aurbach and Potts (1963), 
and used Burrough's Wellcome Antiserum 211/32, p u r i f ie d  bovine 
PTH (k in d ly  supplied by Dr. John Potts, J r . )  as a standard and 
parathyroid hormone fo r  radio iod ination  (75/52) from M.R.C.
National In s t i tu te  fo r  B io log ica l Standards and Controls. This 
assay was k in d ly  performed by Mrs. Catherine Hi I lya rd  o f  Dr. I .  
MacIntyre's labora tory  in  the Royal Postgraduate Medical School, 
Hammersmith Hosp ita l, London.
Calc iton in  Assay Plasma samples were thawed and se r ia l d i lu t io n s  
made in  c a lc i to n in  free plasma. The assay procedure has been 
reported previously (Coombes, H i l ly a rd ,  Greenberg and McIntyre,
1974). This assay was also carried out by Mrs. Catherine 
H i l ly a rd .
25-Hydroxy-vitamin D estimation - Estimation o f serum 
25-hydroxy-vitamin D was performed (Haddad and Chyu, 1971) using 
Vitamin D rep le te  ra t  kidney cytosol protein (McLaughlin, Fairney, 
Lester, Raggatt, Brown and W il ls ,  1974). The resu lts  obtained 
fo r  25-hydroxy-vitamin D were compared with measurements made on 
normal subjects taking in to  account the seasonal va r ia t io n  and 
interassay va r ia t io n  (McLaughlin, et a l ,  1974). Dr. John Babcock 
o f the Upjohn Company, U.S.A. k ind ly  supplied the 25-hydroxy 
e rg o c a lc i fe ro l .
Gastrin Assay - Serum gastr in  was measured using a sensitive and 
s p e c if ic  radio-immunoassay based on antibody raised in rabbits to 
synthetic  human gas tr in . Labelled hormone was prepared using 
m odif ica tion  o f the chloramine-T method (Hunter and Greenwood,
1962) and separation o f  the free hormone from tha t bound to antibody 
was achieved with dextran coated charcoal (Buchanan and McCarrol, 
1971). Cross reaction w ith cholecystokin in and pancreozymin is  
minimal and studies ind ica te  tha t the hormone not only recognises 
the heptadecapeptide hormone, but also "b ig" gastr in  (Yalow and 
Berson, 1970).
Glucagon Assay - Two antibodies raised to pancreatic glucagon were 
used in the glucagon assay, namely YY89 which reacts with the C- 
terminal and YY57 w ith the N-terminal region o f glucagon 
(Flanagan, Buchanan and Murphy, 1974). The assay procedure has 
been previously reported in d e ta i l  (Buchanan, 1973). These two 
hormone assays were k ind ly  performed by Professor Keith D. Buchanan 
o f Be lfas t U n ivers ity .
Urinary D-glucaric acid Excretion as an ind ica tion  o f l i v e r  
microsomal enzyme induction was assayed using the procedure o f Marsh 
(1963) as modified by Simmons, Davis, Dordoni and Williams (1974).
Urinary hydroxyproli.ne was measured in each pa tien t employing the 
Hypronosticon K it  manufactured by Organon Limited (Goverde and 
Veenkamp, 1972).
On a l l  assays, reference data were obtained from estimations 
performed on fas t in g  healthy subjects, matched fo r  age and sex.
Radiological Assessment
Radiological f i lm s  o f hands and w ris ts  obtained at the time o f 
study were examined fo r  evidence o f bone and j o in t  damage. Each 
f in g e r  j o i n t ,  metacarpal bone, carpal bone and the radius and ulna 
were examined separately fo r  erosions. One point was assigned to 
each erosion and f iv e  points to an area of to ta l destruction of 
the a r t ic u la r  surface. Twenty-nine areas in  each hand and w r is t  
(14 f in g e r  jo in t s ,  5 metacarpal bones, 8 carpal bones, the radius 
and ulna) were read in th is  way g iv ing a maximum possible defect 
score o f 290 (Sharp, Lidsky, C o ll ins  and Moreland, 1971). A s im ila r  
grading system was employed to assess j o in t  space narrowing and 
the highest possible score in th is  method was 216.
A corrected erosion or defect score (Dc) was obtained by 
d iv id in g  the to ta l  number o f erosion points on a s ing le f i lm  by the 
maximum possible erosion score. A s im ila r ca lcu la t ion  was made 
to  provide a corrected jo in t  space narrowing score (OSNc) (Sharp, 
e t a l , 1971 ).
The metacarpal index o f  Barnett and Nordin (1960) was used 
as a measurement o f  osteoporosis.
S ta t is t ic a l  Methods
The fo llow ing  tes ts  were used: Student's t  te s t  fo r  comparison 
o f  group means, F ischer's  F te s t  fo r  comparison o f group variances 
and l in e a r  regression ca lcu la tions fo r  association between variables.
The consent o f each pa tien t included in the study was 
obtained a f te r  a f u l l  explanation o f the im plica tions involved 
and approval fo r  the study was granted by the Ethical Committee o f 
Glasgow Royal In f irm ary .
RESULTS
The c l in ic a l  laboratory d e ta i ls  o f  the 
twenty-three female patients included in th is  study are shown in 
Table 11:111. The patients had had th e i r  disease fo r  a mean period 
o f  6.0 years (range 1 to 20 years). Thirteen o f the patients had 
passed the menopause, and resu lts  of rheumatoid fa c to r  and a n t i -  
nuclear fa c to r  t i t r e s ,  haemoglobin concentration and erythrocyte 
sedimentation rate were consistent w ith varying degrees o f disease 
a c t iv i  ty .
Table I I : I V  summarises the essential find ings o f the mineral 
metabolism screen. The serum calcium concentration was not 
s ig n i f ic a n t ly  d i f fe re n t  from the values o f our reference group.
When account is  taken o f  the serum albumin concentration, which was 
s ig n i f ic a n t ly  lower than th a t o f  the reference group ( t  = 9,7; 
p<0,001)î  the corrected serum calcium concentration becomes 
s ig n i f ic a n t ly  elevated ( t  = 8.4; p<0.001). S ig n if ica n t e levation^ 
in  serum ionised calcium concentration was noted ( t  = 4.23; 
p<0.001) in the 23 patients w ith rheumatoid a r t h r i t i s  compared 
to the 23 healthy age and sex-matched control subjects. Eight o f 
the patients w ith  rheumatoid a r t h r i t i s  had serum ionised calcium 
concentrations in the hypercalcaemic range. I t  is  in te res t in g  to 
note th a t although a pos it ive  co rre la t ion  was obtained between 
serum ionised calcium and the observed serum calcium ( r  = 0,55; 
p<0.005)Fig. I I :7 a ,  when the serum calcium is  corrected fo r  serum 
albumin concentration th is  co rre la t ion  becomes much more s ig n if ic a n t  
( r  = 0.71; p<0.001). (Figure I I :7 b ) .
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The corre la t ion  o f  the serum ionised calcium concentration with the 
corresponding to ta l serum calcium concentration uncorrected fo r  serum 
albumin, ( r  = 0.55; p<0,005).
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S im i la r ly ,  the serum phosphate concentration was s ig n i f ic a n t ly  
reduced ( t  = 2.81; p<0 . 0 1 ) ,  and 10 o f the rheumatoid patients had 
elevated leve ls  o f serum a lka line  phosphatase. Plasma chloride 
concentration was s ig n i f ic a n t ly  elevated in the group o f  patients 
w ith  rheumatoid a r t h r i t i s  ( t  = 8.53; p<0.001) but plasma urea, 
potassium, sodium and to ta l CO^  and serum creatin ine revealed no 
d iffe rence from the control group. Five patients had elevated 
ca lc ium /crea tin ine ra t io s .  Examination o f the indices o f renal 
handling o f phosphate revealed tha t f iv e  patients had reduced renal 
tubu la r reabsorption o f  phosphate (TmPO /^GFR) and seven had increased 
phosphate excretion ( I .P .E . ) .  When CaE is  p lo tted  against to ta l 
serum calcium concentration (Figure 11:8) i t  can be seen tha t the 
resu lts  are to the r ig h t  o f the mean value and th a t seven are 
outwith tlie established l im i ts  o f  norm ality , thus ind ica ting  
evidence o f increased renal tubu lar reabsorption o f calcium 
(Marshall, 1976).
The resu lts  o f theore tica l maximal tubular reabsorption of 
calcium TmCa/GFR also show a general increase compared to normal 
values (Marshall, 1976). When the serum ionised calcium, serum 
phosphate and a lka lin e  phosphatase are grouped according to th e ir  
"norm ality" (Table I I :V )  the fo llow ing facts emerge. Of the 
twenty-three patients only seven had a l l  three resu lts  in the 
"normal" range. Of the e igh t patients with elevated serum ionised 
calcium, s ix  had biochemical patterns which might be encountered in 
a hypercalcaemic hyperparathyroid state.
1--Î.1 11:0
Tha ro la t lon  between cal c l uni ékcretton (Ca,.) per TOO nils o f  glomerular 
f i l t r a t e  and serum calcium concentration provid ing indices o f tubu la r 
re«absorpt1on o f ca lcium, in  23 pa tien ts  With rheumatoid a r th r i t is .
The th ick  black lin e  represents thO #an^ ^^ ^^ n^ ^^  ^ values and the 
stipple.d areas are the l im its  o f norm ality.
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Table II i V
Grouping* of combinations of 'normal"and "abnormal” serum ionized
calcium, phosphate and alkaline phosphatase results.
Investiga tions o f  serum a lka line  phosphatase w ith  other tests 
o f  l i v e r  function in the form o f serum b i l i r u b in ,  serum AST and ALT 
are recorded in Table I I :V I .  I t  can be seen tha t the mean serum 
a lka lin e  phosphatase, l ie s  above the upper l im i t  o f  the normal range.
Indeed 10 o f the 23 patients had elevated serum a lka line  phosphatase
le ve ls ,  whereas there was no pa tien t who showed elevations o f serum
b i l i r u b in ,  AST or ALT. One pa tien t had an extremely high serum
a lka lin e  phosphatase and th is  was associated with the highest serum
ionised calcium concentration. The results  o f the urinary
hydroxypro line estimation showed tha t nine o f the patients with
rheumatoid a r t h r i t i s  had leve ls in excess o f  the normal l im i ts
(0.05 - 0.17 m.mol/24h). However, when these resu lts  were subsequently
recalculated fo r  accuracy o f in te rp re ta t io n  in terms of the hydroxyproline/
c rea tin ine  ra t io  only s ix  patients had abnormally high resu lts
(Table I I : I V ) .
Urinary hydroxypro line is  regarded as providing evidence o f the
rate o f  collagen destruction and also has been shown to re la te  to bone
destruction (Turek and Goverde, 1973), Since, the fas t ing  calcium/ 
c rea tin ine  ra t io  also suggests possible evidence o f bone destruction 
(Nordin, Horsman and Aaron, 1976) the results  fo r  ur inary calcium and 
hydroxypro line excretion were corre lated in the patients  studied 
(Figure 11:9). Their indices were not expressed in terms o f the 
crea tin ine  level since i t  was possible tha t a spurious corre la t ion
might be reached i f  each index was divided by the same denominator.
I t  can be seen th a t Jthere is  a h ighly s ig n if ic a n t  pos it ive  co rre la t ion
( r  = 0,54; p <0.005) between these indices.
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The co rre la t io n  betiveen the ur inary  hydroxyprolihe concentration 
and urinary calcium concentration obtained frpm 23 patients w ith  
rheumatoid a r t h r i t i s  in  the fas t in g  s ta te .
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Serum magnesium concentrations in the pa tien t groups,
0.80 _+ 0.06 m .m o l. / I . ,  were not s ig n i f ic a n t ly  d i f fe re n t  from those 
o f  normal group, 0.82 + 0.06 m .m o l. / I . ,  (m ean+S.D .),
In an attempt to ascertain whether hypercalcaemia was a 
re f le c t io n  o f disease a c t i v i t y ,  those patients w ith elevated serum 
calcium concentrations were compared with those who had normal serum 
calcium concentrations, in  terms o f  erythrocyte sedimentation ra te , 
haemoglobin concentration, rheumatoid fac to r  t i t r e  and functional 
grade. No s ig n i f ic a n t  d iffe rence between the groups emerged.
I t  was apparent th a t the patients in th is  study manifested 
many features suggestive o f abnormalities in calcium metabolism, 
and the question arose as to whether these abnormalities were 
confined so le ly  to those patients with hypercalcaemia. The patients 
were therefore divided in to  normo and hypercalcaemic groups as 
determined by the serum ionised calcium concentrations and th e i r  
data re-analysed (Table I I : V I I ) .
I t  can be seen th a t  those w ith serum ionised calcium concentrations 
exceeding 1.13 m .m ol./I.  had s ig n i f ic a n t ly  higher leve ls  ( t  = 3.45; 
p<0.005) o f to ta l serum calcium. In addition they also had lower 
serum phosphate concentrations and TmP/GFR and higher TmCa/GFR, but 
these resu lts  fa i le d  to reach s ign if icance at the 5 per cent le ve l.
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Calcium A bso rp t ion  Study
Table I I ; V I I I  demonstrates the number o f subjects in each group 
and i t  can be seen th a t there is  no s ig n if ic a n t  d ifference in th e i r  
respective mean ages.
Group A represent the normal values obtained from Professor Nordin, 
hereafter designated NORMALS (N) and Group B represent the normal 
values obtained in th is  study, hereafter designated NORMALS {K],
47The plasma Ca a c t iv i t y  curves fo r  each o f the four groups are 
seen in  Figure 11:10. I t  can be seen tha t both the groups o f  patients 
w ith  rheumatoid a r t h r i t i s  appear to have a higher rate o f  calcium 
absorption compared to the control group (K). Although th is  trend 
is  also evident when the patients with rheumatoid a r t h r i t i s  are 
compared to the control group (N) the difference is  not so marked.
The s ign if icance  o f these resu lts  are demonstrated more c le a r ly
by examining the mean two hour peak ^^Ca plasma a c t iv i t y  levels o f
each o f the fou r groups (Table I I : V I I I ) ,  I t  can be seen tha t both
groups o f patients  with rheumatoid a r t h r i t i s  have s ig n i f ic a n t ly  
47higher plasma Ca leve ls  compared to the local normal group - 
NORMALS (K). However, although the calcium absorption curves o f 
both the rheumatoid groups ind ica te  increased absorption compared
to the Normal group (N) (Figure 11:10) when the two hour peak plasma
47 'Ca a c t iv i t ie s  are compared, p n ly  the non-corticoste ro id  treated
patients  demonstrate evidence o f  increased calcium absorption which
is  s t a t i s i c a l l y  s ig n i f ic a n t .  Also i t  is  important to  note tha t
there is  a s t a t i s t i c a l l y  s ig n if ic a n t  d ifference between the Normal
Group Number
Age
in
Years
2 hour peak per cent 
Plasma activity
A 54 24.5
28 + +
formais (n )
11.3 7 .2
1 ^ 56.4 18.41 10 4 +
1 Normals (k ) 11.0 9*3
1 ^ 59.8 28.8
1 Rheumatoid
13 +
8 .0
+
7 .01 Arthritis (non C.S^)
1 D 56.2 3 = . 0  ~ ~ \
1 Rheumatoid
10 Jt
9*0
± Ï
15.0
........... ................................................. ... ,i.i|
1 Arthritis ( C . S . )
f -  - -.......... -,—  - - -  - -
Comparison between groups.
A and B t 2.12 P < 0.025
A and C t 1.79 P < 0.05
A and D t 1.52 P N . S .
B and 0 t 3.06 P < 0.005
B and D t 2.43 P ,  < 0.025
T a b l e  I I ;  V I I I
The results of the tv/o hour peak plasma Ca activity (x I5 per 
cent body weight) in each of the four groups studied. All 
results are expressed as mean +_ I . S . D .  and statistically 
significant differences between the groups are noted below the 
table.
Fig 1 1 : 1 0  : .. V  ' " y  ;
The plasma a c t iv i t y  o f  Ca a t in te rva ls  o f  30 minutes fo r  each o f  
4 groups,viz. patients w ith rheumatoid a r t h r i t i s  receiving cp rt icos te rp id  
therapy - R.A. (C .S .), those not receiving such therapy -  R.A. (non C.S.) 
and the normal control population fronr Professor B.R.C.TNordin - NoNal 
(0 ) together w ith the resu lts  f o r  local normal çon&olsY-
•LIA
RA (C.S.) 
RA(non C.S.)
NORMAL (N) 
NORMAL (K)
120 150 180
time in minutes
Group (N) and the Normal Group (K) with the former showing a higher 
mean plasma 'Ca level than the la t te r .
HORMONE ASSAYS
The resu lts  o f  the parathyroid hormone estimation, using both 
assays revealed no raised leve ls o f  th is  hormone. In the f i r s t  
technique i t  was possible to obtain absolute resu lts  and these have 
been tabulated.. In the second technique a l l  resu lts  lay w ith in  the 
normal range (100 - 730 pg/ml) and have not been tabulated since i t  
was not possible to establish abnormally low resu lts  in th is  assay. 
The resu lts  o f  serum PTH (Technique 1), c a lc i to n in ,  25-hydroxy- 
vitamin D and gas tr in  measurements, together w ith serum calcium 
parameters, u r inary  calcium and hydroxy-proline measurements, and 
indices o f  bone damage, are shown in Table I I : IX .
From th is  table i t  can be seen tha t the immunoassay re su lt  fo r  
serum PTH ind icates tha t none o f the patients had an elevated re su lt  
and indeed, sixteen patients had resu lts  below the reference range. 
Two patients were noted to have elevated serum ca lc ito n in  levels 
and both o f  these had high serum ionised calcium concentrations 
together w ith low PTH leve ls . One pa tien t had an elevated serum 
gastr in  (p a tien t 1 1 ) and also had elevated serum ca lc i to n in  and 
ionised calcium le ve ls ,  together with a low PTH level and a high 
serum a lka lin e  phosphatase. Analysis o f the 25-OH-vitamin D levels 
revealed tha t one pa tien t (pa tien t 23), had a reduced concentration 
while a l l  the others were w ith in  the normal range. I t  is  in te res ting  
to note tha t th is  pa tien t also had an elevated ur inary  D-glucaric
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acid concentration. The mean g lucaric  acid concentration fo r  the 
whole group was 31.2 m.mol/1, (normal range 10-46 m .m o ls ./ l) .
Immunoassay o f glucagon employing both the 57 and 89 antibodies 
showed normal leve ls .
Radiological Assessment
A s ig n i f ic a n t  co rre la t io n  was found between the erosion score,
Dc, and the metacarpal index ( r  = 0.6, p<0.01) and the erosion score 
and j o in t  space narrowing score (JSNc) ( r  = 0.77, p<0.001). No 
co rre la t io n  however existed between serum ionised calcium concentrations 
and any o f  these indices o f  j o in t  destruction and osteoporosis.
DISCUSSION
The f i r s t  and most crucia l question in th is  study is  whether 
or not the serum ionised calcium estimations v a l id ly  support the 
contention th a t hypercalcaemia in rheumatoid a r t h r i t i s  is  a real 
e n t i ty .  The study was c a re fu l ly  con tro lled  both in terms of 
matching patients fo r  age and sex with healthy subjects and in the 
methodology employed in determination o f  serum ionised calcium 
concentrations.. The patients and controls were studied in the 
fas t in g  s ta te  and p a r t ic u la r  care was taken in withdrawal o f 
venous blood to ensure tha t no a i r  entered the syringe and tha t 
the arm was not constr ic ted . The patients and controls were 
studied contemporaneously and the laboratory estimations were 
performed under id e n t ica l conditions. The temperature at which 
the estimations were performed was constant (37°C) fo r  a l l  
samples, and the resu lts  were corrected fo r  pH and sodium 
in te rference . Hence, there are strong grounds fo r  accepting that 
e igh t o f  the 23 patients w ith rheumatoid a r t h r i t i s  did have 
elevated serum ionised calcium concentrations.
I t  might be argued tha t the mean control value o f  serum 
ionised calcium concentration was somewhat lower (1,07 m .m o l. / l . )  
than th a t reported by other workers (Table I I : I I ) .  However, i t  
is  extremely d i f f i c u l t  to make comparisons of normal values 
obtained in d i f fe re n t  la b o ra to r ie s , in p a r t ic u la r  when there are 
so many variables which can a f fe c t  such resu lts . Moreover, a
l i t e ra tu r e  survey revealed tha t only three other groups have reported 
serum ionised calcium determinations using the ion electrode method 
employed in  the present study w h i ls t  also studying patients in the 
fas t in g  s ta te . Robertson and Peacock (1968) and Laoenson and Bowers 
(1973) both obtained higher mean values, 1.23 and 1.28 m .m o l./ l ,  
respec tive ly , but Ryden et al (1976) obtained a mean value o f  1,03 
m .m o l. / l .  which was lower than tha t obtained in the control subjects 
in  the present study. I t  should be noted tha t Ladenson and Bowers 
(1973) carr ied  out t h e i r  estimations a t a temperature o f  25°C which 
would tend to increase the serum ionised calcium re s u lt ,  Ryden and 
her colleagues (1976) do not, un fortuna te ly , quote a temperature at 
which they ca rr ied  out th e i r  estimations. Varghese (1973) using 
spectrophotometry obtained a mean value s l ig h t ly  lower (1,04 m .m o l, / l . )  
than th a t obtained in  the present study. His subjects were also fast ing  
and the working temperature was 37^C. The re p ro d u c ib i l i ty  of the 
method employed in the present study was high with a c o e f f ic ie n t  o f 
va r ia t io n  o f  0.76 per cent in 20 samples from the same bulk source 
(vide supra). Thus, i t  seems reasonable to conclude tha t the eight 
patients  w ith  rheumatoid a r t h r i t i s  had d e f in i te ,  a lb e i t  in some 
patients s l ig h t ,  e levations in serum ionised calcium leve ls .
Further confirmation o f  the find ing  o f raised serum ionised 
calcium leve ls  in  rheumatoid a r t h r i t i s  has been obtained in a study 
o f  52 patients  w ith  the disease studied personally in  South A fr ica , 
Approximately one th i rd  (17) o f the patients had elevated serum 
ionised calcium leve ls  when compared to an age and sex matched healthy 
contro l group (Meyers, La id ley , Levine, Milne, Salant and Kennedy,
1976). I am g ra te fu l to Dr. Anthony Meyers o f Professor Bothwell's
Department of Medicine in Johannesburg fo r  the estimations o f  serum 
ionised calcium concentrations [F ig . I I ; 11), The method employed an 
Orion calcium ion exchange electrode model SS-20 and the temperature 
a t which estimations were performed was 37^C.
In the in troduction  to th is  chapter the ra tiona le  and methodology 
o f  correcting serum calcium concentration fo r  low leve ls o f serum 
albumin was discussed in depth because o f  the relevance to th is  
current inve s t iga t io n . The correction fa c to r  employed in the present 
study is  central to the in ve s t ig a t io n , and i t s  va lida t ion  is  therefore 
c ru c ia l.  As previously discussed the regression l in e  o f serum calcium 
concentration on serum albumin level (Fig. 11:4) when extended to the 
Y axis when the albumin concentration is  zero in te rsects  a t 1.43 
m .m o l./ l .  which corresponds to the serum u l t r a f i 1 terable calcium 
concentration found by others (Robertson, 1969; Pedersen, 1970; Rose, 
1972; Payne, e t a l ,  1973). Of greater importance is  whether there is  
concordance between hypercalcaemia estimated from the correction 
formula and hypercalcaemia confirmed by a high value o f  serum ionised 
calcium. Of the 23 patients with rheumatoid a r t h r i t i s  in the present 
study seven had hypercalcaemia as estimated by the correction formula 
fo r  a low serum albumin concentration. Six o f these seven patients 
had elevated serum ionised calcium leve ls . The pa tien t (pa tien t 4) 
(Table I I : IX )  who had a normal value fo r  serum ionised calcium 
( 1 . 1 2  m .m o l. / l . )  had a corrected to ta l serum calcium concentration 
ju s t  over the upper l im i t  o f normal (2,65 m .m o l. / l . ) .  Of the 16 
patients  who had normal values fo r  corrected serum calcium 
concentrations two had elevations o f serum ionised calcium (patients
Fig-  ^ - X . / : ' ,  .  ^ , : % :
The serum ionised calcium concentrations obtained from 52 female 
patients w ith rheumatoid a r th r i t i s ,  and 40 sex-matched normal ; '
con tro ls ; in  a recent South A frican study employing an ion se lective  
e lectrode. '' vW -, _ '< '
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14 and 15; Table I I ; I X ) ,  There is  thus reasonable concordance between 
the corrected to ta l serum ionised calcium concentration and the serum 
ionised calcium le v e l,  and th is  supports the v a l id i t y  o f the 
correction formula. .Further support is  provided by the fa c t  tha t 
the co rre la t io n  between serum ionised calcium concentration and the 
corrected to ta l serum calcium level ( r  = 0.71; p<O.OQl) is  higher 
than w ith the uncorrected to ta l serum calcium ( r  = 0,55; p<0.005)
(Fig. I I ;7 a  and b ) .
Hypercalcaemia does not appear to be a constant phenomenon in 
rheumatoid a r t h r i t i s .  The 23 patients in the study were selected 
on the basis th a t they had been noted to have hypercalcaemia s ix  
months p r io r  to the study as defined by correcting the to ta l serum 
calcium level fo r  hypoalbuminaemia. However, at the time o f study 
only seven pa tien ts  had an elevated corrected to ta l serum calcium 
le v e l .
The serum ionised calcium is  the phys io log ica lly  active fra c t ion  
o f  to ta l  serum calcium, and consequently, when elevated, i t  is  o f 
c l in ic a l  s ign if icance . The associated biochemical resu lts  o f the 
mineral metabolism screen are therefore o f in te re s t .  The find ing  o f 
hypophosphataemia, increased serum a lka line  phosphatase, hyperchi- 
oraemia, reduced tubu lar reabsorption o f phosphate, and increased 
tubu la r reabsorption o f calcium suggest possible parathyroid 
o v e ra c t iv i ty .  The e levation o f  serum a lka line  phosphatase in 
patients w ith  rheumatoid a r t h r i t i s  may be o f e i th e r  bone (Maddison 
and Bacon, 1974) or l i v e r  o r ig in  (Webb, Whaley, MacSween, Nuki,
Dick and Buchanan, 1975), Unfortunately isoenzyme studies were not 
ava ilab le  to determine the source o f the increased serum a lka line  
phosphatase leve ls  in the present study. However, none o f the 
patients had c l in ic a l  evidence o f l i v e r  disease and a l l  had normal 
serum leve ls  o f  b i l i r u b in  and the enzymes AST and ALT. I t  is  of 
in te re s t  tha t o f  s ix  patients w ith elevated hydroxyproline/ 
c rea tin ine  ra t ios  fou r had elevated serum a lka line  phosphatase 
leve ls . However, s ix  patients w ith  elevated serum a lka line  
phosphatase leve ls  had normal hydroxypro line/creatin ine ra t io s .  
Increased hydroxyproline excretion in the urine re f le c ts  an 
increased turnover o f collagen, and has been reported by some 
(Hartmann, Rohde and Schmidt, 1969) but not a l l  workers ( Z i f f ,  
K ib r ick , Dresner and G ir ib e tz ,  1956) in patients w ith  rheumatoid 
a r t h r i t i s .  The s ig n i f ic a n t  co rre la t ion  between the increased 
ur inary  calcium and hydroxyproline resu lts  (Fig. 11:9) suggests 
th a t the underlying cause fo r  th is  is  l i k e ly  to be increased bone 
turnover. The question arises as to whether th is  evidence 
suggesting increased bone turnover and the other biochemical 
abnormalities noted might be in te rpre ted as ind ica ting  hyperpara­
thy ro id  a c t iv i t y .  I t  is  therefore o f in te re s t  th a t patients who 
had an elevated serum ionised calcium level had lower serum 
phosphate leve ls  and TmP/GFR and higher TmCa/GFR. Thus, one can 
only te n ta t iv e ly  conclude tha t there is  some evidence of increased 
bone turnover and possible parathyroid ove ra c t iv i ty .
In th is  context the resu lts  o f  the separate study o f calcium 
absorption were o f fu r th e r  in te re s t .
Calcium A bso rp t ion  Study
This separate study was an attempt to assess calcium absorption 
in  patients w ith rheumatoid a r t h r i t i s  and i t  was in te res t in g  to 
observe th a t the resu lts  suggested tha t patients with th is  disease 
appeared to e x h ib i t  increased calcium absorption ir respec t ive  of 
treatment w ith  oral co r t ico s te ro id  therapy. This was less evident 
when comparing the resu lts  o f the rheumatoid patients with 
Professor Nordin‘ s normal group (N) but the trend was s t i l l  present. 
The apparent non e f fe c t  o f co rt icos te ro ids  on calcium absorption in 
rheumatoid a r t h r i t i s  is  o f in te re s t  since these drugs generally 
diminish calcium absorption (M iravet, Hioco, Debeyre, D ry l l ,  
Ryckewaert and De Seze, 1966; Gallagher, Aaron, Horsman, Wilkinson 
and Nordin, 1973) except in primary hyperparathyroidism where they 
appear to have l i t t l e  e f fe c t .
This study, however, su ffe rs  from several disadvantages.
F i r s t l y ,  i t  is  genera lly acknowledged tha t v i r t u a l l y  a l l  methods 
o f  measuring calcium absorption are re la t iv e ly  imprecise. Even 
w ith  double isotope methods, calcium pool exchange rates and processes 
are d i f f i c u l t  to take account o f ,  and therefore even in  the best 
hands in te rp re ta t io n  o f calcium absorption studies must be treated 
w ith  caution.
The in te rp re ta t io n  o f the resu lts  in th is  study are fu r th e r  
complicated because the method employed was perhaps a l i t t l e  outdated 
re ly ing  on a s ing le  isotope. Also when considering possible 
comparisons w ith  resu lts  o f other workers, the question o f calcium 
c a r r ie r  doses is  o f some importance, since differences in these 
w i l l  produce va r ia t io n  in the shape o f resu ltan t -calcium absorption
curves, thus negating such comparisons, There is  no c lear agreement 
on what is  the ideal c a r r ie r  dose, e .g . ,  Nordin's group now favour 
20 mg. calcium ch lo ride  (personal communication) whereas Dr, I , I ,  Boyle 
in  Glasgow now favours 100 mg, (personal communication) in contrast 
to th is  study where 50 mg, calcium chloride was employed in a l l  
groups.
In ad d it ion , the number o f controls obtained lo c a l ly  were 
un fortuna te ly  ra ther small, although th e i r  mean age was comparable 
w ith tha t o f both groups o f patients with rheumatoid a r t h r i t i s ,
The relevance o f comparing the resu lts  of the study w ith  the normal 
resu lts  obtained from Professor Nordin may also be questioned since 
although the technique employed was exactly s im i la r ,  the time and 
place o f study were d i f fe re n t .
These constra in ts the re fo re , m itiga te against any d e f in i te  
conclusion being reached regarding calcium absorption in rheumatoid 
a r t h r i t i s .  Nevertheless, accepting these provisos, the resu lts  of 
the study do seem to ind ica te  th a t there is  s u f f ic ie n t  evidence to 
suggest abnormalities in calcium absorption in patients w ith 
rheumatoid a r t h r i t i s  thus warranting fu r th e r more accurate 
assessment o f calcium absorption preferably carried out in a 
specia lised calcium metabolic u n it ,
At th is  juncture in view o f the biochemical evidence in one 
group o f patients w ith rheumatoid a r t h r i t i s  and the calcium 
absorption evidence (although not e n t i re ly  sa t is fa c to ry )  in another 
group a trend towards hyperparathyro id-like a c t iv i t y  seemed possible.
HORMONE ASSAYS
The cruc ia l te s t  fo r  parathyroid o ve ra c t iv i ty  is  regarded as 
the d ire c t  measurement o f serum PTH, By both methods o f immunoassay 
the serum levels o f  PTH were normal or reduced. Serum ca lc ito n in  
leve ls  were elevated in two patients on ly, and i t  is  o f in te re s t  
th a t  one o f those had the highest serum ionised calcium concentration 
(Patient 11, Table I I : I X ) .  The cause o f the elevated ca lc ito n in  
level may be a response to the elevation o f serum ionised calcium 
as has been shown in some mammalian species (Gray and Munson, 1969), 
but not ye t in man (Schneider and Sherwood, 1974).
Hypercalcaemia and hyperparathyroidism may be associated with 
hypergastrinaemia (Turbey and Passaro, 1972; Barreras, 1973), and 
rheumatoid a r t h r i t i s  may also be associated with high serum 
immuno-reactive gas tr in  leve ls (Rooney, Kennedy, Gray, Sturrock, 
Buchanan and Dick, 1976). This suggests a possible l in k  between 
e n te r ic  hormones and anomalies in  calcium metabolism occurring in 
rheumatoid a r t h r i t i s .  However, only one of the patients in the 
present study (Patien t 11, Table I I : IX )  had an elevated serum 
immuno-reactive gas tr in  le v e l,  although i t  is  o f in te re s t  tha t th is  
pa tien t had the highest serum ionised calcium concentration. In 
add it ion  th is  pa tien t had an elevated serum ca lc ito n in  le v e l,  and 
i t  might be due to the fa c t  tha t hypergastrinaemia can stimulate 
c a lc i to n in  secretion in  man (Hennessy, Gray, Cooper and Ontjes,
1973). Serum glucagon leve ls were normal in a l l  patients studied.
The ro le o f vitamin D in calcium metabolism in  patients with 
rheumatoid a r t h r i t i s  to date has not been thoroughly investigated.
In a recent study of f iv e  patients with rheumatoid a r t h r i t i s ,  bone 
biopsy evidence o f  osteomalacia and secondary hyperparathyroidism 
was found and these f ind ings were considered to be secondary to a 
d ie ta ry  defic iency o f vitamin D, assessed re trospec tive ly  by d ie tary  
h is to r ie s  (Maddison and Bacon, 1974). However, the analysis o f 
serum 25-hydroxy-vitamin D resu lts  in th is  study revealed only one 
abnormally low re s u l t ,  in a pa tien t w ith associated high level of 
ur inary  D-g lucaric acid who was receiving phenobarbitone fo r  
treatment o f epilepsy. I t  seems reasonable to postulate tha t the 
low level o f vitamin D was due to l i v e r  microsomal enzyme induction 
secondary to anticonvulsant therapy (Hahn, Birge, Scharp and A v io l i ,  
1972; Rowe and Stamp, 1974). A number of anti-rheumatic drugs are 
also known to be associated with l iv e r  microsomal enzyme induction 
in experimental animals (Conney, 1967) but there was no evidence o f 
th is  occurring in patients in the present study as judged by urinary 
D-glucaric acid leve ls . The patients in Maddison and Bacon's study 
were selected because they had bone fractures and they tended to be 
o lder and more severely affected by the a r t h r i t i s  than the patients 
in  th is  study. In add it ion , i t  seems germane to note tha t in the 
rad io log ica l studies o f skele ta l status in very large numbers of 
pa tients  w ith  rheumatoid a r t h r i t i s  reported in the f i r s t  chapter 
o f th is  thes is , no evidence o f osteomalacia was found. In addition 
the absence o f supportive biochemical evidence in th is  study would 
seem to suggest tha t the incidence o f hypovitaminosis D is  probably
confined to a very small se lect group of the rheumatoid population and 
indeed perhaps not to any greater extent tha t tha t in the general 
population. Examination o f the a r t ic u la r  bone damage indices showed 
s ig n i f ic a n t  co rre la t ion  between the erosion score and the metacarpal 
index, tending to suggest tha t whatever is  occurring at the jo in t  
surface is  also being re f lec ted  at the midpoint o f the shaft of the 
metacarpal. Thus, the metacarpal index would seem to provide a 
reasonably simple guide to the extent o f bone damage occurring in 
the hand o f a rheumatoid pa tien t. There was also a good corre la t ion  
between the erosion score (Dc) and the jo in t  space narrowing score 
(JSNc) suggesting tha t the development o f bony defects pa ra l le ls  the 
development o f ca r t i la ge  destruction.
In th is  context i t  is  In te res ting  to note that the corre la t ion  
c o e f f ic ie n t  between JSNc and Dc observed in th is  study compares 
very c lose ly  to the co rre la t ion  c o e f f ic ie n t  between the same two 
indices in another study o f  rad io log ica l abnormalities occurring in 
rheumatoid a r t h r i t i s  (Sharp, e t a l ,  1971) lending fu r th e r  support to 
the p a ra l le l  progression o f the two lesions in th is  disease.
None o f the patients in  th is  study had any evidence o f any 
a lte rn a t ive  disease which could have explained the hypercalcaemia such 
as the m i lk -a lk a l i  syndrome, hypervitaminosis D, sarcoidosis or 
malignancy. I t  is  possible tha t the increased serum calcium 
concentrations might be due simply to erosion o f bone in which case 
i t  might be an tic ipa ted tha t they would corre late w ith a c t iv i t y  o f 
j o in t  disease as judged by c l in ic a l ,  laboratory and rad io log ica l
parameters. There was no such corre la t ion  between hypercalcaemia 
and disease a c t iv i t y  based on the pa t ie n t 's  pain index, a r t ic u la r  
index o f  j o i n t  tenderness, functional grade, haemoglobin concentration, 
erythrocyte sedimentation rate and serum protein concentration, nor 
w ith the rad io log ica l indices o f bone damage. However, th is  does 
not t o t a l l y  exclude the p o s s ib i l i t y  o f any influence o f disease 
a c t i v i t y  on the production o f hypercalcaemia, since the number o f 
patients studied was small and the disease re la t iv e ly  long standing. 
Nevertheless, the fa c t  th a t the hypercalcaemia is  apparently not a 
constant feature fo r  any one pa tien t could be consistent w ith 
va r ia t io n  in the rate o f bene destruction which is  a not u n like ly  
p o s s ib i l i t y  in a disease w ith  such c l in ic a l  va r ia t io n .
Another variab le  which might explain the elevated serum ionised 
calcium leve ls is  adm in istra tion o f anti-rheumatic drugs. None o f 
the pa tients  had taken any medication w ith in  12 hours o f the study, 
but persistence o f  drug e f fe c t  cannot be discounted. Also i t  is  
possible th a t non-steroidal anti-inflammatory drugs or cort icoste ro ids  
may in te r fe re  w ith plasma binding o f calcium, thus producing 
abnormalities in  serum ionised calcium measurements. Against th is  
however is  the fa c t  th a t a l l  the patients in th is  study had had no 
drug therapy fo r  a minimum of 12 hours p r io r  to the commencement o f 
the study, and a d d it io n a l ly  there is  no previous evidence in the 
l i t e r a tu r e  th a t these drugs do produce in terference in th is  way.
I t  might be argued tha t cessation o f therapy in i t s e l f  could 
cause a release o f  calcium from i t s  binding s ites  on albumin.
However, i t  is  o f  in te re s t  tha t the patients w ith rheumatoid a r t h r i t i s
studied in South A fr ica  [32 per cent) (Fig, 11:11) had approximately 
the same incidence o f increased serum ionised calcium leve ls and a l l  
were non-fasting , and were cu rren tly  receiving non-steroidal a n t i ­
inflammatory drugs. Northover [1973) has shown, in v i t r o , using 
amounts o f indomethacin in excess o f  normal therapeutic doses, tha t 
the drug w i l l  reduce calcium binding to the membranes o f endothelial 
c e l ls ,  but the relevance o f th is  s ing le observation to the present 
c l in ic a l  studies is  not apparent. .Careful search, of the l i te ra tu re  
has fa i le d  to f in d  any other pub lica tion  on the e ffec ts  o f non­
s te ro ida l an ti- in flam m atory drugs on serum ionised calcium 
determ inations.
I f  hyperparathyroidism is  not the cause o f the increased serum 
ionised calcium concentrations and the other biochemical abnormalities 
observed, the question arises as to what they may be due to .  The 
s i tu a t io n  in rheumatoid a r t h r i t i s  has some resemblance to tha t 
perta in ing  to increased serum ionised calcium concentrations in 
neoplasm, where in the presence o f  biochemical evidence strongly 
suggestive o f  hyperparathyroidism immuno-assay o f PTH may be normal 
(Heath, 1976; Woodhead and Walker, 1976). Conceivably in  rheumatoid 
a r t h r i t i s  and in certa in  neoplasms polypeptides may be produced which 
have PTH l ik e  a c t iv i t y  but cannot ye t be measured by the current 
Immuno-assay procedures. An a lte rn a t ive  explanation is  tha t the 
hypercalcaemia may be the re su lt  o f e ffec ts  o f prostaglandin E. 
Prostaglandin leve ls are increased in the synovial f l u id  in  rheumatoid 
a r t h r i t i s  (Higgs, Vane, Hart and Wojulewski, 1974), and Robinson 
Tashjian and Devine (1975) have shown in in v i t r o  bone cu ltu re
studies tha t a l l  the bone resorp tion-s tim u la t ing  a c t iv i t y  in rheumatoid 
synovial f l u id  can be accounted fo r  by prostaglandin Krane (1974 
also demonstrated bone resorbing fa c to r  from synovial ce l l  cu lture 
media but did not consider th is  to be due to prostaglandin E^, To date 
no measurement has been made o f prostaglandin in the sera of patients 
w ith  rheumatoid a r t h r i t i s ,  but conceivably th is ,  i f  i t  were elevated, 
could cause bone resorption and hypercalcaemia. I t  is  not known 
whether prostaglandin Eg could account fo r  the other biochemical 
abnormalities o f  mineral metabolism observed in  the present study, 
and c le a r ly  th is  is  worthy o f  fu r th e r  study.
Another substance w ith PTH-like action is  os teoc las t-ac tiva t ing  
fa c to r ,  OAF (Horton, Raisz, Simmons, Oppenheim and Mergenhagen, 1972), 
a substance which has been iso la ted  from lymphocytes. The e ffec ts  of 
OAF on bone in  v i t r o  resembles those o f PTH (Raisz, e t a l ,  1975) but 
e ffe c ts  o f  in je c t io n  o f  equipotent in v i t r o  doses o f the two substances 
in vivo in  rats d i f f e r  in  th a t  PTH a ffec ts  serum calcium and phosphate 
while OAF does not, suggesting tha t OAF is  a local ra ther than a 
systemic bone resorbing fa c to r .  This would also seem an obvious area 
fo r  fu r th e r  inve s t iga t io n . Biochemical e ffec ts  p a r t ic u la r ly  regarding 
renal handling o f  calcium and phosphate have, l ik e  PGEg, not been 
studied w ith OAF, and c le a r ly  also require fu r th e r  inves tiga tion .
«-t. DU
SECTION 2
Prevalence o f Hypercalcaemia in Rheumatoid A r th r i t i s  and 
other A r th r i t id e s
The studies described in 23 patients with rheumatoid 
a r t h r i t i s  suggest tha t hypercalcaemia is  not uncommon in th is  
disease. To ascertain the prevalence o f hypercalcaemia, and 
any e f fe c t  o f  co r t ico s te ro id  therapy upon i t ,  a large number o f 
patients with the disease were studied. Since the measurement of 
serum ionised calcium is  te ch n ica lly  very d i f f i c u l t  and time- 
consuming, corrected to ta l  serum calcium leve ls were u t i l is e d .
I t  has been previously shown in  th is  chapter tha t there is  a high 
co rre la t io n  between the serum ionised fra c t io n  and the corrected 
to ta l serum calcium level (Fig I I :  7b), thus reasonably 
va l id a t in g  the use o f the la t t e r  fo r  epidemiological purposes.
In add it ion , patients with other a r th r i t id e s  were studied to 
determine whether hypercalcaemia was peculiar only to patients 
w ith  rheumatoid a r t h r i t i s .
Patients Studied
The c l in ic a l  and labora tory data in 364 patients with 
"d e f in i te "  or "c la s s ic a l"  rheumatoid a r t h r i t i s  (Ropes, e t a l ,  1959) 
are shown in Table I I :  X. The age and sex d is t r ib u t io n  and duration 
o f  a r t h r i t i s  in patients w ith o s te o a r th r i t is , ankylosing sp o n d y l i t is ,  
p so r ia t ic  a r t h r i t i s ,  and gout, are shown in Table I I :  XI.
The diagnostic c r i t e r ia  fo r  these diseases were as described in 
Copeman (1978). A l l  patients included in th is  study were 
non-fasting and receiv ing th e i r  current anti-rheumatic therapy.
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Laboratory Procedures
The methods fo r  measuring the to ta l  serum calcium, to ta l 
serum pro te ins , serum albumin and serum phosphate concentrations 
were as ou tl ined  in  the Material and Methods section o f  the 
previous study. The serum a lka line  phosphatase was estimated 
by the method o f Kind and King (1954) as modified fo r  Auto-Analyzer 
(Axelson, Ekman and Knutsson, 1965). The procedure fo r  correcting 
serum calcium fo r  corresponding albumin concentrations was as 
ou tl ined  previously.
Reference normal biochemical values were obtained from 
280 healthy subjects o f both sexes (age range 16-67 years).
Results
From Table EX i t  can be seen tha t the c l in ic a l  and laboratory 
data in  the co r t ico s te ro id  and non-corticostero id  treated male 
and female groups o f  patients with rheumatoid a r t h r i t i s  were 
comparable. The reciprocal o f the t i t r e  o f  rheumatoid fa c to r ,  
however, was lowest in the non-corticostero id  treated male pa tients , 
and was s ig n i f ic a n t ly  d i f fe re n t  from the other groups. No other 
s ig n if ic a n t  d ifferences were found. When biochemical resu lts  (serum 
albumin, g lo bu lins , calcium, phosphate and a lka line  phosphatase) 
o f patients were compared to those o f the reference group (Table 
I I :  X II and Figure I I :  12), the observed serum calcium resu lts  
did not d i f f e r  s ig n i f ic a n t ly ,  whereas the most noticeable 
abnormality was the outstanding hypoalbuminaemia in patients and, 
hence, the s ig n i f ic a n t  d ifference in serum albumin.
II!
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The resu lts  o f the biochemical analysis o f sera from three hundred and 
s ix ty  fou r palMnus with rheumatoid a r t h r i t i s .  The v e r t ic a l  bars 
represent the ? S.D. spread on e ith e r  side o f  the nieanj the la t t e r
being represi nted by the symbol À fo r  males and o fo r  females. The
horizontal in te rrupted l ines  represent the mean + 2 S.D. o f  resu lts
fo r  the reference groupé ■ "
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When the to ta l  serum calcium concentrations were 
corrected fo r  th e i r  corresponding serum albumin concentration 
i t  can be seen ( F ig . I I :  12) tha t they now a tta in  a s t a t i s t i c a l l y  
s ig n i f ic a n t  e levation compared to normal values.
Serum a lka lin e  phosphatase a c t iv i t y  and g lobu lin  
concentration were also s ig n i f ic a n t ly  higher. The mean values 
fo r  serum phosphate concentration were lower than normal values 
but the d iffe rence in mean was very small (0.048 m.mol/l.
Table I I :  X I I )  and although th is  was a s t a t i s t i c a l l y  s ig n if ic a n t  
d iffe rence i t  was f e l t  tha t th is  s ign if icance resulted mainly 
because o f the comparison o f two large populations.
The corrected serum calcium concentrations in both male 
and female patients bore no consistent re la t io n  to age (Table 
I I :  X I I I ) ,  except in the male non-cort icoste ro id -treated subgroup 
where corrected serum calcium was s ig n i f ic a n t ly  higher in  those 
aged over 45 years than in  those under 45 years old. The age 
o f  45 years was chosen because in  the studies in the f i r s t  chapter 
'osteoporosis ' was found to be more pronounced in patients over 
th is  age.
When the number o f  patients with corrected serum calcium 
leve ls  exceeding the two standard deviation range o f  the normal 
population (Table I I :  X I I I )  is  considered, the m a jo r ity  are in 
the over 45 years o f age group. Only three females had corrected 
serum calcium below the lower l im i t  o f normal.
il
When the resu lts  o f serum calcium, serum phosphate, 
and a lka lin e  phosphatase in ind iv idua l patients (a l l  resu lts  
were ava ilab le  in  118 male and 21 2  female patients) are grouped 
according to th e i r  'no rm a lity ' and subsequently examined 
fo llow ing  correction  of serum calcium fo r  albumin (Table I I :  XIV), 
some in te re s t in g  features become apparent. The number o f  patients 
who, p r io r  to  correction were considered to have normal serum 
calcium concentrations became considerably reduced in  both sexes, 
a f te r  correc tion  is  made fo r  th e i r  serum albumin concentrations.
I t  is  in te re s t in g  to note th a t,  even before correction fo r  albumin 
concentration, four males and s ix  females were already hypercalcaemic 
and, as has been shown already, these numbers are g rea tly  increased 
when serum calcium was corrected fo r  albumin. The la s t  three 
patterns o f  abnormalities in  Table I I :  XIV represent various combin­
ations o f abnormalities o f  serum calcium, phosphate and a lka line  
phosphatase, which may be encountered in  the hypercalcaemic 
hyperparathyroid s ta te .
No s t a t i s t i c a l l y  s ig n i f ic a n t  co rre la t ion  was found between 
corrected serum calcium leve ls  and duration of a r t h r i t i s  or o f 
any o f the indices o f osteoporosis-metacarpal index (Barnett and 
Nordin, 1960), femoral index (Barnett and Nordin, 1960), c la v icu la r  
c o r t ic a l  width (Anton, 1969), and standard aluminium equivalent 
(Anderson, e t a l ,  1966) (Table I I :  XV).
I t  can be seen from Table I I :  XVI tha t the corrected to ta l 
serum calcium concentrations in the a r th r i t id e s  other than 
rheumatoid a r t h r i t i s  did not d i f f e r  s ig n i f ic a n t ly  from the control 
values.
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1S im ila r ly ,  no s ig n i f ic a n t  differences emerged when serum 
phosphate concentration and a lka line  phosphatase values from 
the disease groups are compared with the contro ls except fo r  the 
group o f  patients with ankylosing spondy lit is  where the mean 
level o f a lka lin e  phosphatase a c t iv i t y  lay near the upper l im i t  
o f  normal and 54 o f these patients had elevated leve ls  o f th is  
enzyme.
In th is  study o f  a large group o f patients with rheumatoid 
a r t h r i t i s  the prevalence o f hypercalcaemia was approximately 
50 per cent. This contrasts to 34 per cent found in the 23 patients 
with rheumatoid a r t h r i t i s  who were studied in greater depth.
In the study o f  52 patients in South A fr ica  mentioned previously 
(F ig. I I :  11) the prevalence o f  hypercalcaemia was found to be 
32 per cent. These d ifferences in prevalence may be explained 
by d ifferences in the size o f the populations studied. Further in 
the group o f  23 pa tien ts , the duration o f disease was shorter 
( 6  years compared to 12 years in  the large group), and the patients 
were in  the fas t in g  state and not receiving th e i r  usual a n t i ­
rheumatic drugs in contrast to the patients in the other studies.
In add it ion , i t  must be recognised tha t i t  is  extremely d i f f i c u l t  
to match p rec ise ly  patients w ith rheumatoid a r t h r i t i s  in terms 
o f the numerous c l in ic a l  and laboratory indices o f disease a c t iv i t y .  
The three stud ies, although d i f fe r in g  in the percentage presence 
o f hypercalcaemia, do a l l  ind ica te  tha t th is  is  a not unusual 
labora tory  abnormality in  the disease.
I t  is  o f  in te re s t  tha t hypercalcaemia appears to have 
c l in ic a l  s p e c i f ic i t y  fo r  rheumatoid a r t h r i t i s .  I t  should be 
noted, however, tha t hypoalbuminaemia also tends to occur more 
frequen tly  in patients with rheumatoid a r t h r i t i s .  However, none o f the 
other a r th r i t id e s  with the exception o f the group with ankylosing 
spo n d y li t is  had biochemical abnormalities in serum phosphate 
and a lka lin e  phosphatase in contrast to the patients with rheumatoid 
a r t h r i t i s .  This suggests the p o s s ib i l i t y  tha t there may be 
something pecu lia r to rheumatoid a r t h r i t i s  which is  causing 
hypercalcaemia. Inflammation, per se, cannot be the cause since 
th is  is  common, although not so severe, in o s te o a r th r i t is  (Boyle 
and Buchanan, 1971) and in p s o r ia t ic  a r t h r i t i s  the h is to log ica l 
changes in synovium and the rad io log ica l appearances in the 
jo in ts  may be ide n t ica l to those in rheumatoid a r t h r i t i s .
The relevance o f the increased serum a lka line  phosphatase a c t iv i t y  
in  patients  with ankylosing spondy lit is  is  uncerta in, since i t  
was not possible to ascerta in i t s  source, i . e .  l i v e r  or bone.
To date there is  no evidence o f  s ig n if ic a n t  l i v e r  involvement 
occurring in  th is  disease and i t  is  tempting to postulate tha t 
the increase in th is  enzyme might be re la ted to possible increased 
osteob las tic  a c t iv i t y  associated with extensive ligamental 
o s s i f ic a t io n .  However th is  is  purely speculative, and must 
remain so u n t i l  isoenzyme investiga tion  can be carried out.
Rheumatoid a r t h r i t i s  d i f fe rs  from the other a r th r i t id e s  
in  tha t i t  is  associated with profound disturbances in  both 
humoral and c e l lu la r  immunity (Anderson, Buchanan and Goudie,
1967; Froebel, Sturrock, Dick and MacSween, 1975).
Log ica lly  the next step in  inves tiga tion  o f the phenomenon 
would seem to be the study o f the e f fe c t  of rheumatoid 
sera on bone in an in  v i t r o  s itu a t io n  and such a study forms 
the f in a l  section o f  th is  Chapter.
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SECTION 3
In V it ro  Studies on the Effects o f Rheumatoid Serum on a 
Bone-Culture Model
Despite the fa c t  th a t erosive changes in a r t ic u la r  bone 
and generalised osteoporosis are so common in patients 
w ith rheumatoid a r t h r i t i s  i t  is  surpris ing tha t no-one has published 
studies on the e ffec ts  o f  rheumatoid sera on bone in  tissue cu ltu re . 
In the inves tiga tion  o f th is  phenomenon I was p r iv i leged  to have 
the able d ire c t io n  and assistance o f Dr. R. Lindsay o f the Dept, 
o f  Medicine Unit a t the Western In f irm ary , Glasgow.
Methods and Materi als
The sera studied was obtained from 14 o f  the 23 patients 
included in  the biochemical and hormonal p ro f i le  reported in  the 
e a r l ie r  section o f  th is  Chapter. The sera were obtained a t the 
same time o f the ionised calcium determinations.
Methods
Bone Culture Model
The bone cu ltu re  model employed in th is  study is  a modification 
o f  those described by Raisz and Niemann (1969) and Reynolds and 
Minkin (1970).
Female Sprague-Dawley ra ts were in jected with 100yuCi o f 
45caCl2 on the seventeenth day o f pregnancy. Not less than 24 
hours and not more than 48 hours la te r  the rats were s a c r if ice d , 
and under aseptic conditions, the calvariae o f  the foetuses were
dissected out. The paired h a lf  calvariae were subsequently 
washed in  medium No. 199 and placed on a metal g r id  whose 
lower surface was immersed in  the growth medium (No. 199) contained 
in  an organ cu ltu re  dish (Fig I I : 13). One o f  each p a ir  o f  h a l f  
ca lvariae served as a control w ith pooled human serum added ( 0 . 1  
m l.) and the serum to be tested was added to the other h a lf  ( 0 . 1  
m l.) .  The organ cu ltu re  dishes were kept at a constant temperature 
o f  37°C fo r  48 hours.
Resorption was measured in terms o f the percentage o f 
45ca released in to  the medium, determined by a l iq u id  s c in t i l l a t io n  
well counter a t 48 hours a f te r  the te s t  sera were added. Serum 
from each pa tien t was always tested in t r ip l i c a te  and the mean o f 
the three readings gave the f in a l  re su lt .  Two cu ltu re  dishes 
w ith  0.1 ml. each o f a so lu tion  containing 0.5 and one u n it  o f 
PTH per ml. were added during each experimental run to act as 
con tro ls .
Results were expressed as the ra t io  o f  ^^Ca released by 
treated and control members o f  each bone pa ir  ( te s t /c o n tro l ^^Ca 
r a t io ) .  Cell mediated bone resorption was calcu lated by subtracting 
the 45ca released from a dead explant ( k i l le d  by freezing and 
subsequently thawing three times) from tha t o f  the l iv in g  paired 
bone (Raisz and Niemann, 1969; Reynolds and Minkin, 1970).
' ) . .  ‘‘
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Diagrammatic representation o f  the 1n y i t r o  bone cm1ture model 
employed in  the study o f bone resorption a c t iv i t y  in  rheumatoid sera.
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Results
Table I I :  XVII shows the resu lts  of ^^Ca released from 
the bones cu ltu red with sera from the rheumatoid pa tien ts . In each 
case the resu lts  have been calculated as the ra t io  o f  the ^^Ca 
released from the bone treated with rheumatoid sera to tha t released 
from i t s  control treated w ith normal sera.
The pa tien t number corresponds to the number given to each 
p a t ien t in  Table I I :  IX o f the previous study. The serum ionised 
calcium concentration fo r  each pa tien t is  the re s u lt  obtained 
during the study described previously (Table I I :  IX) and are la id  
out in  descending order o f  ionised calcium concentration. I t  
was not possible to measure the ionised calcium concentration 
o f the sera samples a t  the time o f  th is  bone resorption study 
because o f the small volumes o f  sera which were ava ilab le .
The re su lts  ly in g  above the in terrupted l in e  belong to the 
pa tien ts  who were hypercalcaemic, and those below to the patients who 
were normocalcaemic. A co rre la t io n  c o e f f ic ie n t  was carried between 
the serum ionised calcium concentration and the corresponding 
ra t io  o f  bone resorption (F ig. I I :  14). I t  can be seen that a 
h igh ly  s ig n if ic a n t  pos it ive  co rre la t io n  ex is ts  between these 
indices ( r  = 0.76; p <0.001).
The re su lts  were then divided in to  two groups, hypercalcaemic 
(6 ) and normocalcaemic ( 8 ) and the mean o f the resu lts  o f ^^Ca 
resorption fo r  each group compared with each other and with the 
responses to the two concentrations o f parathyroid hormone (PTH)
Patient Number
Serum Ionised 
Calcium Concentration 
mmols/1
Test/Control 
^^Ga ratio
11 1.27 1.86
16 1.25 1.68
7 1.19 1.54
14 1.17 1.30
12 1.16 1.58
3 1.13 0.91
6 1.12 0.95
4 1.12 1.04
13 1.11 0.93
18 1.09 1.08
19 1.09 0,95
9 1.08 1.25
8 1.05 1.17
1
,
1.04
;________________ _______ ....
1.18
Table II: XVII
The individual results of the serum ionised calcium 
concentration and test/control ^Ca ratios in the 14 patients 
studied. The patient numbers correspond to those in tableH'IX 
and the interrupted line divides the patients hyper and 
normocalcaemic groups.
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Tflo co rre la t ion  between 4 ca released from bone cu ltu re  by rheumatoid 
sera and che Ionised calcium concentrations o f the same sera samples.
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SERUM IONIZED CALCIUM 
CONCENTRATION 
m  mol/l
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1 25 -
1 20
115
110
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P = 0-001
1-05
100
0 80 100 120 1-40 160 1 80 2 0
RATIO OF t e s t / c o n t r o l  45ca RELEASED
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in  the same system (Table I I :  X V II I ) .  I t  can be seen tha t there 
was a s ig n if ic a n t  increase in  '^^Ca resorption in the hypercalcaemic 
group corresponding approximately to the resorption induced by
0.1 ml. o f  a so lu tion  o f PTH containing 0.5 un its /m l. When 0.1. 
ml. o f a so lu tion  containing 4 m un its /m l. o f salmon ca lc ito n in  
was added to the bone cu ltu re  a t the same time as sera from a l l  
the patients who were hypercalcaemic the resorbing e f fe c t  o f  these 
sera was in h ib ite d  (Table I I :  X V II I) .
Experiments w ith dead bone by the technique o f  Reynolds 
and Minkin (1970) showed no evidence o f  ^^Ca resorption when te s t  
sera and PTH were added confirming tha t the increased ^^Ca 
resorption noted in the l iv e  bone s itua t ion  was ce ll  mediated.
Assessment o f  the Action o f  Other Factors on the Bone Resorption 
induced by the Hypercalcaemic Rheumatoid Sera
The apparent an ti resorption e f fe c t  exerted by the salmon 
ca lc i to n in  on the hypercalcaemic sera was o f in te re s t  and i t  was 
decided to te s t  other re levant factors and substances in th is  
model to determine th e i r  e ffec ts  on the bone resorption induced 
by the hypercalcaemic sera.
Corticostero ids The resu lts  o f the e f fe c t  o f hydrocortisone in 
varying molar concentrations is  shown in Figure I I :  15. I t  can 
be seen tha t as the concentration o f hydrocortisone increases from 
10“ ^M to 10"^M there is  a progressive in h ib i t io n  o f ^^Ca 
release, u n t i l  a t  the la t t e r  concentration there is  no evidence 
o f  resorption present.
70)
g
E
U
.B
•H
O
-pcd
k
cd
h
(ütQ
•H0 
+>
1
.B
K
-P•r-i Olî
L
LT\x_/
Ü
•H
Ocd o 
O  -P  VO
'hn  ' ^  S  ttO rH
Id g 
+
cdo
• s 7
•H  Ü
Cdo
CO
ii
%
COCM
+ 1v~
CM
OJ
I'
VO
9
OJ 04
I'
O
VÛ K
OJ
I
cd
f
' i
U
§
- s .4J
(0CD64
o
■H
4-)CÜ
k
O
ü
§
ü
•H4-t
•H
•HCO
«H
O
U
CD
?
O o
cd A o
O tp
r \ hO
t Ed
•H
4> X oXi u Xx> o CQ
mo CD CD
+> u
cd CD
U X CDo -P G
CO O
CO E
T3 +> U
•H ■H O
O X X
■p ■fH
cd X •xi
E C •H
•rH O
CD UX FdU -H .G
fd -PX o cd
-P -p y
•H •H d
> ü Pc
*r5 «H
CD O O
-p
cd CQ
CD Gu O
-p •H
(dM •ë -P
•H u CQ+ 1-p P
Cd G 4J
> P
iH ü X
Cd E G G
ü P O cd
1 U ü U
■H CD
Ë w O CO
@)
X Fd G
E
O
'Xi
Q)
f .
O
T) CDO ta
§ 
ü  
CO fH
c:  ^
o o 
o A  ^
Çk CO
CO CD ■G
CD fH Pd G
G O G
cd
G •H
Cd -P G
G o G CO -P
CD lA O G
CO -d- ü O
•H
O
Td «H X X G
•H O X G G
O •H G G
-P o -P 3
. Cd •H G•Ë •P nd P W
P G CD O G
m G -p G P
G O iH
G CD X ü G
«H
,G P >
-P o S
O G P G
CO •H •fH G
ï>> Cd ü G
-p
Td
G H G
•H •H G ü
> CD G ü • r l
•H CÛ P , Ch
-P CO .G -H
U CD CO t£- G
Cd G X •H
M P i •H JG •H
H tû X CO
M G CD e
> •H o -P
X X CD G •H
G G «p G
O G O
CO Td G W
W CD CO CD G • fHG + J X G G
p 1 iH G OJ G
iH CD P O P h
X G CQ CO G E
cd O CD P X o
EH pq M G X ü
The e f fe c t  o f  Increasing molar concentration o f hydrocortisone on 
thci capacity o f  rheumatoid sera to resorb bone in  v i t r o ,
SS'g
45Ca RELEASE
test/ c o n t r o l
RATIO
1* 6 —1
V 5 -
\
\ T
1-3-
1* 2 -
HYDROCORTISONE (m )
Indomethacin - Since PGE9 had been incrim inated as a possible 
bone resorp tive agent in rheumatoid a r t h r i t i s  (Robinson, et a l ,  
1975) i t  was decided to te s t  an anti-prostag land in (synthetase 
inh ib ito r) ,  v iz .  Indomethacin on the resorption e f fe c t  o f the 
rheumatoid sera. To th is  end the hypercalcaemic sera was 
pre-incubated fo r  6 hours with 0 . 1  ml. o f a so lu tion  containing 
1 mg. indomethacin in 1 ml. o f absolute alcohol. The control 
sera were pre-incubated with 0 . 1  ml. o f absolute alcohol.
No in h ib i to ry  e f fe c t  o f indomethacin on ^^Ca resorption 
induced by the hypercalcaemic sera was observed.
Heat The hypercalcaemic sera was heated in a water bath to 
60°C fo r  20 minutes and subsequently re-tested in  the bone 
cu ltu re  model. A l l  ^^Ca resorption a c t iv i t y  was lo s t .
Acid Following add it ion  o f MCI to the hypercalcaemic sera, 
the pH was reduced to 1, and subsequently converted back to 
7.4 by a lk a l i .  A l l  ^^Ca resorption a c t iv i t y  was lo s t  when the 
treated sera was re-tested.
F in a l ly  incubation with a so lu tion o f  tryps in  destroyed 
the 4^Ca resorption a c t iv i t y  o f  the sera whereas incubation 
w ith papain did not.
DISCUSSION
Recent study o f the development o f erosive bone disease 
in  rheumatoid a r t h r i t i s  has swung towards po ten tia l local biochemical 
and immunological events occurring in or around the inflamed 
jo in t s .  Robinson, Tashjian and Levine (1975) demonstrated tha t 
synovial c e l ls ,  from patients with rheumatoid a r t h r i t i s ,  maintained 
in  organ cu ltu re  secreted in to  the media a substance which released 
calcium from cultured mouse ca lvaria . They postulated tha t th is  
substance was PGE2 c i t in g  as proof the facts tha t the presence 
o f indomethacin (a potent prostaglandin synthetase in h ib i to r )  
in  the synovial cu ltu re  abolished the bone resorption e f fe c t ,  
th a t th is  a c t iv i t y  could be q u a n t ita t iv e ly  extracted in to  ether 
and th a t  i t  could be accounted fo r  by measuring the concentration 
o f  PGEg in the synovial cu ltu re  medium.
In a not d is s im i la r  experiment Krane (1974) also demonstrated 
bone resorption a c t iv i t y  in rheumatoid synovial cu ltu re  media.
However, in  his experiments, un like those o f Robinson and his 
colleagues, incubation o f  the cu ltu re  in the presence o f 
indomethacin did not in h ib i t  th is  bone resorption a c t iv i t y .
Krane therefore concluded th a t the observed resorptive e f fe c t  
was u n l ik e ly  to  be due to the presence or production o f prostaglandins 
In comparing such d i f fe r in g  resu lts  i t  is  an important fa c t  tha t the 
m a jo r ity  o f patients with rheumatoid a r t h r i t i s  receive non­
s tero ida l anti- in flammatory agents and, to date, these drugs, 
many o f which are potent in h ib i to rs  o f prostaglandin synthetase.
have not been shown to a l te r  s ig n i f ic a n t ly  the progression of 
bone destruction in th is  disease.
Horton and his colleagues (1972) demonstrated tha t,  when 
normal human peripheral blood leucocytes in cu ltu re  were 
stimulated by e ith e r  antigen or a mitogen, they produced a 
polypeptide, osteoclast ac t iva ting  fac to r  (OAF), which in i t ia te d  
bone resorption in v i t r o .  S im ilar a c t iv i t y  has been found 
in  the supernatants o f cu ltu res o f marrow c e l ls  from patients 
w ith  myeloma, in  which massive loss of bone often occurs (Mundy, 
e t a l ,  1974), and i t  could be’ postulated tha t such OAF a c t iv i t y ,  
i t s  production stimulated lo c a l ly  at the jo i n t ,  could account 
fo r  Krane's re su lts .  OAF not only stimulates bone resorption 
in  v i t r o  but also in h ib i ts  bone collagen synthesis and i t s  e ffec ts  
are not in h ib ite d  by prostaglandin synthetase in h ib i to rs  (Raisz, 
D ie tr ich  and Conalis, 1976).
The biochemical f ind ings ind ica ting  abnormal calcium 
metabolic status in  some patients with rheumatoid a r t h r i t i s  
described previously suggested fu r th e r  c ircum stantia l evidence 
of an active process of bone loss at the c l in ic a l  le ve l.  I t  
therefore seemed appropriate to te s t th is  sera fo r  any evidence 
o f bone resorbing a c t iv i t y .  The bone cu ltu re  model provided 
an ideal in  v i t r o  method of assessing th is  p o s s ib i l i t y .
The resu lts  of the study ind icate that sera from some 
patients with rheumatoid a r t h r i t i s  can indeed induce bone 
resorption in v i t r o . The s ig n i f ic a n t  pos it ive  co rre la t ion  
(FigJT14) noted between the degree of ^^Ca resorption and the serum 
ionised calcium concentration demands some explanation and 
con s ide ra t ion ..
The ionised calcium resu lts  were those measured at the time 
o f the i n i t i a l  biochemical, hormonal p ro f i le  described previously. 
I t  was not possible to measure the ionised calcium concentration 
o f the sera a c tu a l ly  used in th is  current study because s u f f ic ie n t  
volumes were not ava ilab le . Thus the concentration of the
ionised calcium in the sera sample a t the time o f th is  study is
unknown. However, i t  is  u n l ik e ly  tha t they would be the same 
as the o r ig in a l values because they were not handled in  the same 
way at the time of venesection, i . e .  no care was taken to exclude 
oxygen and they were stored at -20°C before use. In addition 
the time o f the experiment (48 hours) would conspire together 
w ith these fac to rs  to change the o r ig ina l ionised calcium levels 
because o f changes in  COg and pH of the sample. Thus i t  seems 
most u n l ik e ly  tha t the o r ig in a l serum ionised calcium values would 
be the same as those in the te s t  sera used in  the bone cu ltu re  
model. This is  o f importance because i t  might be assumed that 
the 45ca resorption was a function  of the serum ionised calcium 
concentration i t s e l f .  Further evidence against th is  p o s s ib i l i t y  
was noted in a study by Raisz and Niemann (1969) using a
s im i la r  bone cu ltu re  model. They showed tha t when the calcium
concentration in the te s t  media was increased calcium loss from 
the cu ltu re  bone was decreased. Thus the actual level o f 
calcium in  the te s t  sera is  u n l ike ly  to account fo r  the degree of 
45ca resorbed. The a lte rn a t ive  p o s s ib i l i t y  is  th a t some 
substance/s was/were present in  the hypercalcaemic sera which had 
the capacity to induce resorption of calcium. That th is  
is  an active  process seems to be confirmed by the fa c t  tha t 
there was no e f fe c t  by the same sera on dead bone, suggesting that 
the resorbing fa c to r  acted through l iv e  bone c e l ls .
I t  is  conceivable tha t enzymes in  the serum, such as 
lysosomal enzymes and neutral proteases, could stimulate osteoc last ic  
a c t i v i t y  and cause bone resorp tion . However, these enzymes 
have not been found to be elevated in  rheumatoid sera (Oasani,
Katori and Lewis, 1969; Wood, Pryce-Jones, White and Nuki, 1971), 
and plasma in h ib i to rs  such as a2 macroglobulin are also present 
in  abundance to block th e i r  action. There is  no l i te ra tu re  on the 
e ffe c ts  o f such enzymes on e ith e r  bone or ionised calcium in 
rheumatoid a r t h r i t i s ,  and although possible i t  seems u n l ike ly  tha t 
such enzymes could explain the phenomenon.
The bone resorbing e f fe c t  o f the hypercalcaemic sera was not 
in h ib ite d  by freezing and thawing the sera several times. S im ila r ly  
the presence of a prostaglandin synthetase in h ib i to r  in the te s t 
s i tu a t io n  did not prevent ^^Ca resorp tion. This suggests that 
production of prostaglandin is  not involved, however i t  does not 
exclude the p o s s ib i l i t y  tha t pre-formed prostaglandin might be
responsible fo r  the resorption. When salmon ca lc i to n in  
(4m u n its /m l. )  was added to the cu ltu re  medium a l l  bone 
resorption a c t i v i t y  was t o t a l l y  abolished. The fa c t  tha t the 
resorp tion a c t i v i t y  of the sera is  destroyed by acid and heat and 
is  digested by tryp s in  but unaffected by papain suggests that 
the resorp tive  substance may well be s im ila r  to osteoclast 
ac t iva t ing  fa c to r  (OAF) (Raisz e t a l ,  1975). The in h ib i to ry  
e f fe c t  o f hydrocortisone in high concentrations (F ig. I I :  15) 
is  also a fa c to r  common to th is  study and to the study of the 
a c t iv i t y  of OAF.
Although these various studies have apparently c o n f l ic t in g  
re s u lts ,  i t  is  e n t i r e ly  possible th a t local bone resorption 
occurs through both mechanisms, i . e .  an immunological e f fe c t  (OAF) 
and a biochemical one (PGE2 ) and tha t these mechanisms are 
in te r re la te d .  Both are potent stimulators of bone resorption 
in  v i t r o  (Horton e t a l ,  1972; K lein and Raisz, 1970) and i t  has 
been suggested tha t in some s itua tions  s tim ula tion o f prostaglandin 
synthesis may be complement dependent (Raisz e t a l ,  1975), and th is  
w i l l  occur w ith in  and around the diseased synovium. The 
re la t io n sh ip  between OAF and prostaglandins therefore remains to 
be c la r i f ie d  fu r th e r  and both may be synthesized around a c t ive ly  
inflamed jo in ts  as part of a humoral immune response. Whether or 
not the substance id e n t i f ie d  in th is  current study is  re la ted to 
OAF and to a local immune response in th is  context requires fu r th e r  
proof. I t  is  o f p a r t ic u la r  in te re s t  tha t bone resorption was
Stimulated only w ith sera from patients with hypercalcaemia 
and i t  should be noted tha t prostaglandins can produce 
hypercalcaemia when infused in to  animals but only in  tox ic  
doses (K le in  and Raisz, 1970), while OAF apparently does not 
a f fe c t  serum calcium when in jec ted intravenously (Raisz, et a l ,  
1975).
The nature o f the bone resorbing substances present in 
rheumatoid sera therefore remains obscure, but i t s  detection 
and in d e n t i f ic a t io n  may improve fu r th e r  the understanding of 
the pathogenesis o f bone loss occurring in  rheumatoid a r t h r i t i s
SUMMARY
The resu lts  o f  the studies in  th is  chapter demonstrate the
fo llow ing  f in d in g s :-
1. Serum ionised calcium concentrations were found to be 
elevated in e ight o f 23 patients with rheumatoid 
a r t h r i t i s  studied. The co rre la t ion  c o e f f ic ie n t  between 
serum ionised calcium and to ta l serum calcium corrected 
fo r  albumin was found to be more s ig n if ic a n t  than the 
co rre la t io n  c o e f f ic ie n t  between serum ionised calcium 
and to ta l  serum calcium not-corrected fo r  albumin. This 
together w ith  the acceptable value fo r  u l t r a f i l t r a b le  
calcium a t 0 albumin concentration obtained from th is  
correction formula suggests tha t the correction fa c to r  
employed in  the study reasonably re f le c ts  the status of 
serum ionised calcium concentrations.
2. Associated biochemical abnormalities in some o f these 
patients such as increased a lka line  phosphatase a c t iv i t y  
reduced tubu la r reabsorption o f  phosphate, increased 
tubu lar reabsorption o f  calcium, increased urinary 
excretion o f  calcium and hydroxyproline and evidence
o f possible increased calcium absorption in a separate 
study were also found.
3. The p o s s ib i l i t y  o f  a trend towards primary hyperparathyroidism 
accounting fo r  the above features was disproved by the immuno­
assay resu lts  from two separate techniques which convincingly 
demonstrated no e levation in  serum parathyroid hormone leve ls .
4. Plasma leve ls o f  25 - OH vitamin D were normal.
5 .  Two patients had increased plasma levels o f ca lc ito n in
and one o f  these also had an elevated serum gastrin
le v e l .
6 . The prevalence o f hypercalcaemia was assessed in  a study 
o f  364 patients with rheumatoid a r t h r i t i s ,  employing the 
correction  fa c to r  fo r  serum calcium concentration.
Approximately 50 per cent o f these patients were found to be 
hypercalcaemic when due correction was made fo r  hypoalbuminaemia.
7. In a study o f  other a r th r i t id e s ,  namely, o s te o a r th r i t is ,  
ankylosing s p o n d y l i t is ,  p s o r ia t ic  a r t h r i t i s  and gout, no 
trend towards hypercalcaemia was evident. However, 
approximately 40 per cent o f patients with ankylosing
sp o n d y li t is  were noted to have elevated serum a lka line
phosphatase leve ls .
8 . Increased bone resorption was noted in  an in v i t r o  bone 
cu ltu re  preparation when sera from patients with rheumatoid 
a r t h r i t i s  who were hypercalcaemic was added. This e f fe c t  
was abolished by administering th y roca lc ito n in , increasing 
molar concentrations o f hydrocortisone and incubating the 
sera w ith  t ryp s in . I t  was unaffected by incubating the 
sera w ith  indomethacin or papain.
9. F in a l ly ,  the index o f bone resorption was found to corre la te  
well w ith the ionised calcium concentration o f  the te s t  sera.
«l OB
CONCLUSIONS AND SUGGESTIONS FOR FURTHER STUDIES
This thesis has c le a r ly  shown tha t osteoporosis is  a 
generalised phenomenon in patients with rheumatoid a r t h r i t i s .  
The most important variables in determining bone loss were: 
age, duration o f a r t h r i t i s ,  and co r t icos te ro id  therapy. Bone 
loss is  p a r t ic u la r ly  marked in  post-menopausal females.
Perhaps the most surpris ing  f ind ing  was tha t a high 
proportion o f ambulant patients with rheumatoid a r t h r i t i s  
have hypercalcaemia. In view o f the high prevalence o f  th is  
disease in the community i t  seems tha t rheumatoid a r t h r i t i s  
should now be recognised as a not uncommon cause o f  hyper­
calcaemia.
The fa c t  tha t th is  is  the f i r s t  time hypercalcaemia has 
been recognised in  rheumatoid a r t h r i t i s  is  probably due to 
i t  being masked by hypoalbuminaemia.
The cause o f  the hypercalcaemia was not ascertained and 
c le a r ly  deserves fu r th e r  study. I t  is  not due to primary 
hyperparathyroidism as the serum immunoreactive parathyroid 
hormone leve ls are not elevated. However, there were some 
biochemical features consistent with a state o f primary 
hyperparathyroidism, which ra ise in te res ting  p a ra l le ls  with 
some forms o f  hypercalcaemia o f malignancy. I t  is  possible 
tha t a polypeptide is  being produced by one or more o f the 
c e l ls  involved in  synovial inflammation which has para­
thy ro id  hormone-like a c t iv i t y  but which is  not detected by 
standard radioimmunoassay techniques. The fa c t  tha t some 
rheumatoid sera have an o s te o ly t ic  e f fe c t  on bone in tissue 
cu ltu re , which can be blocked by ca lc ito n in  and increasing 
molar concentrations o f  hydrocortisone is  not inconsis ten t
with th is  hypothesis. However, i t  w i l l  be necessary to carry out 
studies to determine the ro le ,  i f  any, o f prostaglandin in 
causing bone erosion in  th is  disease.
Perhaps the most exc it in g  prospect is the fa c t  tha t a means 
may be found fo r  a rres ting  bone erosions in rheumatoid a r t h r i t i s .  
For example, i t  might be possible to prevent or minimise bone 
erosions in  rheumatoid a r t h r i t i s  by treatment with ca lc ito n in .
In add it ion , a new i n vi t ro  model may be derived from the tissue 
cu ltu re  experiments to ascertain the po tentia l fo r  in h ib i t in g  
s tru c tu ra l j o i n t  damage by slow acting drugs such as gold,
D-penici 11 amine, and levamisole.
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